Beruflich Dokumente
Kultur Dokumente
American Association of
Clinical Endocrinologists
1st Annual Meeting
October 12, 2012
CHAPTER V: OFFICERS
Section 1. Officers. The officers of the Chapter
shall consist of the President, President Elect, the
Secretary/Treasurer and the Immediate Past
President.
Section 2. Election and Term of Office. The term
of office of shall be for one year and the Chapter
Officers shall be elected by the members of the
Chapter at an annual meeting.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
Secretary/Treasurer Nominees
1. Wiam Ibrahim Hussein, MD FACE FACP;
Bahrain
2. Khalid Faiq Mohammed Salih, MD FACE; UAE
President Nominees
1. Fatma AlMarashi, MD FACE; UAE
2. Kamal A S Al-Shoumer, BSC, MB, DIC, PhD,
FRC FACE; Kuwait
3. Mahmoud Mohamed A Fikri, MBBCh, PhD;
UAE
4. Ahmed A K Hassoun, MD FACE; UAE
Candidate
Information
Submissions
*The following materials were submitted to AACE by the
candidate and appear in alphabetical order by position. Click on
the name to be directed to the appropriate candidate materials.
Board of Director
Candidates
1. Thamer Alessa, MD; Kuwait
2. Eman M Alfadhli, MD; KSA
3. Mohammed Hussein Al-Ghamdi, MBChb,FRCPC,FACP FACE;
KSA
4. Naji Jameel Aljohani, MD; KSA
5. Juma M Alkaabi, MD FACE; UAE
6. Aishah Ali Alkhzaimi, MD, KSA
7. Mohamed Abdullah Al-Lamki, MBChB, MSc, FRCP; Oman
8. Nasreen Abdulkarim Al-Sayed, MD FACP; Bahrain
9. Salem Arifi Beshyah, MBBCh MRCI MRCP (UK) FRCP PhD;
UAE
10. Nabil Kamal Elnaggar, MD; KSA
11. Imad El-Din Ginawi El-Sadig, MD; UAE
12. Amin Ahmad Jayyousi, MD; Qatar
13. Satendra Kumar Multani, MD FACE; UAE
14. Huda Ezzeddin Mustafa, MD ECNU; UAE
15. Mahmoud Ali Zirie, MD FACE; Qatar
Personal
Statement
Serving
a
role
of
a
promoter
of
health
and
well
being
has
always
been
my
ambition,
beginning
in
medical
school,
going
through
the
journey
of
medical
residency
and
fellowship
in
the
United
States
and
then
taking
the
responsibility
of
a
full
time
physician
in
Kuwait
taking
care
of
patients
and
engaging
in
social
and
scientific
activities.
I
have
learned
the
role
of
AACE
and
other
similar
scientific
societies
very
early
in
my
medical
career
and
through
the
mentoring
from
great
physicians
and
professors
in
the
University
of
Miami,
like
Dr.Paul
Jellinger,
a
past
president
of
AACE,
who
taught
me
during
my
fellowship
the
importance
of
medical
knowledge
and
how
to
share
them
to
other
colleagues.
To
be
a
part
of
such
a
very
well
known
medical
society,
AACE,
and
be
serving
in
the
Gulf
Chapter
Board
of
Directors,
is
a
promising
goal
and
would
love
to
fulfill
it.
I
see
any
medical
society
like
a
bridge
between
clinical
knowledge
and
clinical
practice
specially
with
using
the
well-known
AACE
excellent
medical
and
scientific
reputation.
I
see
the
role
of
the
Gulf
Chapter
to
be
establishing
this
bridge
by
several
ways:
1) Providing
medical
information
for
physicians
2) Conducting
annual,
or
similar,
scientific
meetings
to
discuss
medical
literature,
medical
updates
and
Gulf
based
research
developments
and
presentations
3) Sharing
the
medical,
clinical
and
research
experience
from
AACE
Faculty
4) Proving
mentoring
opportunities
in
the
Gulf
region
for
research
and
medical
experience
5) Periodic
newsletters
describing
latest
Endocrine
news,
like
medical,
legal,
research
and
even
social
activities
6) Promoting
Endocrine
science
to
medical
student
and
young
physicians
through
encouraging
attending
the
AACE
annual
and
the
Chapter
meetings
with
a
learning
track
specified
to
them
plus
the
experience
from
AACEs
own
Endocrine
University
7) Involving
the
public
in
promoting
health
by
establishing
ways
to
reach
media
outlets
or
by
using
social
networking
or
through
educational
or
social
institutions
I
believe
the
AACE
Gulf
Chapter,
will
serve
a
big
role
in
the
local
Endocrine
medical
society
and
I
would
love
to
be
a
part
of
it.
Contact Information
Cell: (+965) 99877855
Email: thamermd@gmail.com
Twitter : @thameralessa
EDUCATION
July 2009June 2011
20002003
19962000
EXPERIENCE
Aug 2011 Present
Jul 2001
June 2010
Poster Presentation at the Endocrine Society 92nd Annual Meeting in San Diego,
California with a title Pituitary Dysfunction in a Patient with RosaiDorfman
Disease.
Alessa T.
Aug 20062008
2002
7th Annual Health Sciences Poster Day, Health Science Center. Faculty of Medicine
- Kuwait University
Alsuwaidan MT, Alessa TM, Almutawa FA. Assessing Personality Profiles Among
Physicians of Different Specialties in Kuwait.
2002
2001
2000
1997
MEMBERSHIPS
2010Present
2009Present
2006Present
2003Present
Endocrine Society
American Thyroid Association
American Association of Clinical Endocrinologists.
Kuwait Medical Association.
CERTIFICATIONS
CURRICULUM VITAE
Name
Place of birth
Marital status
Married
Present position
:
Assistant professor of Medicine at Taibah
University, Madinah
Al-Monawara
Vice Dean of the Pharmacy Collage at Taibah
University- girls section
Contact information:
Education
Medical School
Internship
Residency
Fellowship
in
Certifications
1. Membership of Royal College of Physicians (MRCP) of Internal Medicine, June
1999
2. Arab Board of Internal Medicine, February 2000
3. Jordanian Board of Internal Medicine, February 2000
4. Saudi Board of Internal Medicine, November 2000
3
Presentations at Symposiums:
10
42- Maternal and Child Health Care Course, Madinha, Saudi Arabia, December
29, 2007.
43- 7th Clinical Research Professionals Course, Riyadh, Saudi Arabia, King
Faisal Specialist Hospital & Research Centre, Riyadh, 19-30/1/ 2008
44- Diabetic Foot mini-Symposium, Taibah University, Madinha, Saudi Arabia,
2/3/2008.
45- Symposium in Growth Hormone, Jeddah, Saudi Arabia, February 21 2008.
46- Symposium in Disorders of Vitamin D Deficiency, at King Fahad Medical
City, Riyadh, Saudi Arabia, February 27 2008.
47-Update in Diabetes & Endocrinology symposium, Madinha, Saudi Arabia,
March 22-23, 2008.
48- First International Diabetes & Obesity Conference, Taif, Saudi Arabia, April
27-29, 2008.
49- Accreditation for Healthcare Institutions workshop, Central Board of
Accreditation for Healthcare Institutions, Jeddah, May, 4-7 2008.
50- Diabetes Care Course, Madinha, Saudi Arabia, May 21-22, 2008.
51-The Second Diabetes and Endocrinology Conference, Jeddah, Saudi
Arabia, August 26-27, 2008.
52- International Diabetes Day, Madinha, Saudi Arabia, November 12, 2008.
53- Advances and management of thyroid and parathyroid diseases
symposium, Cedar- Sinai Medical Center, Los Angeles, California, United
State, March 14-15, 2009.
54- Annual Rachmiel Levine Diabetes and Obesity Symposium, City Of Hope,
Los Angeles, United State, March 18-21, 2009.
55- The 31st Symposium on Thyroid 2009, University of Southern California,
Los Angeles, California, United State, May 9, 2009.
11
82- First Update Internal Medicine Conference, Madinha, Saudi Arabia, April
25-26, 2012.
Awards:
-
Award for obtaining annual Internal Medicine prize in Riyadh Armed Forces
Hospital for 2 years, 1997 & 1998
14
15
Member of:
-
Chief of Taibha club for Diabetes & Endocrinology, Madinha, Saudi Arabia.
16
Papers:
1. Edmond A. Ryan, Breay W. Paty ,Peter A. Senior David Bigam, Eman Alfadhli,
Norman M. Kneteman, Jonathan Lakey and A.M. James Shapiro. Five year
follow-up after clinical islet transplantation, Diabetes, VOL. 54, JULY 2005.
2. Intesar Sultan, Eman Alfadhli, Lobnha Saber, and Nahid Abdulgani. Is type 2
diabetes mellitus a risk factor for vitamin D insufficiency, Journal of Taibah
University, Medical Science, 2007; 2 (1, 2): 30 - 41.
3. Hussein Raef, Eman Alfadhli, Alya Al Hajjaj, Siema Bakheet and Abdulrahman
Al-Nuaim. High rate of persistence/ recurrent disease among patient with
thyroid cancer: Factors affecting non-remession. Ann Saudi Med 28(4) JulyAugust 2008
4. Raef H, Malabu UH, Alfadhli E, Al-Hajjaj A, Al-Sobhi S, Rifai A, Al-Nuaim A.
Prognostic value of postoperative and post-ablative serum thyroglobulin
levels in patients with differentiated thyroid cancer. Niger J Med. 2008 OctDec;17(4):391-5.
5. Alfadhli E, Koh A, Albaker W, Bhargava R, Ackerman T, McDonald C, Ryan EA,
Shapiro AM, Senior PA. High prevalence of ovarian cysts in premenopausal
women receiving sirolimus and tacrolimus after clinical islet transplantation.
Transplant International, 2009 Jun; 22(6):622-5 .
6. Eman M Alfadhli. Secondary adrenal insufficiency
antiphospholipid syndrome. Intern Med. 2009;48(22):1963-6.
and
primary
7. Eman Alfadhli, Manal Ibrahim Hanafi, Intessar Sultan. Assessment of selfreported cardoimetabolic risk awareness among physicians. Bulletin of
Alexandria Faculty of Medicine. 2009 Nov.
8. Eman Alfadhli. Cholesterol deposition around small joints of the hands in
familial hypercholesterolemia mimicking Bouchard's and Heberden's nodes
of osteoarthritis". Intern Med. 2010;49(15):1675-6.
9. Eman Alfadhli, Andrew G. Gianoukakis. Management of severe thyrotoxicosis
when gastrointestinal tract is compromised. Thyroid. March 2011, 21(3): 215220.
17
Abstracts:
10. E Alfadhli, M Ahmed, A Almahfouz, A Alarifi, H Raef, F Al Dayel and S Al
Sobhi. Vitamin D Deficiency (VDD) Associated with Primary
Hyperparathyroidism (PHPPT) Presenting With Giant Brown Tumors (BT)
Mimicking Primary Bone Malignancy (PBM). Presented at the Endocrine
Society 84th Annual Meeting, June 2002, San Francisco
11. E Alfadhli, M Ahmed, A Arifi, A Almahfouz, F AlDayal and S AlSobhi. (Poster)
Adrenalcortical Carcinoma (ACC): Long Term Remission. Presented at the
Endocrine Society 84th Annual Meeting, June 2002, San Francisco
12. H Raef, E Alfadhli, A Almahfouz. TB of the thyroid Gland Mimicking
Subacute thyroiditis. Presented at the Endocrine Society 84th Annual Meeting,
19-22 2002 June, San Francisco
13. E Alfadhli, M Ahmed, S Alsifri, A almahfouz, F AlDayel and S. Alsobhi.
Vagaries in the Presentation of Primary Hyperparathyroidism (PHPPT).
Presented at the Endocrine Society 84th Annual Meeting, June 2002, San
Francisco
14. E Alfadhli, A AlHajjaj, S Bakheet and H Raef. Succesful Ablation Rate of
Differentiated Thyroid Cancer at KFSH&RC Using I123 for Pretreatment Whole
Body Scan (WBS) and Factors Affecting Remission. Poster presentation at the
American Thyroid Association, Oct 2002.
15. Hussein Raef, Eman Alfadhli, Alya Al Hajjaj, Siema Bakheet and Abdulrahman
Al-Nuaim. Contributing Factors to the High Recurrence/Persistence Rate
among Patients with Differentiated Thyroid cancer in the Kingdom of Saudi
Arabia.
Presented at the Endocrine Societys 85th Annual Meeting,
Philadelphia, USA, 19-22 June 2003
16. Nora Kahtani, Abdullah Alarifi, Eman Alfadhli, Suzan Salam, Mohammed
Ahmed, and Saif al Sobhi. The Usefulness of T3/T4 ratio in Early Detection of
18
Referees:
- Entessar Sultan, MD. Professor of Medicine
Consultant Endocrinologist
Department of Medicine, Taibah University.
Jameat Road, Madinha.
Saudi Arabia. Po Box 344
- Ali S. Alzahrani, MD, FRCP, FACE, FACP.
Visiting Professor at Johns Hopkins University, Baltimore, USA
Consultant Endocrinologist
King Faisal Specialist Hospital & Research Centre
P.O. Box 3354, Riyadh 11211
Kingdom of Saudi Arabia
- Ronald S. Swerdloff, M.D. Professor of Medicine
David Geffen School of Medicine at UCLA
Chief Division of Endocrinology
Harbor-UCLA Medical Center
1000 W. Carson St. Box 446, Torrance, CA 90502
Phone: (310) 222-1867
Fax: (310) 533-0627
19
ALKHOBAR 31952
Country:
Email:
Mohammed H AL-Ghamdi.FRCPC,FACE,FACP
P O Box 20610
2
Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the
purposes of Chapter business? _x__ yes ___ no
3
Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)
___ President
___ Vice President
___ Secretary
___ Treasurer
_x__ Board of Director Member
Many thanks.
Juma M Alkaabi
CURRICULUM VITAE
Nationality
Professional address
U.A.E. National.
Faculty of Medicine and Health Sciences,
Department of Internal Medicine
UAE University,
PO Box 17666,
Al Ain,
United Arab Emirates.
Telephone:
Fax:
E-mail:
+971 3 7137472
+971 3 7672995
j.kaabi@uaeu.ac.ae
QUALIFICATIONS
BSc, MBChB, MRCP(UK), DTM&H, FRCP, FACP, FACE and a Canadian Clinical Fellowship in
Endocrinology and Metabolism.
CURRENT POSITION
Associate Professor of Medicine at the Faculty of Medicine and Health Sciences- UAE University,
Consultant, Internal Medicine/Endocrinology-Diabetes & Metabolic Diseases at Al Ain and Tawam
Hospitals.
LIST OF DEGREES
1985-1987
Scottish Highers
1987-1990
Bachelor of Medical Sciences
1990-1993
MBChB
April 1999
Diploma of Tropical Medicine and Hygiene (DTM&H), The University of London.
July 1999
Membership of The Royal College of Physicians MRCP(UK)
October 2005
Clinical Fellowship Program in Endocrinology and Metabolism - University of Alberta,
Edmonton- Canada
March 2008
June 2008
Fellowship of the American College of Physicians
July 2008
Fellowship of the Royal College of Physicians of London
December 2008
Fellowship of the American College of Endocrinologists
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
Member of the Scientific Committee of the Shaikh Hamdan bin Rashid Al Maktoum Award
for Medical Sciences.
12.
13.
1987-1990
Eight merit certificates in different medical science courses were awarded during Bachelor of
Medical Sciences studies at the University of St. Andrews-Scotland.
2000-2001
Elected by the medical students of College of Medicine, SQUH, Oman to be awarded Clinical Tutor
of the Year.
2008-2009
Elected by students and faculty to receive the FMHS Distinguished Teaching Award .
17 Nov. 2011
May 2012
Elected by students and faculty to receive the FMHS Distinguished
ADVISORY COMMITTEES
2010 and up-to-date
Scientific Committee of the Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences
Oct. 2011
PhD Advisory Committee
Dec.2011
Fellowship Program at the UAE University.
Jan. 2012
Raffan E, Soos MA, Rocha N, Tuthill A, Thomsen AR, Hyden CS, Gregory JW, Hindmarsh
P, Dattani M, Cochran E, Al-Kaabi JM, Gorden P, Barroso I, Morling N, O'Rahilly S,
10
UAE.
11
25th Feb.2012
Conducting and participating as an examiner in the one-day Mock-OSCE examination of the Internal
Medicine residents preparing for the Board examination. There were 28 residents from various
hospitals in the Emirates.
3rd March 2012
Invited chairman
ed by multidisciplinary team from
Tawam hospital looking after difficult pituitary cases requiring surgical intervention or radiation
therapy, Al Ain UAE.
12
th
annual conference on
Diabetes
Al Ain- UAE.
4th Jan.2011
Scientific Interview at Sama Dubai TV with Prof. Ibrahim Galadari (30 min.)
21st Febraury 2011
Invited Examiner for the MRCP (UK) PACES Examinations, Al Ain hospital -UAE.
22 -24 March 2011
Attendance of the International Osteoporosis Foundation Conference Meeting. Valencia- Spain.
16th April 2011
Organizer, Chairman and Speaker at the 16th Annual Diabetes Workshop at the FMHS.
26th May 2011
at 1st Al Buraimi International Endocrine
Conference, Buraimi- Sultanate of Oman.
4-8th June 2011
Attendance and poster presentation in the 93rd Annual Meeting of the Endocrine Society, BostonUSA.
12th -16th September
Attendance of the Annual Meeting of the European Association for the Study of Diabetes (EASD);
Lisbon- Portugal.
13
Ain, UAE.
14
Pan Arab
, Syria.
15
Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the
purposes of Chapter business? yes
Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)
___ President
___ Vice President
___ Secretary
___ Treasurer
___ Board of Director Member
CV or bio-sketch included
Dear Sir,
AACE is well-known world wide of their excellent activities that attract the endocrinologists all
over the world to attend and participate in. I have attended the meetings of AACE and they were
very impressive along with their thyroid workshops.
With every AACE meeting, there is always an appreciation of the role of other chapters of
ACCE in different countries and their contributions in AACE are well recognized. I felt that we
need to have a role too to participate and support AACE by having our Gulf Chapter of AACE.
At the moment, Im a board member in Saudi society of endocrinology and metabolism since
March 2010 and I have been organizing many educational activities including latest international
conference by Saudi society that is going to be held in November 2012.
I have organized an endocrine course over 6 weeks for all the family physicians in the kingdom
of Saudi Arabia in September 2011 and February 2012 beside , another endocrine teaching
course for all the clinical fellows in September 2012. I have been attending all the board
meetings of the Saudi society of endocrinology that is held monthly.
I feel I have the energy, the motivation, the commitment to participate actively to serve the Gulf
Chapter. For that reason, I would like to nominate myself as a board member in the Chapter.
Sincerely,
Dr.Aishah Alkhzaimi, MBBS, FRCPC
Assistant professor of medicine
Endocrinology Consultant
King Saud University
King Khalid University Hospital
Tel: +966542763640
CURRICULUM VITAE
PERSONAL DATA
Name: Aishah Ali Mohd Ahmed Ekhzaimy
Date of birth: 15th January 1975Sex: Female
Nationality: United Arab Emirates
ACADEMIC QUALIFICATIONS
Year
School
2009
MCC I and
2007
American Board of
Endocinology and Metabolism
2006
II
Place
Canada
Achievements
Full MCC lisence
American board of
Endocrinology and Metabolism
Mcgill University,
Canada
FRCPC, Subspecialty in
Endocrinology and Metabolism
FRCPC, Internal Medicine
2005
QueensUniversity,
Canada
2005
2000
MCCE Exam
Muscat,Oman
MCCE
2000
United Arab
Emirates
M.B.B.S
(Bachelor Of Medicine &
Bachelor Of Surgery)
1992
UAE
PROFESSIONAL EXPERIENCE
January 2010- current:
Assistant professor, Internal medicine and Endocrinology consultant at King Saud
University, KKUH, Riyadh, Saudi Arabia
October 2009 January 2010:
3 months of Locum as an endocrinology consultant at KFMC in Riyadh, SA
June 2009- September 2009:
Internal medicine and endocrinology consultant at Humber River Regional Hospital,
Toronto, Ontario, canada
August 2008- March 2009
Working as a consultant endocrinology/internal medicine at Fujairah Hospital, Ministry
of Health
January 2008-June 2008
Worked with Dr. S. Ezzat in clinical Endocrine oncology at University of Toronto
February 2007-June 2008
Third year clinical training in thyroid cancer and endocrine oncology at Western Ontario
University
January 2005- January 2007
Residency training program as a clinical fellow in Endocrinology and metabolism at
Mcgill University
January 2002- December 2004
Residency training program in internal medicine at Queens university, Ontario
November 2001- December 2001
Pre-assessment period of 2 months( PEAP) at Queens University, Ontario
October 2000- October 2001
12 months of working experiences as a resident in internal medicine department in AlAin Hospital in UAE taking the 1st call responsibility to cover Emergency medicine unit,
outpatient clinics and coronary care unit.
June 1998
Summer elective in general internal medicine and infectious disease in Cleveland
hospital, Ohaio, USA for 2 months
During these periods I gained considerable experience in the management of emergency
cases and critically ill patients. I have been involved in the management of large number
of diabetic patients and patients with different endocrinological and metabolic problems.
I have performed lots of clinical skill procedures : arterial and venous canulation, central
lines, endotracheal intubation, swan ganz catheterization ,chest tube insertion,
thoracocentesis , paracentesis,bone marrow aspiration and biopsy. I have done many
thyroid FNA s during my training and my practice with and without US guidance.
Power of
September 2007
Teaching Medical students at University of Western Ontario
July 2006
A chief resident in endocrinology department at Mcgill Univesity
June 2006
Participated in improving residents teaching skills workshop at Mcgill University
May 2006
Summer course in clinical epidemiology at Mcgill University
February 2006
Teaching medical students at Mcgill University basic physiology of endocrinology
July 2004
PROFESSIONAL ORGANISATIONS
REFERENCES
1. Dr. P. Doran
Program director of Endocrinology program at Mcgill University
687 Pine Avenue West Montreal, Quebec H3A 1A1
Tel: 1514 934 1934
Fax: 1514 982 0825
2. Dr. Simon Wing
Director, Division of Endocrinology and Metabolism, McGill University
Address:
City:
P O BOX 399
MUSCAT
Country:
Email:
SULTANATE OF OMAN
m allamki@gmail.com
2
Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the
purposes of Chapter business? ___ yes ___ no
3
Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)
___ President
___ Vice President
___ Secretary
___ Treasurer
___ Board of Director Member
I propose by Candidancy as board member to facilitate and oversee the establishment /activities of the AACE Gulf Chapter.
Personel details:
Full name:
Title:
Biography text:
Address: ARABIAN GULF UNIVERSITY, COLLEGE OF MEDICINE & MEDICAL SCIENCES- ALJAWHARA
MEDICAL CENTER.
City:
Country:
Email:
2
Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the
purposes of Chapter business? ___ yes ___ no
3
Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)
___ President
___ Vice President
___ Secretary
___ Treasurer
___ Board of Director Member
The Gulf AACE chapter will have a tremendous scientific impact on the Endocrinology field in the region
and Middle East. Knowing how prevalent diabetes and other common endocrinological disorders are in
the region, The Gulf AACE chapter will, no question, have a great influence in promoting scientific
awareness and guidance among Endocrinologists in the region.
I am currently working as a full time faculty staff at The Arabian Gulf University, College of Medicine
and Medical sciences and practicing as Endocrinologist and Lipidologist at the University Clinics at
Princess Aljawhara Medical Center which will eventually transform to King Abdulla Medical city in the
very near future in Bahrain.
I did Internal Medicine residency training at Sinai-Grace Hospital, Wayne State University, Detroit,
Michigan (USA) and Endocrinology fellowship at Cleveland Clinic Foundation (USA). In addition, I
recently had a Board Certification in Clinical Lipidology.
I have been very active in the field at professional as well as at community level. I am currently working
on several research papers pertaining to diabetes, lipids and endocrinological disorders through my post
with the University. In addition, I am chairing the scientific and event committee for the upcoming First
Regional Diabetes Symposium in Bahrain. I am active member in several Endocrine/Diabetes
organizations and societies such as American Diabetes Association, The Endocrine Society, National lipid
association and Fellow of American College of Physicians. At community level, I have attributed to
several community based lectures and awarenesss, several TV and radio interviews locally and
regionally and community health projects the latest being The Diabetic Project for School Children and
The Metabolic Syndrome Network Project with Bahrain Ministry of Health. I am one of the very few
Endocrinologists in the region and Middle East to hold board certification in clinical Lipidology and to
treat resistant cases of hypoparathyroidism with parathyroid hormone. I have good working relationships
with authorities in Bahrain Ministry of Health as well as the Endocrinologists in Bahrain and the gulf
region.
Because of all the benefits I have gotten from AACE, I feel it is only right that I do what I can to give
back to this organization. Running for Board of Director Member is the best way I can think of to say
Thank you to AACE.
Looking forward to your support,
Nasreen AL-Sayed, BMedSci., MD, FACP.
CURRICULUM VITAE
Dr. Nasreen AbdulKarim AlSayed M.D. FACP
Date of Birth :
Place of Birth:
Manama, Bahrain
Nationality
Bahraini
Mobile
Residence :
Email
:
+973- 33989330
+973-77173939
nasreen.alsayed@yahoo.com
Marital status:
Qualifications:
Work Experience:
November 2011-August
2012
February 2012-current
September 2012
Research &
Conferences:
1. Nasreen Al-Sayed, Mona Areqat, Wassim Almawi,
"Association of comorbid Depression, Anxiety, Stress
Disorders in Bahraini type 2 diabetes patients.", a clinical
Research, Bahrain, Journal of Endocrinological Investigation, 2008 Nov; 31(11):1020-4.
.
2. Wassim Almawi, Nareen AL-Sayed, Mona Areqat,
Association of selective HLA class II susceptibility
Conferring and protective haplotypes with type 2
Diabetes in patients from Bahrain & Lebanon.
Published: Clinical & Vaccine Immunology, Nov-2006
P-1296-1298, Vol.13. No.11.
3. Nasreen AL-Sayed, Robert Zimmerman, ACE Inhibitors
better than ARBs In Reducing Albuminuria in Type 2
Diabetics, Cleveland Clinic Foundation, Abstract presented
in Endocrine Society meeting 2011, in process for
publication in Endocrine practice.
4
Extra Curricular
Activities &
Memberships:
1.
2.
3.
4.
5.
Clinical
Languages:
Arabic (Fluent written and spoken)
English (Fluent written and spoken)
Name:
Address:
Center for Diabetes and Endocrinology, Sheikh Khalifa Medical City, Karamah Street
City:
Abu Dhabi
Country:
Email:
Beshyah@yahoo.com
Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the
purposes of Chapter business? Yes
Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)
___ President
___ Vice President
___ Secretary
___ Treasurer
X
Overview:
Salem Beshyah qualified from the Medical School of Tripoli in 1981. He started his
clinical training in Tripoli till 1985 when he moved to the UK. He obtained his MRCP
(UK) and MRCPI during his introductory year in Scotland under the auspices of the
Royal College of Physicians and Surgeons of Glasgow. He then trained as a clinical
registrar in Leicester and Bedford (1987-1989). He did four-year clinical research
fellowship in working on the clinical and metabolic consequences of hypopituitarism
and growth hormone deficiency which was the subject of his PhD thesis. After further
clinical training, he was appointed consultant physician in diabetes and
endocrinology in Harlow, Essex UK for 10 years; Very keen on education and was
the Royal College of Physicians Tutor for the last 3 years in Harlow. In 2006, he
moved to his current post and has been very active in organizing CME local, national
and regional activities.
Why I am nominating myself for Board member of Gulf Chapter Interests:
Wide clinical interests:
I am a clinican with wide range range of interests who has been in practice for a
good while of 16 years as a consultant endocrinologist. I have clinical interests
covering thyroid disease, practical management of diabetes, diabetic foot and
cardiovascular disorders in diabetes. My academic Interests: Cultural aspects of
diabetes care, continuous medical education, translational Research.
Contributions:
Contributed as volunteer to many activities. Regular visitor to the relevant clinical
units in Libya (Tripoli, Zawia, Sebha and Benghazi) to support, teach and examine.
Founding member and Honorary Treasurer and Web master of the Libyan
Association for Diabetes and Endocrinology; Contributed to the organization and
conduct of the 4th ,5th ,6th ,7th and 8th National Congress for Diabetes and
Endocrinology as a true non governmental activity.
Personal skills:
Skilled organizer of academic activities (see www.endodiablibya.org &
www.excellenceincme.org), sponsorship negotiator, researcher and author (over 50
publications; 38 of which are medline), speaker (Arabic and English) and editor (3
years standing as the associate editor of Ibnosina Journal of Medicine and
Biomedical Sciences see www.ijmbs.org).
If elected, I will work with the president and other members of the board to see the
Gulf Chapter as an effective trans-national body of experts that help the profession
and patients in the fields care, education and research.
CURRICULUM VITAE
Doctor Salem Arifi BESHYAH
MBBCh DIC PhD FRCP
CONTACT DETAILS:
Home:
Villa 3,
Street 1 (joining 25 and 23),
Sector 23, Al Moshref,
Zone 1,
Abu Dhabi, UAE
Work:
E-mail:
beshyah@yahoo.com
CURRICULUM VITAE
I. PERSONAL DETAILS:
Name:
Gender
Date of birth:
Marital status:
II. EDUCATION:
1971-1974
1974-1981
1989-1993
III. QUALIFICATIONS:
M.B., B.Ch. (1981)
M.R.C.P.I. (1987)
M.R.C.P. (U.K.) (1987)
D.I.C. (1994)
Ph.D. (1994)
F.R.C.P. (2000)
1.5.1996 8.9.2006
Consultant Physician in General Medicine, Diabetes and Endocrinology, Princess
Alexandra Hospital, Harlow, Essex, UK.
Clinical Audit Lead (1.1.1997 - 31.12.1999)
Unit Training Director/Royal College Tutor (1.1.2003 - 31.8.2006)
I initially started this job as a locum for 4 months (May to August, 1996) during
which I was appointed to the substantive post on the 26.July 1996.
This is a full-time NHS post. The fixed sessions include 2 ward rounds and 4 OPD
clinics together with acute medical on call rota of 1:6 for the first 4 years, now
1:12. One of the OPD clinics is a medical/endocrine and the other three are
diabetic clinics (on three different sites to meet the geographical needs of the
district).
The medical/diabetic firm consists of four junior doctors (a Diabetes Specialist
Registrar on North Thames Rotation, Staff Grade Doctor, a medical SHO on our 24
month rotation and a pre-registration House Physician), three Diabetes Specialist
Nurses and a part time Diabetes Link Midwife, and two Clinical Assisstant
sessions in Diabetes Care.
The diabetic care is delivered via the conventional diabetic clinics and by the three
nurses following patients up in the community. A new Diabetes Education Centre
is used for educational sessions, walk-in services and to see out of clinic
consultations for urgent and high risk patients. All OPD diabetic clinic sessions are
supported by dietary advise and chiropody services.
There is a close cooperation with the local medical opthalmology unit (Miss
Dierdre Flaye), and the vascular surgeon (Mr Refson). I have Combined Thyroid
Clinic (1st Friday of the month) with the local thyroid surgeon (Miss Jenkins) and a
Diabetic Ante-natal Clinic (Jointly with Mr Hartwell). I have established a close
working relationship with Professor John P. Monson (Saint Bartholomews
Hospital) for tertiary endocrine referrals and the Renal physicians in the
surrounding hospitals for joint management of diabetic renal disease.
During this appointment I had been the Clinical Audit Lead and I ran an effective
well attended programme. For three years. (1.1.1997-31.12.1999).
I was the Unit Training Director/Royal College Tutor. I run an active educational
programme catering for the needs of the SHOs preparing for the MRCP and other
juniors. 1.1.2003-31.8.2006.
I am very keen on continuing education. I regularly lecture and lead workshops for
GP and Practice Nurses in the locality and the region in addition to my commitments
to teaching of medical students and Junior Doctors in Hospital
1.10.95 - 18.2.96
Short Locums in General Internal Medicine & Diabetes/Endocrinology:
During this period I have took up short term appointments in general and geriatric
medicine including a locum consultant physician in general medicine and
diabetes/endocrinology working with Dr. Richard Paisey at Torbay Hospital, Torquy
(5 weeks) and a locum registrar/senior registrar in medicine at the West Middlesex,
Mayday, Chase Farm, Royal Free, Edgware General and Wexham Park hospitals.
29.5.95 to 13.9.95
Senior Registrar (Loum)
In general medicine and diabetes/endocrinology at Guy's Hospital, London. This
locum post included the cover for ward rounds, OPD clinics and acute medical on
take (1:6). The OPD cover included 2 diabetic, 1 endocrine and 1 general medical
clinics. I also support the metabolic ward staff in the care of walk-in diabetic
patients and supervision of patients undergoing dynamic endocrine investigations.
Consultants:
1.1.95 - 28.5.95
Senior Registrar (Temporary)
In general internal medicine and diabetes/endocrinology at St. Mary's Hospital,
London. The range of clinical duties cover ward rounds, OPD clinics and acute
medical on take (1:5). The weekly OPD cover included 2 diabetic, 1 endocrine and 1
lipid clinics in addition to an alternate weekly attendance at the reproductive
medicine clinic and doing a once monthly joint diabetic-renal clinic.
Consultants:
1.8.94 - 30.9.94
Consultant Physician in GIM/Diabetes & Endocrinology (Locum)
In acute general medicine and diabetes/endocrinology at Hillingdon Hospital,
Uxbridge, Middlesex. The duties include ward rounds, OPD clinics and acute medical
on call rota of 1:5.
1.4.94 - 31.7.94
Medical Registrar/Senior Registrar (locums)
In acute general medicine at several hospitals in and around London (Central
Middlesex, West Middlesex, Wittington Hospitals in London and Medway Hospital,
Kent). The duties included ward rounds, OPD clinics and resident acute medical on
take including cover for the accident and emergency department and coronary care
unit.
1.1.94 - 31.3.94
PhD Writing up Period
Unit of Metabolic Medicine at St. Mary's Hospital Medical School, London.
Thesis Title: Clinical and Metabolic Studies on Hypopituitarism and Growth
Hormone Treatment in Adults Submitted to St Marys Hospital Medical School,
Imperial College of Science, Technology and Medicine, University of London, London.
13.9.89 - 31.12.93
Clinical Research Fellow/Honorary Registrar
Unit of Metabolic Medicine at St. Mary's Hospital Medical School, London.
During this research fellowship, I have conducted clinical and metabolic studies on
the consequences of conventionally-treated hypopituitarism in adults (body
composition, bone mass and metabolism, quality of life and cardiovascular risk). I
was also responsible on the planning and running of a trial of GH replacement
therapy in hypopituitary adults to assess the effects on well-being, body
composition, physical performance, bone mass and metabolism, lipid metabolism
and carbohydrate tolerance. The work resulted in numerous presentations at
national and international meetings and several publications in quality journals.
In addition to the research work, I was doing regular endocrine, diabetes and lipid
clinics at St. Mary's, St Charles and Northwick Park hospitals. Research fellows are
also involved in the academic and clinical activities of the unit of metabolic medicine
including teaching of medical students and supervision of the B.Sc. (Clinical Science)
students during their research project module.
During this period, I kept my skills in acute general medicine by covering absent
colleagues at the registrar/SR level on regular basis. I have also done a full time
locum senior registrar at Northwick Park Hospital, Harrow in acute general medicine
and diabetes/endocrinology between 1.10.1992 and 31.12.1992. The acute on take
rota was 1:5. (Consultant: Dr Charles. Edmonds).
Consultant:
1.2.89-12.9.89
Medical Registrar
General medicine, Bedford General Hospital, Bedford.
I was working for two consultant physicians with interest in diabetes and
gastroenterology. The on take rota was 1:3. The duties include one general medical
and two diabetic clinics and one GI endoscopy session per week. In addition to the
normal medical ward work, the registrar looks after patients in the coronary care
and intensive care units.
Consultants:
23.3.87 - 16.1.89
Medical Registrar:
General medicine, Leicester General Hospital, Leicester.
Working for a consultant physician with interest in diabetes and endocrinology (19
months). I used to assist and supervise the SHOs and HOs on the ward and on
coronary care unit (when on call). Regular OPD work includes a general medical
clinic, a diabetic clinic and a diabetic foot clinic per week. There are 3 other less
frequent diabetic clinics conducted in the community around Leicester. The team
takes part in care of diabetic patients during pregnancy both as in and out-patients.
For the remaining 3 months of this post I worked for two consultant physicians with
special interest in gastroenterology. Duties include 3 OPD clinics a week and one
endoscopy session. The on call rota throughout the post was 1:4.
Consultants:
1.12.86 - 20.3.87
Medical Registrar:
General medicine, Hairmyres Hospital, East Kilbride, Scotland
This was an acute medical post with on take rota of 1:6. In addition to ward work, I
was doing 2-3 general medical OPD clinics weekly.
Consultants:
Dr D. Datta, FRCP
Dr Chris J. Clark, MD FRCP
1.3.86 - 30.11.86
Senior House Officer:
General medicine, Victoria Infirmary , Glasgow, Scotland.
I was involved in the day-today care of acute patients with unselected medical
problems and doing twice a week general medical, cardiology and diabetes OPD
Clinics.
Consultants:
1.11.85 - 26.2.86
Clinical Attachment:
General medicine, St Laurence's Hospital, Dublin, Ireland.
During this period I was attending ward rounds, OPD clinics and the clinical meetings
in the hospital.
Consultant:
1.11.83 - 30.9.85
Medical S.H.O./Registrar:
In general medicine, Tripoli central hospital. During this post I have acquired more
experience in acute medicine and endocrinology. I also had some experience in
gastroenterology, including upper GI endoscopy and flexible sigmoidoscopy. I was
doing general medical, endocrine and gastroenterology OPD clinics. I also had the
opportunity of bedside teaching of medical students.
Consultants:
1.5.83 - 31.10.83
Medical Senior House Officer:
Intensive Care Unit, Tripoli Central Hospital. During this period I gained clinical
experience in all aspects of intensive care medicine including resuscitation, cardiac
pacing and care of patients on assisted ventilation.
Consultant:
1.3.82 - 30.4.83
Senior House Officer:
In general medicine, Tripoli Central Hospital, Tripoli Libya. I have been involved in the
day to day care of patients with acute medical problems, and in a unit with particular
interest in general endocrinology. I had extensive practice in all bedside clinical
procedures I was doing a general medical and an endocrine clinic weekly.
Consultant:
1.3.81 - 28.2.82
Junior House Officer:
Internship rotation in medicine and surgery, in the main teaching hospitals in Tripoli,
Libya.
Consultants:
PUBLICATIONS:
Full Paper:
A. Original Publications:
Sherif IH, Vanderley C, Beshyah S & Bosairi S. Sella size and contents in Sheehan's
syndrome. Clinical Endocrinology 1989; 30: 613-618.
Jones R, Beshyah SA, Curryer G & Burden AC. Modification to the "Leicester
Scotchcast Boot". Practical Diabetes 1989; 6: 118 -119.
Beshyah SA, Anyaoku V, Niththyananthan R, Sharp P & Johnston D G. The effect of
subcutaneous injection site on absorption of human growth hormone: Abdomen
versus thigh. Clinical Endocrinology 1991; 35: 409-412
Shahi M, Beshyah SA, Hackett D, Sharp P, Johnston DG & Foale R. Myocardial
dysfunction in treated hypopituitary adults: a possible explanation for increased
vascular mortality. British Heart Journal 1992: 67: 92-96
Beshyah SA, Jowett NI, Burden AC. Metabolic control during Ramadan fasting.
Practical Diabetes 1992; 9: 54-55
Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN and Johnston DG.
Detection of premature atherosclerosis by high-resolution ultrasonography in
symptom-free hypopituitary adults. Lancet 1992; 340: 1188- 1192
Beshyah SA, Markussis V, Harbourne T, Nicolaides AN and Johnston DG. Normal
haemostatic mechanisms despite increased vascular mortality in hypopituitary
adults. Hormone and Metabolic Research 1993; 25: 449-450.
Beshyah SA, Sharp P, Gelding SV, Halliday D & Johnston DG. Whole- body leucine
turnover in adults on conventional treatment for hypopituitarism. Acta
Endocrinologica 1993; 129: 158-164.
Beshyah SA, Thomas E, Kyd P, Sharp P, Fairney A & Johnston DG. Effect of growth
hormone replacement therapy on calcium and bone metabolism in hypopituitary
adults. Clinical Endocrinology 1994; 40: 383-392.
Beshyah SA, Shahi M, Skinner E, Sharp P, Foale R and Johnston DG. Cardiovascular
effects of growth hormone replacement therapy in hypopituitary adults. European
Journal of Endocrinology 1994; 130: 451-458.
Rutherford OM, Beshyah SA & Johnston DG. Quadriceps strength before and during
growth hormone treatment in hypopituitary adults: relationship to changes in lean
body mass and IGF-I. Endocrinology and Metabolism 1994; 1: 41-47.
Lynch S, Merson S, Beshyah SA, Sharp P, Skinner E, Priest RG & Johnston DG.
Psychiatric morbidity in adults with hypopituitarism. Journal of The Royal Society of
Mustafa HE, Bernsen RM, Beshyah SA. Glycaemic management of type 2 diabetic
patients attending a tertiary care centre in United Arab Emirates. Submitted to:
Journal of Diabetology.
B. Review Articles
Beshyah SA and Sherif IH. Ramadan fasting and diabetes mellitus. Practical Diabetes
Digest 1989; 1: 31-32
Sharp P, Beshyah SA and Johnston DG. Growth hormone disorders and diabetes. In:
Alberti KGGM & Johnston DG (eds.): Secondray Diabetes.
Bailliere's Clinical
Endocrinology and Metabolism 1992; 6: 819-828
Johnston DG, Beshyah SA, Markussis V, Shahi M, Sharp P, Foale R and Skinner E.
Metabolic changes and vascular risk factors in hypopituitarism. Hormone Research
1992; 38(S1): 68-72.
Al-Shoumer KAS, Beshyah SA and Johnston DG. Growth hormone and malignancy.
Endocrine-Related Cancer 1994 1: 19-26.
Beshyah S. Islamic views on medical ethics. [Translation to Arabic]. Bulletin of the
Islamic Call Society (Tripoli, Libya). 1998; 15:827-832
. ( )
1998 827-832 15 .
Beshyah SA and Johnston DG. Cardiovascular disease and risk factors in adults with
hypopituitarism. Clinical Endocrinology. 1999; 50:1-15
Johnston DG, Al-Shoumer KAS, Chrisoulidou A, Kousta E, Beshyah S. and Robinson S.
Long term effects of growth hormone therapy on intermediary metabolism and
insulin sensitivity in Journal of Endocrine Investigations 1999; 22: 37 - 40.
Beshyah SA, Benbarka MM and Sherif IH. Practical management of diabetes during
Ramadan fast. Libyan Journal of Medicine. 2007; 2
Beshyah SA and Sherif IH. Care for People with Diabetes during the Moslem
Pilgrimage (Haj): An Overview . Libyan Journal of Medicine. 2007; AOP: 071211
Zaidi MA, Beshyah SA and Griffith R. Needle Stick Injuries: An Overview of The Size of
The Problem, Prevention And Management. Ibnosina Journal of Medicine and
Biomedical Sciences 2010;2(2):53-61.
Beshyah SA. Non-Communicable Diseases And Diabetes Care Guidelines:
Epidemiology And Call For Collective Action. February, 6th 2010, Dat Elmad
Conference Hall Complex, Tripoli, Libya Ibnosina Journal of Medicine and Biomedical
Sciences. 2010;2: 142-148.
Beshyah SA. Fasting During The Month of Ramadan for People with Diabetes:
Medicine and Fiqh United at Last Ibnosina Journal of Medicine and Biomedical
Sciences. 2009; 1(2): 58-60
Beshyah SA, Fathalla W, Saleh A, Al-Kaddour A, Noshi M, Al Hatheethi H, Al-Saadawi
N, Elsiesi H, Amir N, Almarzouqi M, Khalil A, Benbarka M, Ahmed U, Mustafa HE, AlMahmeed W. Ramadan Fasting and The Medical Patient: An Overview for Clinicians.
Ibnosina Journal of Medicine and Biomedical Sciences 2010; 2(5): 240-257.
Book Chapters:
Beshyah SA, Shahi M, Mayet J, Foale R and Johnston DG. Growth hormone and the
cardiovascular system. In: M. Ranke and J.S. Christiansen (eds). The Complexity of
Endocrine Systems. J &J-Verlag , Mannaheim, 1996: pp 131-155.
Johnston DG, Al-Soumer KAS, Beshyah SA, Chrisoulidou A, Kousta E & Anyaoku.
Interactions of cortisol and growth hormone replacement: Intermediary metabolism.
In: SWJ Lamberts (Ed.) The Diagnosis and Treatment of Pituitary Insufficiency.
BioScientifica Ltd. Bristol. 1997: pp 63-77.
Sherif IH & Beshyah SA. Diabetes and Ramadan. In: G.V.Gill, J-C Mbanya & G. Alberti
(Eds.) Diabetes in Africa. FSG Communications Ltd. Cambridge. 1997, pp 269-273.
Johnston DG, Al-Shoumer KAS, Beshyah SA, Chrisoulidou A, Kousta E & Anyaoku.
Growth hormone replacement in young adults: if and when to continue. In: R
Stanhope (ed) Adolescent Endocrinology BioScientifica Ltd. Bristol. 1998; pp
Beshyah SA. Is cardiovascular mortality increased in hypopituitary adults ?. In:
J.P.Monson (ed) Challenges in Growth Hormone Therapy. Blackwell Science. pp 93105; 1999
Beshyah SA, Lakhdar A and Gill GV. Acute diabetic emergencie in the Arab World.
In: A A Lakhdar & GV Gill (editors): Diabetes in The Arab World. FSG Communications
Ltd. Cambridge. 2005, pp: 199-210.
Beshyah SA and Sherif I. Diabetes during Ramadan and Haj. In: A A Lakhdar & GV Gill
(editors): Diabetes in The Arab World. FSG Communications Ltd. Cambridge. 2005,
pp: 225-240.
Beshyah SA and Blouza-Chabchoub S. Diabetes and Pregnancy. In: A A Lakhdar & GV
Gill (editors): Diabetes in The Arab World. FSG Communications Ltd. Cambridge.
2005, pp 249-267.
Beshyah SA & Burden AC. Haemoglobin, haematocrit and foot ulceration. Diabetic
Medicine 1988; 5 (Suppl): 30
Burden A C, Jones R, Beshyah S A & Curryer G. Modification of the "Scotchcast Boot".
Diabetic Medicine 1988; 5 (suppl): 30
Beshyah S A, Jowett N I & Burden A C. Effects of Ramadan fasting on metabolic
control in diabetes. Diabetic Medicine 1988; 5 (suppl.): 32-33.
Jowett N I, Ray-Chaudri K, Beshyah S & Burden A C. Standard diabetic care and
serum cholesterol. Diabetic Medicine 1989; 6 (suppl 2): 27A
Lynch S, Beshyah SA, Merson S, Sharp P, Priest RG & Johnston DG. Psychological
features of growth hormone deficiency in adults. Journal of Endocrinology 1990; 127
(Suppl): 60
Copping D, Beshyah SA, Baynes C, Henderson A, Richmond W, Sharp P & Johnston
DG. Plasma lipids, body fat distribution and plasma lipase activity in growth
hormone deficient adults. Journal of Endocrinology 1990; 127 (Suppl): 61
Beshyah SA, Sharp PS, Anyaoku V, Fishman D & Johnston DG. Absorption of
subcutaneously injected human growth hormone. Journal of Endocrinology 1990;
127 (Suppl): 59
Beshyah SA, Freemantle C, Parnell J, Johnston DG & Sharp P. Body composition in
hypopituitarism: bioelectrical impedance versus total body potassium. Journal of
Endocrinology 1991; 129 (Suppl): 232
Shahi M, Beshyah S, Hackett D, Sharp P, Foale R & Johnston D G. The effect of
growth hormone deficiency on cardiac structure and function in hypopituitarism.
Journal of Endocrinology 1991; 129 (Suppl): 179
Shahi M, Beshyah S, Hackett D, Sharp P, Johnston D G & Foale R. Cardiac structure
and function in growth hormone deficiency. British Heart Journal 1991; 66(1): 58
Shahi M, Beshyah S, Hackett D, Sharp P, Johnston D G & Foale R. The effects of
growth hormone deficiency on cardiac structure and function. European Heart
Journal 1991; 12 (8-Abstracts Supplement): P389
Beshyah SA, Thomas E, Sharp P and Johnston DG. Bone mineral status in
hypopituitary adults. Journal of Endocrinology 1991; 131 (Suppl): 95
Markussis V, Beshyah S A, Fisher C, Renton S, Nicolaides AN and Johnston D
G.Increased carotid intima-media thickness in hypopituitary adults. Journal of
Endocrinology 1991; 131 (Suppl): 96
Newton PJ, Beshyah SA, Anyaoku V, Sharp P and Johnston DG. Time course of
(Suppl 30):P22
Beshyah SA, Freemantle C, Shahi M, Foale R and Johnston D.G. Effects of long term
growth hormone replacement in hypopituitary adults on body composition, exercise
tolerance and muscle strength. Journal of Endocrinology 1994; 140 (Suppl.) :P166.
Beshyah SA, Henderson, A, Richmond, W and Johnston, D.G. The effect of long term
growth hormone replacement in hypopituitary adults on plasma lipids, lipoproteins
and apoproteins. Journal of Endocrinology 1994; 140 (Suppl.) :P165.
Al-Shoumer KAS, Andres C, Beshyah SA, Gray, IP and Johnston DG. Day to day
variation in pancreatic beta cell products caused by glucocorticoid replacement
therapy in hypopituitary adults. Journal of Endocrinology 1994; 140 (Suppl.) :P164.
Beshyah SA, Niththyananthan R, Skinner E, Sharp P and Johnston DG. The effect of
long term growth hormone replacement on carbohydrate tolerance in hypopituitary
adults. Endocrinology and Metabolism 1994;1 (Suppl. B): 32
Beshyah SA, Skinner E, Aghil FM and Johnston DG. Resting energy expenditure in
growth hormone deficient adults. Journal of Endocrinology 1994; 143 (Suppl.): P75.
Beshyah SA, Kyd P, Fairney A and Johnston DG. The effects of long term growth
hormone replacement therapy on calcium and bone metabolism in hypopituitary
adults. Bone 1994; 15: 729-730.
Beshyah SA, Skinner E, Aghil FM and Johnston DG. The effect of growth hormone
replacement on resting energy expenditure in growth hormone deficient adults.
Journal of Endocrinology 1995;144: P293.
Beshyah SA, Shahi M, Mayet J, Skinner E, Foale R and Johnston DG. Heart size and
function in hypopituitary adults: Comparison with normal controls and clinical and
metabolic correlations. Journal of Endocrinology 1995; 147: OC46.
Al-Shoumer KAS, Hughes C, Richmond W, Beshyah SA and Johnston DG. Beneficial
changes in plasma lipids, lipoproteins in hypopituitary adults after 4 years of growth
hormone replacement therapy. Journal of Endocrinology 1995; 147: OC47.
Chrisouidou A, Anyaoku V, Beshyah SA, Al-Shoumer KAS, Robinson S and Johnston
DG. Effects of GH treatment for 7 years versus no treatment on anthropometry and
vascular risk factors in adult hypopituitarism. Journal of Endocrinology 1998;
150(Suppl.): P151
Chrisoulidou A, Kyd P, Beshyah SA, Rutherford O, Fairney A and Johnston DG. Effects
of 7 years of growth hormone (GH) treatment on bone metabolism in adult
hypopituitarism. Endocrinology. Proceedings of the 81st Meeting of the Endocrine
Society, San Diego, 12-15 June 1999. p394,
Chrisoulidou A, Ariff B, Mayet J, Beshyah SA, Shahi M, Foale R and Johnston DG.
Effects of 7 years of growth hormone (GH) treatment on heart function and structure
in adult hypopituitarism. Proceedings of the 81st Meeting of the Endocrine Society,
San Diego, 12-15 June 1999: P2-528 pp 392.
Bosseri, S, Beshyah SA, Ismail MMA, Lazreg I, Shafeh T & Sherif IH. Clinical and
biochemical characteristics of 270 Sheehans syndrome patients. Journal of
Endocrinology. 2000; 164(Suppl):P202
Ismail MMA, Alaswad M, Ejamail A, Abdelaziz H, Shawesh K, Dorar N, Beshyah S &
Sherif I. Metabolic control of type 2 diabetes using Repaglinide during the fasting
month of Ramadan; IDF Programme Book; Abstract P332, November 2000.
Khawaja T, Alaswad M, Kekkli M, Beshyah SA & Sherif IH. Reduced bone mass in
Sheehans syndrome. Endocrine Abstracts 2001; 1: P11
Abouglila K, Magbari M, Sayer JW & Beshyah SA. Management of hyperglycaemia
during acute myocardial infarction: an audit of DIGAMI-based practice Diabetic
Medicine 2001;
Beshyah SA, Bay NA and Sherif IH. Awareness of Libyan women of the menopause.
Third Pan Arab Congress on Endocrinology and Diabetes. Damacus October 25th-28th
2001. Proceedings Book.
Beshyah SA, Bisheya AF, El-Mijbri S. and Sherif IH. Role of community pharmacists
in diabetes care.Third Pan Arab Congress on Endocrinology and Diabetes. Damacus
October 25th-28th 2001.
Beshyah SA and Sherif IH. A Short Diabetes Knowledge Test in Arabic. Third Pan
Arab Congress on Endocrinology and Diabetes. Damacus October 25th-28th 2001.
Beshyah SA, Aylwin S, Abouglila K & Monson JP. 'Brittle Addison's disease' but not
'Brittle diabetes' in a young woman with Addison's disease and type 1 diabetes
mellitus. I. Endocrine Abstracts 2002, 3: P19
Khoo B, Field B, Rosenfelder B, Lowe DG, Beshyah SA & Monson JP. Cushing's
syndrome due to apparently autonomous adrenal hyperplasia in a patient with
multiple endocrine neoplasia type I. Endocrine Abstracts 2002, 3: P122
Beshyah SA, Bay NA & Sherif IH. Awareness of Libyan women of the menopause and
their attitudes to hormone replacement therapy. Endocrine Abstracts 2002, 3: P214
Ravikumar C, Mukhtar SF & Beshyah SA. Transient thyrotoxicosis following total
laryngectomy. Endocrine Abstracts 2002; 4: P8
Mukhtar SF and Beshyah SA. Unusualy long 'honeymoon' in a 45 year old man with
type 2 diabetes mellitus. Diabetic Medicine 2004; 21(suppl.):P214.
Beshyah SA, Al-Fallouji H & Neave F. Complete right vocal cord paralysis: a very rare
complication of radioiodine therapy for hyperthyroidism. Endocrine Abstracts 2004,
7: P301
Beshyah SA. (invited speaker) Epidemiology, clinical management and outcome of
diabetic pregnancies in the Arab world: An overview. Int J Diabetes & Metabolism (2005)
13: 30-59
Beshyah SA, Thomas E, Skinner E, Sharp P & Johnston DG. Total body and spine bone
mineral density in women with hypopituitarism (Proceedings). In: Ring EFJ, ed.
Current Research in Osteoporosis and Bone Mineral Measurement II:1992. London:
The British Institute of Radiology,1992: pp 17-18
Beshyah SA, Thomas E, Freemantle C, Parnell CJ and Johnston DG. The place of dual
energy X-ray absorptiometry in measurement of lean body mass and percent body
fat in hypopituitary adults (Proceedings). In: Ring EFJ, (ed). Current Research in
Osteoporosis and Bone Mineral Measurement II:1992. London: The British Institute
of Radiology, 1992: pp 62-63
Sharp P, Beshyah SA and Johnston DG. Cardiovascular risk factors in growth
hormone deficiency: effects of growth hormone replacement Endocrinology and
Metabolism 1995; 2 (Suppl A): 13-14.
Lynch S, Beshyah S & Merson S. Psychiatric aspects of hypopituitarism (letter).
Journal of The Royal Society of Medicine 1995; 88:603-604 [PubMed Indexed]
Beshyah SA, Schiff R & Al-Jehani FS. National crash call number is needed (letter). Br.
Med. J. 1996; 313; 429. [PubMed Indexed]
Al-Shoumer KAS, Kousta E, Beshyah S and Johnston DG. GH deficiency - Does it cause
atherosclerosis? The 3rd Internationational hGH symposium on GH deficiency in
Adults. Vienna , 6 September 1996.
Beshyah SA. Taking growth hormone away from paediatrics (Book review). Lancet,
1997; 349:366-367.
Beshyah S (Editor) Supplement The Fifth Libyan Diabetes and Endocrinology
Conference, 1-3 May 2007, Teachers Union Hall, Tripoli, Libya. Libyan Journal of
Medicine. 2007, 2
Salhin AA, Hajjaji IM, Deeb AA and Beshyah SA. Meeting Report: The Fifth Libyan
Diabetes and Endocrinology Conference, 1-3 May 2007, Teachers Union Hall, Tripoli,
Libya. Libyan Journal of Medicine. 2007, 2
Al Hajjery, OM, Majdi G and Beshyah SA. Meeting Report: Sheikh Khalifa Medical City
Medicine Update 2007, Hilton Hotel, Abu Dhabi, UAE. 24-26th April 2006. Libyan
Journal of Medicine. 2007 (volume 2)
Beshyah S and Salhin AA. (Guest Supplement Editors). Supplemnt The Sixth Libyan
Diabetes and Endocrinology Conference, 28-38 April 2008, Skydome, Tripoli, Libya.
Libyan Journal of Medicine. 2008 (volume 3)
Beshyah SA. Libyan Journal of Medicine: Achievements and challenges. (Letter)
Libyan Journal of Medicine. Libyan J Med. 2008 Dec 1;3(4):204-5.
Salhin A, Besheya TA, Beshyah SA. Conference Report: The Seventh Libyan Diabetes
and Endocrinology Conference (LDEC2009), April 7-9, 2009 Tripoli, Libya. Ibnosina
Journal of Medicine and Biomedical Sciences Vol 1, No 3 (2009)
Elamami A, Gad S, Beshyah SA. The fourth annual conference of the Arab Association
for the Study of Diabetes and Metabolism (AASD); 1820 November, 2009, Cairo
Sheraton Hotel, Cairo Egypt. Ibnosina Journal of Medicine and Biomedical Sciences
Vol 2, No 2 (2010)
Salhin A, Beshyah S. Abstracts of the 7th Libyan Diabetes and Endocrinology
Conference. Ibnosina Journal of Medicine and Biomedical Sciences 2009; 1(1): 25-43
Salhin AA, Eltabal SA, Habeb AM, Beshyah SA. Abstracts of the Eighth Libyan
Diabetes and Endocrinology Conference. Ibnosina Journal of Medicine and
Biomedical Sciences. 2010; 2(5): 212-236
Beshyah SA, Deeb A. Excellence in Diabetes and Endocrinology 2010. Ibnosina
Journal of Medicine and Biomedical Sciences 2010; 2(6): 294-306
Beshyah SA. Book Review: Textbook of Diabetes. Ibnosina Journal of Medcine and
Biomedical Sciences 2011,3(4):133-134
Patients Educational Leaflets/Booklets:
Beshyah SA. The Basic Information on Diabetes: A simplified guide for Arab diabetic
patients in Britain (Patients Information Booklet; Arabic). Arab Health Care
Foundation, London. 1996
Issam M Hajjaji & Salem A Beshyah. Guide to Diabetes in Libya (in Arabic): 2002
Media Interviews:
Interview with National Libyan Radio: Health and safety during Ramadan fasting.
1985. Broadcast divided on several episodes during the month of Ramadan 1985.
Interview with Radio Spectrum International- Arabic Services 1996: On General
Health Issues with live Q&A.
Interview with MBC Satellite TV 1997: On General Health Issues with live Q&A.
Interview on the Daily Paper Al-Sharq Al-Awsat (Arabic) on Ramadan Fasting and
Diabetes 2002.
Interview with Ghazala Magazine (Arabic): Diabetes in Libya. January 2005:
Interview with OEA Daily Paper (Tripoli, Libya) on the Diabetes in Libya, The Sixth
Libyan Diabetes and Endocrinology Conference. Oea 2008; Year 2, Number 219 Page
3. (date 5th May 2008).
Interview with Al-Bayan News Paper (Abu habi, UAE) on 16 December 2007
WORK IN PROGRESS:
1. Book: Basic Information on Thyroid Disease (Arabic); Stage 80% Complete
2. Book: Basic Information on Diabetes (Arabic) Stage 60% completion.
3. Paper: Central Hospital Abu Dhabi (1966-2008): Over 40 years of Services to
the Community. A short historical account of the journey of Central hospital.
Stage: data collection and early drafting.
4. Type 2 Diabetes: a chapter in a multi-author book Oea Medical Review
5. Causes and management of Osteoporosis: a survey of the knowledge,
attitudes and practices of physicians in the United Arab Emirates - Survey
completed; data analysed, first draft of manuscript produced.
6. Causes and management of obesity: a survey of the attitudes and practices of
physicians in the United Arab Emirates Survey completed; data being
analysed.
IX. OTHER ACADEMIC ACTIVITIES:
1. Membership of learned societies:
Member, British Diabetic Association,
Member, British Society for Endocrinology
Member, Growth Hormone Research Society
Member, British Medical Association.
Member, Arab Medical Association (UK & Ireland)
Member, ABCD: Association of British Clinical Diabetologists.
Fellow; Royal Colleges of Physicians of London
Member, Libyan Doctors Society.
Founder Member, Pan Arab Congress of Endocrinology and Diabetes
Founder Member, Libyan Association for Diabetes and Endocrinology
Full Member, Emirates Endocrine Club 2006-2008
2. I have acted as a referee for the following journals:
Chair of the Programme Organizing Committee for The Fourth, Fifth, Sixth and
Seventh Libyan Diabetes and Endocrinology Conferences.
Member, The UAE National Diabetes Committees Guidelines Advisory Group 20072008 and Reviession group 2011.
Founder Honorary Treasurer, The Libyan Association for Diabetes and Endocrinology,
Tripoli, Libya 2008-todate (two terms).
Member, The National Libyan Diabetes Care Guidelines Task Force 2008-2010.
Web master of The Libyan Association for Diabetes and Endocrinology Official Web
Site www.endodiablibya.org
Coordinator: LADE Summer School 2007-2010, a series or lectures and minisymposia organized by the Libyan Association for Diabetes and Endocrinology in
Tripoli. www.endodiablibya.org/news.html
Associate Editor, Ibnosina Journal of Medicine and Biomedical Sciences. 2010-to
date. (one term is 2 years).
SUPPORTING DOCUMENTS:
Name:
Address:
City:
JEDDAH 21433
Country:
KSA
Email:
NELNAGGAR@YAHOO.COM
Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the
purposes of Chapter business? ___ yes ___ no
Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)
___ President
___ Vice President
___ Secretary
___ Treasurer
___ Board of Director Member
CANDIDATE STATEMENT
I have the honor to apply for being one of the director group of the AACE chapter in the
GULF area since Im a member of the international committee of the AACE, Ive been
working in the field of diabetes exclusively for the last 30 years in the Kingdom of Saudi
Arabia, Ive been involved in almost all the activities taking place in the middle east, Ive
organized a lot of international conferences and symposia in the region, we carried on a
lot of professional education programs for both physicians and educators along with
training courses for diabetes nurses. Ive instituted the oldest and most reputed society
for diabetologists (Jeddah Diabetes Club) and another one (Jeddah Hypertension &
Atherosclerosis Club) which are very active in promoting updates in diabetes fields.
I have the vision that I can serve and promote AACE Gulf chapter efficiently; supported
by my long experience, extensive relations, popularity and enthusiasm, besides being a
member of the international committee of the AACE.
I have also the goal of developing professional growth in this area through providing
AACE guidance and improving quality of services for both the health care providers and
the patients.
I aim also to initiate and enhance the collaboration of the working and active societies,
associations clubs and authorities in the Gulf to work hand in hand with the AACE
chapter for improving the care of diabetics.
Again, it will be my honor and privilege to share in the Gulf chapter as a member of the
directory board.
PUBLICATIONS:
EDITOR OF JDC newsletter (monthly)
EDITOR OF JHAC newsletter (The Vessel) published monthly
EDITOR OF Mens Health newsletter (Bimonthly)
1.
2.
Saied Khader , Waleed AbdelFattah , Abdulqawi Almansari , Nabil K. Elnaggar.Safety and efficacy of
switching to biphasic insulin aspart 30/70 (BIAsp 30) under the routine diabetic care in patients with
type 2 diabetes: The IMPROVE observational study in the Gulf region. International Journal of Diabetes
Mellitus 2 (2010) 110113.
Philip Home , Nabil El Naggar , Mohammed Khamseh , Guillermo Gonzalez-Galvez,
Chunduo Shen , Praful Chakkarwar , Wenying Yangf. An observational non-interventional
study of people with diabetes beginning or changed to insulin analogue therapy in non-Western
countries: The A1chieve study. Diabetes Research and Clinical Practice,2011, 94: 352-363
3.
4.
Bassam Ben Abbas, MD, Waleed Abdel Fattah, MD, Nabil el-Nagar, MD, Magdy Abdel Fattah Abdouand, MD,
Abdulqawi Almansari, MD, Diaa Mansour Ewais, MD.Insulin detemir: Safety and efficacy of treatment with insulin
detemir in a population of people with diabetes (type 1 or type 2) in Saudi Arabia and the Gulf countries: An open
label non-interventional study on people in routine clinical diabetes treatment (The Predictive Study. The Review
of Diabetic Studies Hermansen, Lund, Clemmensen, et al.Vol. 4 No. 2 2007
5.
Nabil El Naggar, Jihad Haddad, Rachid Malek, Zanariah Hussein, JianWen Chen, Wenying YangImproved
glycaemic control in people with T2D switched from a glargine-based prandial insulin regimen to a basal-bolus
regimen with insulin detemir and insulin aspart: A1chieve data. Submitted To be presented in the EASD annual
Meeting 2012, Berlin, Germany. Control/Tracking Number: A-12-548-EASD.Tracking Number: A-12-548-EASD.
6.
El Naggar N, Soewondo P, Khamseh ME, Chen J, Haddad J. Efficacy and safety of biphasic insulin aspart 30 in
patients on prior biphasic human insulin: Data from A1chieve; a 24-week, international, prospective, multi-centre,
open-labelled, non-interventional study. Under Publication.
7.
Nabil El Naggar, Jihad Haddad, Rachid Malek, Zanariah Hussein, JianWen Chen, Wenying Yang
Improved glycaemic control in people with T2D switched from a glargine-based prandial insulin regimen to a
basal-bolus regimen with insulin detemir and insulin aspart: A1chieve data. Under Publication.
8.
El-Naggar N, Khudada K, Mariswamy N, El-Sayed H, Abdel Fattah W. Safety of Insulin Analogues in People with
Type 2 Diabetes in the Gulf region: a Subgroup Analysis from the A1chieve Study. Presented in the 3rd World
Conference of the Diabetes Asia Study Group (DASG) 2012.
CURRICULUM VITAE
PERSONAL DETAILS:
Name:
Sex:
Male
Date of Birth:
19-January-1955
Place of Birth:
Khartoum, Sudan
Nationality:
Sudanese
Marital Status:
Married
Three children (15, 13 & 11)
Address:
Mobile: 0097150-6258252
0097150-7700402
EDUCATION:
Congress High Secondary School, Omdurman, Sudan
Faculty of Medicine, University of Khartoum, Sudan
1969-73
1973-79
QUALIFICATIONS:
MB, BSc
MRCP-UK
April 1979
March 1996
CLINICAL INTEREST:
REGISTRATION:
General Medicine,
Diabetes & Endocrinology
PRESENT APPOINTMENT:
Medical Specialist & Endocrinologist,
UpToDate Medicare Centre, Dubai
Medical Specialist & Endocrinologist
Ultra Care Medical Group, Dubai
PREVIOUS APPOINTMENTS:
Staff Grade Physician
Diabetes & Endocrinology
Sunderland Royal Hospital-UK
05.08.1999-31.10.1999
01.07.1999-31.07.1999
Medical Registrar
General Medicine & Endocrinology
University Department of Medicine, Glasgow Royal Infirmary
06.08.1997-30.06.1999
05.02.1997-05.08.1997
17.09.1995-30.12.1996
24.04.1986-16.09.1995
Medical Officer
General Medicine
Soba University Hospital, Khartoum, Sudan
07.08.1985-24.11.1985
General Practitioner
Accident & Emergency Medicine
Al-Salam Hospital, Sadah, North, Yemen
19.02.1982-18.12.1984
01.07.1980-18.12.1981
01.07.1979-30.06.1980
03.07.2001-27.07.2001
23.05.1999-28.05.1999
29.07.1998-03.08.1998
POST-GRADUATE TRAININGS:
January 1985
October 1990
August 1990
October 1994
Lisboa Purtugal
Sandeigo USA
Boston US
CV RISK Management
Asia Pacific regional meeting, Istanbul,Turkey
46th Annual Meeting of EASD
Stockholm, Sweden
IDF 2009
18-22 October ,2009
2008
08 September 2006
19 May 1998
September 1997
UK EXPERIENCE:
My post in Sunderland Royal University Hospital, as Staff Grade Physician with Professor
R.L. Kennedy (Professor of Diabetes & Endocrinology) and Dr. A.J. Chapman (Consultant
Endocrinologist) in a busy Diabetes Centre and Endocrinology practice gave me good insight
in the management and care of diabetic patients. I am involved twice weekly in Diabetes New
Patient Clinic and once weekly in Diabetes Review Clinic, Diabetes Foot Clinic, Antenatal
Diabetes Clinic (joint clinic with obstetrician), Thyroid Clinic and Endocrinology Clinic. I do
Diabetics In-Patients ward round once weekly.
My post as a Medical Registrar at the University Department of Medicine, Glasgow Royal
Infirmary-General Medicine and Endocrinology, gave me good chance to practice medicine
in a very busy 920-beds teaching hospital, where I have worked with Professor J.H. Mckillop
(Professor of Medicine), Dr. J.A. Thomson (Reader in Medicine and Consultant
Endocrinologist), Dr. H.W. Gray (Consultant Physician with interest in Nuclear Medicine)
Professor G.D.O.Lowe (Professor of Vascular Medicine, Professor M. Lean (Professor of
Human Nutrition) and Dr. F. Drybrugh (Consultant Biochemist). As the specialty interests of the
Department included General Medicine, Endocrinology, Mineral Metabolism, Nuclear Medicine,
Stroke Unit, and Thrombosis/Hemophilia, I have gained tremendous experience in these
disciplines excluding nuclear medicine.
My responsibility included in-patients Care as far as their investigations, management and day
to day follow up are concerned. I also had full commitment in the Out-Patients Clinics,
including General Medicine Clinic, Thyroid Clinic, General Endocrine Clinic and Mineral
Metabolism Clinic. The Acute Medical Receiving Rota was 1 in 4, in which I was first on-call
covered by SPR and Consultant from home, responsibility here was reviewing all patients with
acute medical emergencies following referral from the community, A & E Department and the
rest of the hospital Non-Medical Departments, arranging their appropriate investigations,
performing emergency procedures and putting into action a clear management plan. I shared
Acute Receiving Duties in the CCU, once or twice every month. I did regular Independent
Ward Rounds at least twice weekly. I used to cover the wards over the week-ends once or
twice per month from home (on call).
Excellent Experience gained in dealing with all medical and cardiac emergencies, stroke
management and in general medicine. Good experience gained in management and
investigations of Thyroid Disease, Adrenal Disorders, Gonadal Dysfunction, Parathyroid
Disease, and Metabolic Bone Disease.
During my post at Roodlands and Eastern General Hospital in Edinburgh, I spent six weeks
each in Medical Unit, Geriatric Assessment and Rehabilitation Wards, Acute Admission wards at
Eastern General Hospital and the long term Residential Wards, Acute Admission wards at
Eastern General Hospital and the long term Residential Wards plus Day Hospital at Edenhall and
Eastfortune Hospitals. In the medical unit, I worked with Dr. R. J. Kellt (Consultant Physician).
I was in charge of a General Medical Ward with direct admission of medical emergencies from
the community for management and further investigations. I worked with Dr. G.B. Rhind
(Consultant Physician) looking after in-patients in the Acute Assessment and Rehabilitation
wards, long term residential wards and day hospitals. During this post, I enjoyed working as part
of a multi disciplinary team including physiotherapists, OT & social workers. Excellent
Experience gained in Geriatric Medicine.
Laboratory and X-Ray facilities and Cardiac Catheterization Laboratory. In addition to General
Medicine with Professor N McD Davidson, I rotated every four months through Cardiology,
Gastroenterology, Diabetes & Endocrinology, Respiratory Medicine, and Infectious
Diseases. There were no house physicians here, so I was first on-call (rota varied between 1:4
and 1:7), with Specialist or Consultant second on-call from home. Duties involved the
management of all medical emergencies with ICU cover (which also receives acute cardiac
emergencies), in-patient care and various specialties out-patients clinics.
I passed the MRCP Part 11 in March 1996.
In 1997, my ambition forced me to come to UK to have some experience in western medicine
and to raise my knowledge in general medicine to the highest level.
CLINICAL SKILLS:
I am competent in routine procedures, including central venous cannulation, Pleural aspiration
and drainage (fluid/air), acetic fluid drainage and lumbar puncture. I am familiar with Treadmill
Exercise Testing, Echocardiography, and Cardiopulmonary Resuscitation. I have recently
updated my ALS PROVIDER Certificate which will expire on 14/09/2000. I can perform
endotracheal intubation, and have limited experience in controlling ventilators. I am familiar
with the various Endocrinological & Mineral metabolism investigations, patients management
and long term follow up. CME is an ongoing personal goal. I have never had any difficulty
learning new techniques, and I am keen to learn all other tasks that develop in the future, which I
should think present no problems.
TEACHING EXPERIENCE:
Based in a teaching hospital (Glasgow University Medical Dept.), I gained an extensive teaching
experience.
I was involved in teaching of both undergraduate and postgraduate MRCP candidates clinical
teaching sessions. Once weekly, I used to teach the final medical students bedside clinical
methods, and another one hour session on practical procedures. I also taught the Dental medical
students bedside medical history taking. Teaching also occurred in the out-patients clinics.
I took an active part in the very successful teaching programme in GRI for candidates sitting part
11 of MRCP, involving preparation for the long and short cases and viva. Since passing the
MRCP, I have been given increasing responsibilities in teaching others and arranging teaching
programmes. I have enjoyed teaching juniors, particularly after passing the MRCP, and I am
keen to continue to do so.
Once weekly, a unit clinical meeting was held for either Case presentation, unit Research results,
Audit or X-ray meeting. I had regular presentation in these meetings.
AUDIT EXPERIENCE:
I am involved in our once weekly mineral metabolism audit in which we discuss selected
patients who imposed either diagnostic or management dilemma.
An audit for endocrinology cases is held every two months, which I also attend.
RESEARCH EXPERIENCE:
PUBLICATIONS:
An abstract: Cushings syndrome caused by CRH secretion from a carcinoid tumour?
Has been accepted for a poster presentation & published in Proceedings of the ACB
(Association of Clinical Biochemists) National Meeting, Focus 99, Manchester UK, 17-21
May 1999.
An abstract: Unnecesarry parathyroidectomy in Familial Hypocalciuric Hypercalcaemia.
A poster and publication of this research study has been presented at the Scottish Society for
Experimental Medicine meeting in Aberdeen on the 7th of May 1999.
An abstract: How useful is nuclear medicine scanning in primary hyperparathyroidism.
Accepted for poster presentation & publication at the Scottish Society for Experimental
Medicine on 7th of May 1999.
CAREER INTENTIONS:
My first aim must be to convey my experience in General medicine, Diabetes and Clinical
Endocrinology gained in UK best Hospitals in this part of the world, as I have already upgraded
my level to match that of my peers working in Western Health Care and western teaching
hospitals. I intend to join a teaching hospital if possible to provide the expertise I gained in UK
in teaching Internal Medicine to the medical undergraduate & postgraduate students. Research
in Diabetes and Endocrinology is also on of my goals under the right setting. Working both in
my chosen Subspecialty, General Medicine & having the joy of Teaching and Research will only
be the driving force for my future career intentions.
RECREATIONAL ACTIVITIES:
Computers
Reading
Exercise: Walking, jogging
REFEREE:
Provided on demand:
Provisional
Old:
Recent:
Address
City:
Doha
Country:
Email:
Qatar
ajayyousi@hmc.org.qa , aminjayyuosi@hotmail.com
2
Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the
purposes of Chapter business? ___ yes ___ no
3
Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)
___ President
___ Vice President
___ Secretary
___ Treasurer
___ Board of Director Member
GENERAL INFORMATION
Required Information:
Name:
Office address:
Office telephone:
Office fax:
Home address:
Home telephone:
Cell phone:
Beeper:
Email:
Citizenship:
If not a U.S. Citizen, do you have,
for the U.S.A., an
Immigrant visa or
Non-immigrant Visa
AMIN A.JAYYUOSI
QATAR- DOHA P.O. BOX 3050
+974-4439-2308
+974-4439-2745
QATAR-DOHA P.O. BOX 39098
+974-4411-3678
+974-5553-0236
211-0284
ajayyousi@hmc.org.qa
QATARI
Yes, I have
Optional Information:
Birth date:
Birth place:
Marital status:
Spouses name:
Childrens name and ages:
Race/Ethnicity:
B.
EDUCATIONAL BACKGROUND
Degree
M.B.B.S
MASTER PROGRAM
INTERNAL MEDICNE
JORDAN
UNIVERSITY
JORDAN
OF JORDAN
UNIVERSITY
JORDAN
Dates
attended
Year
Awarded
1971-1978
1978
1979-1982
1982
C.
1.
ROTATING INTERN
JORDAN
Dates held
UNIVERSITY 1978-1979
RESIDENT 1 IN
INTERNAL MEDICINE
RESIDENT 2 IN
INTERNAL MEDICINE
CHIEF RESIDENT IN
INTERNAL MEDICINE
2.
1980-1981
1981-1982
Dates held
Dates held
SPECIALIST INTERNAL
MEDICINE
HAMAD HOSPITAL/DOHAQATAR
HAMAD HOSPITAL/DOHAQATAR
1982-1984
HAMAD HOSPITAL/DOHAQATAR
HAMAD HOSPITAL/DOHAQATAR
HAMAD HOSPITAL/DOHAQATAR
1992-1996
SPECIALIST
ENDOCRINE &
DIABETES
CONSUALTANT C
CONSUALTANT B
CONSUALTANT A
4.
1979-1980
3.
HOSPITAL
JORDAN UNIVERSITY
HOSPITAL
JORDAN UNIVERSITY
HOSPITAL
JORDAN UNIVERSITY
HOSPITAL
1984-1992
1996-2000
2000PRESENT
Other Employment
Title
D.
1.
Licensure
a. State
JORDAN MEDICAL
LICENSE
QATAR MEDICAL
LICENSE
Number
Dates held
Date of issue
Date of last
registration
1978
TILL NOW
1982
TILL NOW
b. If no license:
1. Do you have a temporary certificate?
2. Have you passed the examination for
foreign medical school graduates?
c. DEA number (Optional):
2.
Board Certification
Full Name of Board
JORDAN BOARD OF
INTERNAL MEDICINE
3.
Board Certificate
1982
Date of Certification
1982
Malpractice insurance
Do you have Malpractice Insurance?
Name of Provider:
NO, I DONT
Member/officer
Name of Organization
Dates held
1978- PRESENT
1984- PRESENT
1989
2010
1996
2000
2007
2012
Name of award
Date awarded
1982
2007
2008
2010
2011
3
Award
DALM VII Diabetes, Obesity the Metabolic
syndrome
Doha-Qatar , March 14th -16th ,2011
Diabetes Awareness Campaign Award
G.
2011
2012
INSTITUTIONAL/HOSPITAL AFFILIATION
H.
EMPLOYMENT STATUS
Dates
1988-1992
1989-1994
2004-present
SINCE 1982
YEARLY
SINCE 1982
SINCE 1982
SINCE 1982
SINCE 1982
Date
1984-present
1984-present
Dates
1990-1992
2010-present
2011
2011
2000-present
2011-Present
2011
2011
4. Research
Description
Dates (if
Applicable)
Teaching
Clinical Care
Administration
Research
TOTAL: 100%
J.
35%
35%
10%
20%
Yes
Yes
NO
Yes
RESEARCH SUPPORT
1.
Source
Amount
27500QR
Lulwa Barakat
Duration of support
(dates)
1 year
K.
Responsibility
Dates
December 26th
2009
October 19th -20
2009
January 16th 2010
September 20th
-24th 2010
March 26th -27th
2010
September 29th
2009
January 20th
2007
November 19th
2005
1989
October 10th 12th 2008
October 30th
November 2nd
2008
May 14th 2008
November 9th
&10th 2007
May 16th-19th
2007
February 5th -7th
2009
September 2011
May 20th-21st
2011
Jun 11th 2011
October 6th 2011
October 2nd -3rd
2011
January 20th 22nd 2012
January 29th
2012
February 25th,
2011
April 30th 2011
May 5-6, 2012
May 10th, 2012
May 15, 2012
May 23-27,
2012
BIBLIOGRAPHY
4. Jayyousi A. NABIL ISSEH. Dyslipidemia in Qatari patients with noninsulin dependent diabetes, international diabetes digest. 1996. Vol.7, No.
1.
5. Jayyousi A., A.Toukan etal Trithiozine in treatment of duodenal
ulcer.Jordan Medical Journal 1984; Vol.18, No.1.
07/06/2012
Signature:
Amin A. Jayyuosi
CURRICULUM VITAE
Dr Satendra Kumar Multani
MBBS, MD (Med), DNB (Med), MNAMS,
DM (Endocrinology),FACE, MRCP-SCE(Endocrinology)
Endocrinologist / Diabetologist
Al Zahrawi Hospital ,PO Box- 5442, Al Nakheel
Ras Al Khaimah, UAE.
Adjunct Faculty, Internal Medicine, RAK MHSU,
Ras Al Khaimah, UAE.
Contact No: - + 971 50 3732514
Fax No.: +971 7 2288588
DOB- 26th April 1975
Email- satendramultani@yahoo.co.in
satendramultani@gmail.com
CARRIER OBJECTIVES:
EDUCATIONAL QUALIFICATION
QUALIFICATION
PERIOD
FROM
TO .
M.B.B.S.
(INTERNSHIP)
September
1992 to
March 1998.
MD
(General/Intern
al Medicine)
May 1998 to
April 2001
ACADEMIC
INSTITUTE
COUNTRY
YEAR
AWARDED
SSMC, APSU,
Rewa, Madhya
Pradesh
India
April, 1998
India
June, 2001
DNB
(General/Intern
al Medicine)
May 1998 to
April 2001
DM(Endocrinology)
August 2001
to July 2004
National Board of
Examinations, New
Delhi
Seth GSMC, KEMH,
Mumbai
India
September,
2003.
India
August, 2004
CURRENT POSITION
Specialist A Endocrinologist & Diabetologist
Al Zahrawi Hospital, Ras Al Khaimah, UAE.
Period From June 2005 to till date (7 years).
Currently I am working as an Endocrinologist & Diabetologist in this private hospital at Ras
Al Khaimah, UAE. I am independently responsible for managing most of the problems
related to diabetes, thyroid, hypertension, lipid disorders and adult endocrinology. I have
started the Endocrine & Diabetes department in this hospital and it is supported by state of
art laboratory.
A. I have been actively involved in Diabetes education for diabetic patients and I
have conducted various diabetes education programmes at hospital and
community level.
B. I have been regularly organizing educational programmes on Obesity Prevention
and Management for general public including my patients.
C. To update the physicians of this Emirate on Diabetes and other Endocrine related
disorders, I started the CME programmes in collaboration with AKMG, Ministry of
Health and Medical Universities. We had organized the First Annual Update on
Endocrinology and Diabetes in September 2006 in RAK. The last meeting
organized by me was on 5th March 2010 3rd Endocrine & Diabetes Update.
D. Guest speaker & chairman for various diabetes & Endocrine related CME
activities at Ras Al Khaimah, Dubai, Ajman, and Fujairah.
E. Besides these, I am constantly updating my knowledge & expertise by attending
national/ international CME programmes and conferences.
I went to this centre to work with Dr. Paresh Dandona who is the founder and director of
the department. This centre is part of a comprehensive clinical care and education
programme sponsored by Kaleida Health , the regions largest health care system and
State University of New York at Buffalo School of Medicine and Biomedical
Sciences . This centre is the regional leader in the advancement of research and
treatment for diabetes and its complication. The centre is renowned for its work on role of
oxidative stress in diabetes and effect of various antidiabetic therapies on it. The
researchers for the centre have demonstrated the unique properties of Insulin in terms of
anti-inflammatory, anti atherogenic, antifibrinoloytic actions. They have also demonstrated
the prevalence of hypogonadism in type 2 diabetes patients and its clinical importance.
It was great opportunity for me to work at this centre and the
experience that I gained as a visiting fellow was unforgettable and outstanding in terms of
learning the American standards of care for diabetes patients, the importance of
aggressive management of diabetes and its related complications, understanding &
implementing the rigorous research protocols etc.
(Fellow-Ship)
Training
(Dm)
In
Duration Three years (From 1st August 2001 to 31st July 2004)
Supervised by - Professor and Head Dr. Nalini S. Shah
Professor and Former Head Dr. Padma S. Menon
King Edward Memorial Hospital is a largest teaching and tertiary care hospital of
approximately 1800 beds established in 1926 and located in Mumbai, India. The
Endocrinology department is nationally renowned, particularly for clinical and research
activities relating to diabetes mellitus and other endocrine disorders. This department
4
handles the adult as well as Pediatric endocrine cases as one of the professors is
trained in pediatric endocrinology at UK.
Both the endocrinology consultants supervised me throughout my training at KEM
Hospital. This was evidence-based comprehensive training and it covered all the aspects
of adult and pediatric endocrinology. During this period, I gained adequate expertise in
diagnosis and management of diabetes mellitus, thyroid disorders, neuro-endocrinology,
growth and puberty disorders, intersex disorders, adrenal disorders, metabolic bone
diseases etc. During this period, I was actively involved in research, teaching & other
academic activities. I had regularly presented interesting cases, seminars & journals in
interdepartmental, intradepartmental & intercollegiate meetings. It was a comprehensive 3
years training covering all the aspects of adult and pediatric endocrinology.
2010
Emirates Endocrine Congress, December 2010,Dubai.
The International Diabetes Summit, October 2010, Dubai.
70TH Scientific Sessions ADA 25th 29th June 2010, Orlando, Florida USA.
IOF World Congress on Osteoporosis & 10TH European Congress on
Clinical & Economical Aspects of Osteoporosis & Osteoarthritis, May
2010, Florence, Italy.
19th Annual Congress of American College of Clinical Endocrinologists
(AACE), April 2010, Boston, USA.
Gulf 6th Growth Update Meeting, April 2010, Dubai, UAE.
GOLD (Global Outreach for Learning in Diabetes) meeting, Feb 2010
Dubai, UAE.
2009
AFES ASEAN Federation of Endocrine Societies, Nov 2009, Bangkok,
Thailand.
Emirates Diabetes Congress 2009, November 2009, Dubai, UAE.
Introductory Hands On Thyroid Ultrasound Workshop at Endo Society
meeting 8th June 2009, Washington DC.
91ST ENDO Society Meeting 9 13th June 2009 Washington DC.
69TH Scientific Sessions ADA 5th 9th June 2009, New Orleans, USA.
7th Gulf Heart Association Conference, 9-11th April, Dubai, UAE.
GOLD (Global Outreach for Learning in Diabetes) meeting, 21-22nd March
2009, Istanbul, Turkey.
Mayo Clinic Endocrine update 2009 (in Collaboration with Al Noor
Hospital) 18-20th March, Abu Dhabi, UAE.
5
TEACHING EXPERIENCE
I have been actively involved in teaching throughout my post graduation, specialist
registrar training and after that till date. Currently I am holding the teaching post at RAK
Medical & Sciences University since last 3 yrs. My total teaching experience after post
graduation is around 8 years.
RESEARCH EXPERIENCE
I have been actively involved in research activity after registration for post
graduation to till date. It was a part of my training during MD and DM and I have done
following prospective studies during my training :
A. During post graduation- Vitamin C (Ascorbic acid) estimation in serum and
gastric juice in patients infected with Helicobacter pylori.
B. During Endocrinology Fellowship Training - Study of Bone Mineral Density and
effect of Various Environmental factors on it, in resident doctors working at
Teaching Hospital.
C. During Current Employment: Currently I am involved in research activities in
collaboration with RAK Medical & Health Sciences University and have presented
papers in various International Conferences.
Multani SK, Sarathi V, Shivane V, Bandgar TR, Menon PS, Shah NS. Study of
bone mineral density and effect of various environmental factors on it, in resident
doctors working at a teaching hospital. J Postgrad Med Jan2010 Vol 56 Issue 1.
LICENSURES
A R Seth award for Year 2004 for best paper presentation at annual Conference
of Endocrine Society of India.
Nominated for A.V. Gandhi Award For Excellence In Endocrinology in India, 2004.
REFERENCES
1. Dr. Paresh Dandona,
MD,Dphil,FRCP,FACP.FACE,FACC
Founder & Director
Diabetes- Endocrinology Centre of
Western New York
Kaleida Health
3 Gates Circle, Buffalo, NY (USA)
14209
Off- 1716 8874069
Fax- 1716 887 4773
Email- PDandona@KaleidaHealth.Org
3. Dr. Ajay Chaudhuri
MD, MRCP(UK)
Assistant Director
Diabetes- Endocrinology Centre of
Western New York
Kaleida Health
3 Gates Circle, Buffalo, NY (USA)
14209
Off- 1716 8874069
Fax- 1716 887 4773
Abu Dhabi
Country:
Email:
2
Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the
purposes of Chapter business? ___ yes ___ no
3
Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)
___ President
___ Vice President
___ Secretary
___ Treasurer
____ Board of Director Member
Candidate Statement
Dear Sir/Madam,
I would like to congratulate all Endocrinologists in the Gulf region for this
great opportunity to have a Chapter Board of Directors in this part of the
world.
By nominating myself to be a member of this prestigious scientific Board, it
gives me a chance to help other colleagues in the field of Diabetes &
Endocrinology to get linked to latest scientific developments, national and
International meetings, research opportunities, and further career
development.
This goes in line with the countrys general mission in encouraging
scientific advances, and to have representatives from the local medical
circle in international scientific bodies like the American Association of
Clinical Endocrinologists, particularly women physicians from the Gulf
region who proved their success in leadership positions.
I believe with my modest expertise, good communication skills, and my
devotion and dedication, I would serve positively on the Gulf Chapter Board
of Directors.
Kind regards,
CURRICULUM VITAE
Dr. Huda Ezzeddin Ibrahim Mustafa
MSc. MRCP (Endocrine & Diabetes), ECNU
Personal Details
Date Of Birth
31 May, 1970
Address
Nationality
Marrital status
Married
Telephone
(Work)
(mobile)
P.O.Box: 45620
Abu-Dhabi, U.A.E.
hezzeddin@hotmail.com
hmustafa@skmc.ae
++ 9712 8191307
++ 97150 6156923
Qualifications
Postgraduate:
Internship: July 92 July 93. King Fahad University Hospital. Al-Khobar, SA.
Undergraduate:
Specialised skills
20 . August, 2011
Endocrine Certification in Neck Ultrasound (ECNU)
American College of Endocrinology, US
27 . June, 2008
Good Clinic Practice training. NovoNordisk.
30 . April, 2008
Certified Pump Trainer. Medtronic Minimed Paradigm Real Time System.
19 23 March, 2007
Understanding Research and Critical Appraisal in Health Care
Warwick Medical School. Coventry. UK
th
th
th
Memberships
H. Mustafa, A.P. Goldstone, S. Bloom. Long Term Follow-up of pancreatic Vipomas. The 16 .
Joint Meeting of British Endocrine Societies. April, 1997. Harrogate, UK (Poster).
H. Mustafa, S. Llahana, R. Bernsen. Glycaemic control in people with DM2 in A tertiary Centre
of the UAE: an audit of A1c in relation to different anti-diabetes management strategies. The
th
14 . Annual International Diabetes Complications Workshop in Al Ain. Faculty of Medicine &
Medical Sciences. UAE University. Al-Ain, Abu Dhabi, UAE. (April, 2009)
H. Mustafa, S. Beshyah. Lesson of the week: Not just another Hairy Woman. The seventh
th
th
Libyan Diabetes & Endocrinology Conference (CDEC 2009), 7 9 April 2009. Tripoli, Libya
(Poster 11).
Beshyah SA, Khalil AB, Benbarka MM and Mustafa HE. Hospitalization Patterns of Diabetic
Patients to a Tertiary Hospital in AbuDhabi, United Arab Emirates. Ibnosina J Med BS
2011,3(4):113-123
H. Mustafa Hirsutism in the Arab World. Pan Arab Congress of Endocrinology & Diabetes.
Beirut, Lebanon (October 2011)
th
th
Clinical Audits
Insulin PumpTherapy Audit in a Tertiary Diabetes Center SKMC. Abu Dhabi, UAE (2011-2012)
Diabetes control in type 2 DM in Primary Health Care of Abu Dhabi (UAE). (2004)
Bed occupancy rate before and after the introduction of outpatient cardiac catheterisation
service. Mafraq Hospital, Abu Dhabi. UAE (2001-2003)
Staff compliance with registration of pre and post cardiac catheterisation checklists. Mafraq
Hospital, Abu Dhabi, UAE (2003)
Country:
Qatar
Email:
mahmoudzirie@usa.net
Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the
purposes of Chapter business? ___
yes
___ no
Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)
___ President
___ Vice President
___ Secretary
___ Treasurer
___
CURRICULUM VITAE
Name: Mahmoud
A. Zirie, MD
A. GENERAL INFORMATION
Office Address:
Office Telephone:
(974)44392488, 44392434
Office Fax:
(974) 44392745
Home Address:
Home Telephone:
(974) 44868436
Cell Phone:
(974) 55564898
Beeper:
2231198
Email:
mzirie@hmc.org.qa
mahmoudzirie@usa.net
Citizenship:
Jordan
B. DEGREES :Degree
Dates attended
Year Awarded
MBBS
School Of medicine,
Jordan university
Amman- Jordan
1973-1980
1980
CERTIFICATION
Name of specialty
Board Certificate #
Date of Certification
Nov. 1997
Aug. 1994
Mar. 1988
Oct. 1987
May 1986
June 1993
Nov. 1990
July
1990
C. BIBLIOGRAPHY
Peer Reviewed Articles
1. "Plantar Temperature Response toWalking in Diabetes with and without Acute
Charcot: The Charcot ActivityResponse Test (CART)," by Bijan Najafi, James
Wrobel, Gurtej Grewal, Robert Menzies, Talal Talal, Mahmoud Zirie and David G.
Armstrong . Accepted for publication in Journal of Aging Research.
2. High Prevalence of the ApoE Arg145Cys Dyslipidemia At-risk Polymorphism in
African- derived Population (submitted for publication) Maen D. Abou Ziki*1,2,
Yael Strulovici-Barel*1, Neil R. Hackett1, Juan L. Rodriguez-lores1, Jason G.
Mezey1,3, Jacqueline Salit1, Sharon Radisch1, Charleen Hollmann1, Lotfi
houchane2, Joel Malek2, Mahmoud A. Zirie4, Amin Jayyuosi4, Antonio M. Gotto,
Jr5, and Ronald Crystal1,5 (1Department of Genetic Medicine ,Weill Cornell
Medical College ,New York, New York,2Department of Genetic Medicine,Weill
Cornell Medical College Qatar 3Department of Biological Statistics and
Computational Biology ,Cornell University , Hamad Medical Corporation
,5Department of Medicine ,Weill Cornell Medical College New York, NY )
3. Quantitative Proteomic And Metabolomic Profiling By UPLC-MS/MS Confirms
Altered Pathways In Diabetes", in the HUPO2010 Sydney, AU.
Authors: *Prabhjit Kaur and *Nasser Rizk (*Equal Contri-bution), Sereen
Ibrahim, Prabhdeep Cheema, Kathryn Sheikh, Mahmood Zirie, Amrita KCheema
4. The utility of an electronic adherence assessment device in type 2 diabetes
mellitus: a pilot study of single medication
Nadir Kheir1, William Greer2, Adil Yousif3, Hajer Al-Geed1, Randa Al
Okkah1, Mahmoud Zirie4, Amy Sandridge5, Manal Zaidan6
1College of Pharmacy, 2Sidra Medical and Research Centre,
3Department of Statistics, College of Arts and Sciences, Qatar
University, 4Hamad General Hospital, Hamad Medical Corporation,
Doha, Qatar; 5Private Research Consultant, 6Al Amal Cancer Centre,
Hamad Medical Corporation, Doha, Qatar, Dove press Journal : Patient
Preference and Adherence July 2010, Volume 2010:4 Pages 247 - 254
13. Intelligent Diabetes Assistant: Using Machine Learning to Help Manage Diabetes
Duke D.L., Thorpe C., Mahmoud M, Zirie M. Camegie Mellon Univ. Qatar
Campus, Doha. Computer System and Applications, 2008 AICCSA 2008
IEEE/ACS International Conference. April 2008(913-914).
14. Metabolic Syndrome and its components among Qatari population. Musallam M ,
Bener A, Zirie Mal-Gaud Y, Al-Hamaq A, Othman M, Tewfiq I. Int. J. Food
Safety, Nutrition and Public Health, Vol. 1, No.1,2008 (88-102).
15. Lipids, Lipoprotein (a) profile and HbA1c among Arabian Type 2 diabetic patients.
Abdulbari Bener, Mahmoud Zirie , Mohammed H. Daghasg, Abdulla O.A.A Al
Hamaq, Ghazi Daradkeh, Ammar Rikabi. Biomedical Research 2007; 18 (2): 97102.
16. Prevalence and predictors of osteoporosis and the impact of life style factors on
bone mineral density; Abdulbari Bener, Mohammed Hammoudeh and Mahmoud
Zirie; APLAR J. of Rheeumatology 2007; 10: 227-233
17. Lipoprotein profile in Arabian type 2 diabetic patients. Relationship to coronary
artery
diseases. Daghash MH,Bener A,Zirie M,Dabdoob W,Al-Hamaq AO,AlArabi ZA. Int. J Cardiology. 2007 Sep 14; 121(1):91-2...
18. Erectile dysfuncion in men with and without type 2 diabetes mellitus. Bener A,Alansari A,Zirie M,Al-HamaqAO,Janahi I,Mohammed H S.Current Urology 2006
19. Which Comes First- Renal dysfunction or High Blood Pressure?: Elevated Blood
Pressure and Risk of End- Stage Renal Disease in subjects without Baseline
Kidney Disease.(Hsu CY, McCulloch CE,, Zirie M,. Van der Woude FJ) J Am
Soc Nephrol 16:2817-2820,2005
20. Carnosine as a protective factor in diabetic nephropathy: Association with a
leucine repeat of the carnosinase gene CNDP1. Bart Janssen .Mahmoud
ZirieFokko J.van der Woude. Diabetes 2005, 54:2320-2327.
21. Bone density measured by dual energy x-ray absorptiometry in Qatari women,
(Mohammed Hammoudeh, Mohammed Al-Khayarin,Mahmoud Zirie, Abdulbari
Bener), [maturitas.2005 Nov-Dec; 52(3-4)319-27.Epub 2005 Jul 1].
22. Is obesity a protective factor for osteporosis. ( Abdulbari BENER, Mohammed
HAMMOUDEH, Mahmoud ZIRIE, Richard HELLER). Aplar Journal of
Rheumatology 2005; 8: 32-38).
23. Genetics, Obesity and Environmental risk factors associated with type 2 diabetes.
(Abdulbari Bener, Mohamoud Zirie, Ammar Al-Rikabi.), [Croat Med J. 2005 Apr;
46(2):302-7 ].
24. Zinc states in type 2 DM. and its relation to glucose and lipids profile. ( Gazi
Daradkeh, Mahmoud Zirie, Amine Jayyousi, I. Mohammad, B. Al-Owainati, M.
Daghash , M. Othman), [ completed, to be submitted for publications].
25. First documented case of conns syndrome in Hamad Medical Corporation. ( Dr.
Sara Darwish, Mahmoud Zirie, Issam A. Al- Bozom ).Qatar medical journal
5
Mahmoud
Zirie,MD.
Ibrahim Janahi,MD
.Sara
Darwish,MD.
.photographed book for Diabetes, an educational book directed to Diabetic
patients. Published by Hamad Medical Corporation, Doha-Qatar, April
2008
6
Dates
1. In USA
FELLOWSHIP:
RESIDENCY:
PGY I Resident
Internal Medicine
Michigan State University
Hurley Medical Center
Flint, MI 48503
2. Outside USA
Rotating Internship
Jordan University Hospital
Amman Jordan
Resident
Internal Medicine
Jordan University Hospital
Amman Jordan
Resident
Internal Medicine
Hamad General Hospital
Doha Qatar
Dates
Consultant,
Hamad Medical Corporation (HMC)
Head\Endo.Diab .and Doha Qatar
metabolism
Consultant,
HMC
Endocrinology,
Doha Qatar
Diabetes
and
Metabolism
Senior Specialist
HMC
Endocrinology,
Doha Qatar
Diabetes
and
Metabolism
Specialist
Endocrinology,
Diabetes
Metabolism
July 88 Feb.90
July 86 June 88
July 96-April 97
March 90 June
92
and
Specialist
Internal Medicine
Academic Position
Assistant Professor of Medicine -Weill Cornell Medical College in Qatar
E. Licensure
State
Number
Date of Issue
Missouri - USA
106733
Aug.03.94
Valid
Jan.31.2013
DEA
Qatar
BZ 4223830
4597
10/11/2009
present
through
Name of Organization
Dates held
May
2000
present
Jan.
2000
present
April
1998-May
2000
April
1995Jan.2000
July
1992-April
1995
July 1980
present
May
1986
present
Aug.1996-present
Date awarded
April 2007
Nov. 2005
Feb., 2002
April 06 - 10
,2002
13.
WHO work shop on training the trainers, HMC, Doha- Dec. 22 - 26,
Qatar
2000
14.
First
Qatar
International
Oncology
Conference Nov. 18 20,
Management of Breast, Colon, Thyroid and Lymphoma in the 1999
New Millennium, Doha Qatar.
15.
Qatar Diabetes Association.
Participation in the Dec. 12. 1999
leadership Assessment Workshop on childhood and Adolescent
Diabetes.
16.
Qatar Diabetes Association. Participation in the activities Nov. 13 - 18,
during Diabetes Week.
1999
17. The Environment Friend Center, Doha Qatar
March 22 -26,
1998
18.
Arab Board of Internal Medicine, Doha Qatar
Sep. 1998
19.
Qatar Diabetes Association. Diabetes and Human Rights, Nov. 14- 16, 1998
Doha Qatar.
20. Qatar Diabetes Association Volunteers day, Doha Qatar.
Dec. 05, 1998
21. Youth and Sports Association. Umsalal Youth Center, Doha - Nov. 18, 1998
Qatar.
22. Hamad Medical Corporation Public Relations; Diabetes Jan. 01, 1997
TV Program. Doha Qatar.
H. Institutional/Hospital Affiliation
Primary Hospital Affiliation:
Other Hospital Affiliations:
Other Institutional Affiliations:
11
Title
Head
of
Endocrinology, Diabetes
Division
Hamad Medical Corporation
Doha Qatar
and
Date
Metabolism April 1997- present
Committees:
Efforts
Current percent effort
Teaching
Clinical Care
Administration
Research
Total
20%
50%
10%
20%
100%
1. Body Worn Sensor Technology for improving diabetic care during activity of
Daily living. [Proposal No. : NPRP 08 -499-3-109 Funded by QNRF second
cycle]. Dr. Mahmoud A. Zirie, consultant Endocrinology\Diabetes ,Hamad
Medical Corporation Prof. David Armstrong ,University of Arizona-USA Dr.
Bijan Najafi, Rosalind Franklin University ,North Chicago-USA
2. System approach towards diabetes research using molecular profiling tools.
[Proposal No. : NPRP 08-740-3-148 Funded by QNRF second cycle].
Dr.Mahmoud A.Zirie,consultant Endocrinology\Diabetes ,Hamad Medical
Corporation Dr.Nasser Rizk Md, PhD who is a Professor of physiology and
endocrinology at the Qatar
University Dr. Amrita K. Cheema in the
department of Oncology in Georgetown University, Washington D.C. USA.
3. Collection of Blood for Gene Expression/Genomic Studies in Individuals
with Diabetes (Qatar) Ronald G. Crystal, MD Genetic Medicine (WCMC
NY and Qatar) and Medicine (WCMC NY Lotfi Chouchane, PhD Genetic
Medicine (WCMC Qatar) Mahmoud Zirie, MD Head of Endocrinology,
HMC Amin Jayyousi, MD Consultant Endocrinology, HMC Ibrahim
Mohammed, MD Consultant Endocrinology, HMC
4. Characterization of Metabolic Defects in Arab and Mexican American
Subjects at Increased Risk of Type 2 Diabetes Dr. Mahmoud Zirie-HMC Dr.
Muhammed Abdulghani-Texas University USA (NPRP 4-247-3-076 Funded
by QNRF)
5. Metabolic Syndrome in patients receiving antipsychotics in the Qatari and
Kuwaiti population Dr. Mahmoud Zirie, Dr. Hassan Al Amin WCMC-Qatar
(NPRP 4-267-3-085 Funded by QNRF)
K. Abstract:
Zirie, M, Mohammed, I, El-Emadi M, Haider, A. Multiple Endocrine Neoplasia Type
2A: The role of genetic study. 24 28 Oct. 2000. Amman Jordan.
Zirie, M, Griffing G, University of Missouri-Columbia. Ret-Proto-Oncogen in
hereditary Medullary Thyroid Carcinoma. Hamad Medical Corporation, Doha
Qatar, April 6-8, 1996.
Zirie M, Griffing G, University of Missouri-Columbia. Carbamazepine interfering
with 24-hour urine free cortisol. American College of Physicians, Missouri Regional
Meeting, September 29 - October 1, 1995, Lake Ozark, Missouri.
Thanigari S, Zirie M, Horowitz S, Carmigniani S, Griffing G, University of MissouriColumbia. Thyrotoxic periodic paralysis with painless thyroiditis. American College
of Physicians, Missouri Regional Meeting, September 29 October 1, 1995, Lake
Ozark, MO.
Zirie M, Setter M. Michigan State University, Hurley Medical Center, Flint.
Theophylline toxicity and the use of hemodialysis. American College of Physicians,
40th annual Michigan Scientific Meeting, September 22 25, 1994, Grand Traverse
Village, Michigan.
Zirie M, Setter M, Michigan State University Center, Flint. Theophylline toxicity
and the use of hemodialysis. American College of Physicians, 16th Annual Associates
Meeting, May 6, 1994. Flint, Michigan.
M. Conferences:
1. AACE 21st Annual Scientific & Clinical Congress, May 2327,2012.Philadelphia,PA-USA
2. 47th Annual Meeting of the. European Association for the Study of
Diabetes(EASD) 12 - 16 September 2011 Lisbon Portugal.
3. XVII International DALM symposium on Diabetes, Obesity, and the
Metabolic Syndrome, March 14-16,2011 Doha-Qatar
4. First International AACE Conference on Diabetes, Obesity and Other
Endocrine Diseases
The American Association of Clinical Endocrinologists (AACE), in
collaboration with Hamad Medical, Inc, in Qatar, the Qatar Diabetes
Association and the Qatar Foundation, is organizing the First
International AACE Conference on Diabetes, Obesity and Other
Endocrine Diseases to be held at the Sheraton Convention Center in
Doha, Qatar from January 14-16, 2011. (Dr. Mahmoud Zirie, speaker &
Chairman of organizing committee)
5. The 3rd Congress of the Jordanian Society of Endocrinology, Diabetes &
Metabolism (JSED) , The 2nd Joint JSED-AACE Congress & The 9th
Congress of the Pan Arab Society of Endocrinology & Diabetes (PASED).
On May 3-7 2010 Amman Jordan.
6. Secondary Prevention in Diabetes, 2nd Diabetes Asia study Group (DASG)
International Conference, on March 26-27, 2010. [Speaker]
7. The 3rd international Gulf Group for the Study of Diabetes Conference
Feb. 9-11, 2010 , kingdom of Saudi Arabia Jeddah
8. American Association of Clinical Endocrinologists 1st International
Diabetes course in Qatar Module V- March 6th , 2010 [Speaker]
16
19
20
21
Secretary / Treasurer
Candidates
1. Wiam Ibrahim Hussein, MD FACE FACP; Bahrain
2. Khalid Faiq Mohammed Salih, MD FACE; UAE
CURRICULUM VITAE
NAME:
ADDRESS:
P.O.Box 16165
Adliya, Manama
Kingdom of Bahrain
(00973) 39726000
(Mobile)
(00973) 17239200
drwiam@hotmail.com
Fax:
E-mail:
PRESENT POSITION
10/2007-present
I am the Chair, Steering members of the AACE Gulf Chapter and had worked for the last year with
USA- AACE to get their approval for this Gulf Chapter hoping to continue as Secretary/Treasurer
in the Gulf Chapter.
khalid_gittaa@yahoo.com
2
Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the
purposes of Chapter business? _yes__ yes ___ no
3
Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)
___ President
___ Vice President
___ Secretary
yes___ Treasurer
___ Board of Director Member
Curriculum Vitae
Name:Khalid Faiq Mohammad Salih.
Family name: KASHIF AL-GITTAA
Date of Birth: July, 29/1963.
Nationality: Iraqi
Passport No:G1510929
Postal address: United Arab Emirates.Abu
Dhabi,P.OBox:30666
E-Mail Address: khalid_gittaa@yahoo.com
Telephone : mobile
:00971555504255,ground:0097126396002,
Fax: 0097126720900
Qualifications
20.Attend
and
participating
in
RESEARCH PROJECTS:
1. PRIMARY SUBSTERNAL ABERRANT THYROIDS IN IRAQ.
2006
2... Recurrent Laryngeal Nerve Injury is no more a Major
complication in thyroid surgery by using Intracapsular and
Infracapsular resections.2003..
3. The effect of Response of cAMP to TSH stimulation in
Benign and Malignant thyroid gland tumors the activity of
Adenylate cyclase in these tumors. 2001. Published recently.
4.Unusual presentations of Hashimotos thyroiditis in Iraq
.1999.published
5. Stab wounds accidents in Al-Najaf, Morbidity and
Mortality. 1996. published.
6.Lower Urinary tract injury associated with Pelvic
fractures , a prospective study.1997.published.
LOCAL COURSES AND MEETINGS:
1`.Participate in the second national meeting of
Surgery in Iraq from 11-12/12/2002
2. Participate in first national meeting of Surgery from 1416/9/2000.
3. Participate in fourteenth meeting of Cancer in Iraq
from 7-9/3/2000
4. Participate in first meeting of Iraqi society of Surgeon
from 13-14/10/1999.
5. Passes successfully the program of the ways of
teaching in Al-mustansirya university from 1.8.1998 to
26.8.1998.
TEACHING EXPERIENCES:
1.Lecturer in General Surgery in Al-Mustansirya college of
Medicine/Baghdad/Iraq. From Oct.1997 till now teaching from
third year up to sixth year medical students, in clinical bases
and in theory, in addition in putting questions and in
examinations, candidate to assistant prof. in the department of
Surgery.
2. Lecturer in General; Surgery in Kufa college of
Medicine, in Najaf, from Dec.1994 to Oct.1997.
REFEREES:
Vice President
Candidates
1. Ali Saeed Alzahrani, MD FACE; KSA
2. Ali Barnard Khalil MD, FACE; UAE
Ali S. Alzahrani
Address:
City:
Riyadh, 11211
Country:
Saudi Arabia
Email:
aliz@kfshrc.edu.sa az.kfsh@gmail.com
2
Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the
purposes of Chapter business? _X yes ___ no
3
Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)
___ President
__X_ Vice President
___ Secretary
___ Treasurer
___ Board of Director Member
Curriculum Vitae
ALI SAEED ALZAHRANI, MD, FACE
Updated: 01 August 2012
I.
Saudi
Marital Status
Postgraduate Training
1989 1990
1990 1995
IV.
CERTIFICATIONS
March 1994
April 1994
1996
June 1997
V.
VI.
Professional Experience
1998-2000
2000-Present
Consultant Endocrinologist
Department of Medicine
King Faisal Specialist Hospital & Research Centre
Riyadh, KSA
2001-2002
Acting Chairman
Department of Medicine,
King Faisal Specialist Hospital &Research Centre
Jeddah, KSA
2003-2006
Deputy Chairmen
Department of Medicine
King Faisal Specialist Hospital & Research Centre
Riyadh, KSA
2003
1995-1997
Former member of The Medical and Surgical Association of the Johns Hopkins
University
1996-present
2000-present
2000
2000
2003
VII.
May 2002
May 2003
May 2004
May 2006
VIII.
1999-2001
1999- 2001
2000-Present
1998-2001
2001-2002
2001-2002
2001-2002
2001-2002
2001-2002
2001-2002
2001-2002
2001-2002
2001-2002
2001-2002
2001- 2005
2002- Present
2000-Present
2002-2004
2002-Present
2002-2004
2002-Present
2002-Present
2003-2005
2004-Present
2004-Present
2002-2004
2004-Present
March 2006-present
- Present
- Present
Feb 2007-2007
03 April - present
Advanced Cardiac Life Support (ACLS), King Faisal Specialist Hospital & Research
Centre (KFSH&RC), Riyadh, KSA
November 1990
May 1991
December 1992
December 1993
November 1994
June 1995
September 1995
June 1995
November 1996
November 1996
April 1997
June 1997
June 1998
April 1999
October 1999
November 1999
the First National Thyroid Cancer Program Symposium, KFSH&RC, Riyadh, KSA
February 2000
May 2000
June 2000
October 2001
Saudi Preparatory Course Part II for Internal Medicine, King Fahad National Guard
Hospital, Riyadh, KSA
January 2002
February 2002
March 2002
Organizational Politics for PE, online course, as part of ongoing accreditation for The
American College of Physician Executives.
April, 2002
April 2002
May 2002
July 2002
Oxford Teaching Evidence Based Medicine Course 2002, Oxford, United Kingdom
March 2004
Fifth Pan Arab Congress on Endocrinology and Diabetes, Riyadh, Saudi Arabia.
June 2004
June 2004
June 2004
Feb 2005
March 2005
April 2005
June 2005
Oct 2005
June 2006
Sept 2007
June 2008
March 2009
June 2009
1. Bibliography
1.1 Invited Lectures
1.1.1
Ali S. Alzahrani. Medullary Thyroid Cancer; Screening, Diagnosis, and Follow Up. The First
National Thyroid Cancer Program Symposium, 21-23 November 1999, King Faisal Specialist
Hospital & Research Centre, Riyadh, Kingdom of Saudi Arabia.
1.1.2
Ali S. Alzahrani. Tutor, Intensive Review Course in Internal Medicine, King Fahad Specialist
Hospital, 03 February 2000, Buraidah, Qassim.
1.1.3
1.1.4
Ali S. Alzahrani. Tutor; Intensive Course in Internal Medicine, King Fahad National Guard
Hospital, 23 August 2000, Riyadh, Saudi Arabia.
1.1.5
Ali S. Alzahrani. Thyroid Cancer. Medical Grand Rounds, King Faisal Specialist Hospital,
Jeddah, 6 September 2000, Jeddah, Saudi Arabia.
1.1.6
Ali S. Alzahrani. Management of Thyroid Cancer and Thyroid Nodules, Thyroid Disorders
(symposium) Bisha, September 28th, 2000.
1.1.7
Ali S. Alzahrani. Hypertension: Difficult Cases. DM, Dyslipidemia, HTN (symposium). October
2000, Dubai, UAE.
1.1.8
Ali S. Alzahrani. Endocrine Hypertension. DM, Dyslipidemia, HTN (symposium). October 2000,
Dubai, UAE.
1.1.9
Ali S. Alzahrani. Management of Thyroid Cancer. 2nd National Thyroid Cancer Program
Symposium, Ajiad General Hospital, 5-6 November 2000, Makkah.
1.1.10 Ali S. Alzahrani. Management of Thyroid Nodules. 2nd National Thyroid Cancer Program
Symposium, Ajiad General Hospital, 5-6 November 2000, Makkah.
1.1.11 Ali S. Alzahrani. Tutor, Intensive Review Course in Internal Medicine, King Fahad Specialist
Hospital, 3 February 2001, Buraidah, Qassim.
1.1.12 Ali S. Alzahrani. Advances in Thyroid Cancer (state of the art lecture).
Conference, 25-28 October 2001, Damascus, Syria.
1.1.13 Ali S. Alzahrani. How to Approach a Patient with Goiter. Thyroid Diseases Workshop for
General Surgery Residents. King Faisal Specialist Hospital & Research Centre, Jeddah, 10 January
2002.
1.1.14 Speaker- Osteoporosis Workshop, King Fahad National Guard Hospital, Jeddah, 10 Oct 2003
1.1.15 Residents Lecture: Thyroid, Men & Adrenal, King Faisal Specialist Hospital & Research Centre.
17 October 2002.
1.1.16 Examiner, Intensive Internal Medicine Review Course, King Khalid National Guard Hospital
(KKNGH), Jeddah, 12-26 Oct 2002.
1.1.17 Speaker, Non-Communicable Diseases Symposium, Management of HTN in Diabetes & Medical
Management of Obesity, Makkah, 21 Oct 2002.
1.1.18 Speaker, 1st Osteoporosis Scientific Day, National Guard Health Affairs, Riyadh, 24 Oct 2002.
1.1.19 A Speaker & Chairman, One day symposium on Diseases of World Economy, Diabetes, Obesity,
And Hypertension, Arab Health Conference, Dubai, January 2003.
1.1.20 Invited speaker, Management of Hypertension in Diabetes Mellitus, King Abdulaziz University
Hospital, 06 Jan 2003.
1.1.21 Examiner, Intensive Review Course in Internal Medicine, King Fahad Specialist Hospital,
Buraidah, Al Gassim, KSA, 15 Jan 2003.
1.1.22 Speaker, Medical Grand Rounds, Department of Medicine, Stem Cell and Therapeutic Cloning.
The Future of Medicine, 17 Feb 2003.
1.1.23 Speaker, Meet the Expert: Diabetic Nephropathy, 1st Saudi Diabetes Congress SDC, King
Abdulaziz University Hospital, 09 April 2003.
1.1.24 Speaker, 6th Gulf Group for the Study of Diabetes GSSD, Jeddah Kingdom of Saudi Arabia, 2122 May 2003.
1.1.25 Examiner, Clinical and oral exam for Fellowship Program, King Khaled University Hospital,
Riyadh, 04 June 2003.
1.1.26 Speaker, Evaluation and Management of Infertile Male, The Endocrinologist approach, Urology
Department, KFSH&RC, Riyadh, 25 June 2003.
1.1.27 Presenter, Simply unexpected, Medicine Case Presentation, KFSH&RC, 24 Sept 2003.
1.1.28 Presenter, Following a Standard approach: it pays off, Medicine Case Presentation, Department
of Medicine, KFSH&RC, 24 Sept 2003.
1.1.29 Lecturer, 10-Day Subspecialty Review Course, Department of Medicine, KFSH&RC, 10-19 Sept
2003
1.1.30 Examiner, Intensive Internal Medicine Review Course, King Abdulaziz Medical City, Jeddah, 04
October 2003.
1.1.31 Speaker, Combined Adult/Peds Endocrine Rounds, Department of Medicine, KFSH&RC,
Wednesday, 08 October 2004
1.1.32 Examiner, Saudi Board Clinical Course in Internal Medicine, Riyadh Armed Forces Hospital, 15
Dec 2003.
1.1.33 Lecturer, 9th Review Course in Internal Medicine, 17 December 2003, Buraidah, Qassim.
1.1.34 Examiner, Final Saudi Board Clinical Examination, December 2003, Riyadh.
1.1.35 Speaker and Temporary adviser- the Regional Consultation on Hypertension Prevention and
control, World Health Organization, Abu-Dhabi, UAE, 20-22 December 2003
1.1.36 Speaker, Management of Hypertension in DM, World Health Organization, Abu Dhabi, UAE,
February 2004.
1.1.37 Speaker, Issues in the follow-up to Thyroid Cancer, Fifth Pan Arab Congress on Endocrinology
and Diabetes, Riyadh, Saudi Arabia, 28 February 2 March 2004.
1.1.38 Speaker, Hypertension in Diabetes, Fifth Pan Arab Congress on Endocrinology and Diabetes,
Riyadh, Saudi Arabia, 28 February 2004.
1.1.39 Speaker, Primary Hypeparathyroidism: Medical VS Surgical Management, The International
Conference on Advances in Internal Medicine, King Abdulaziz National Guard Medical City,
Jeddah, 16-17 March 2004.
1.1.40 Speaker, Management of Osteoporosis, The International Conference on Advances in Internal
Medicine, King Abdulaziz National Guard Medical City, Jeddah, 16-17 March 2004.
1.1.41 Speaker, Islet Cell Transplantation & Stem Cell Research in Diabetes, Recent Advances in
Diabetes Symposium, Jeddah, 22 March 2004.
1.1.42 Speaker and temporary adviser, Management of Male Osteoporosis: Practical considerations,
World Health Organization, Beirut, Lebanon, 06-08 May 2004.
1.1.43 Presenter, F-18 Fluorodeoxyglucose Positron Emission Tomography (PET) in the Follow-up of
Differentiated Thyroid Cancer (DTC), 6th RPG Day, 24 May 2004, KFSH&RC
1.1.44 Speaker, A Lecturer, 6-Day Subspecialty Review Course, Department of Medicine, King Faisal
Specialist Hospital & Research Centre. 14 September 2004.
1.1.45 Lecturer, Review of Endocrinology, Intensive Internal Medicine Review Course, King Khaled
National Guard Hospital, Jeddah, 15 September 2004.
1.1.46 Speaker, How to manage the bad couples diabetes and obesity, 9th World Diabetes DayProfessional Program, Four Seasons Hotel by King Abdulaziz University Hospital, Riyadh, 25
November 2004.
1.1.47 Speaker, Long-Term Follow-up of Thyroid Ca, Thyroid Seminar, King Abdulaziz University
Hospital, Riyadh, 04 January 2005.
1.1.48 Speaker, Medical Grand Rounds: Thyroid Cancer: A Local and International Perspective,
Department of Medicine, KFSH&RC, 21 February 2005.
1.1.49 Speaker, Saudi Guidelines for Management of Hypertension, 2nd London Symposium on
Vascular Biology of Atherosclerosis and its Impact in Clinical Practice. London, United Kingdom,
27 February 2005
1.1.50 Speaker, Update on Thyroid Cancer, Department of Medicine, Riyadh Military Hospital, 30
March 2005.
1.1.51 Grand Round, Thyroid Cancer: A Perspective from another continent John Hopkins Hospital,
Baltimore, Maryland, 13 April 2005.
1.1.52 Speaker, Thyroid Cancer in Saudi Arabia, King Fahad National Guard Hospital, Riyadh, 21 April
2005.
1.1.53 Speaker, Department of Medicine Case Presentation: Common and Rare, King Faisal Specialist
Hospital & Research Centre, 15 June 2005.
1.1.54 Invited Speaker, Designing the Research, Summarization of Data and the Testing Differences
Between Two Groups, King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia,
14-15 September 2005.
1.1.55 Invited Speaker, 8th Saudi/Arab Board Preparatory Course for Internal Medicine Part II, King
Abdulaziz Medical City, Postgraduate Training Centre, Riyadh, Saudi Arabia, 17-21 Sept 2005.
1.1.56 Invited Speaker, Insulin Therapy in Type 2 Diabetes, International Diabetes Day, King
Abdulaziz Medical City, Riyadh, 23-24 November 2005.
1.1.57 Invited Speaker, Risk Factors for Cardiovascular Disease in Saudi Arabia, 2 nd Partners
International Symposium on Cardiovascular Disease, Dubai, 7-8 December 2005.
1.1.58 Invited Speaker, An update in the management of Thyroid Cancer, 3rd Diabetes Educator
Course, King Faisal Specialist Hospital & Research Centre, Jeddah, 18 April 2006.
1.1.59 Case Presentation, the Mid-Liner and Revisiting a given Diagnosis: A Rewarding Outcome,
Department of Medicine, King Faisal Specialist Hospital & Research Centre, 26 April 2006.
1.1.60 Invited Speaker, Management of Hypertension in Diabetes Mellitus. The National Hypertension
Symposium, Jubail, Saudi Arabia. 30 May 2006.
1.1.61 Invited Speaker, Hypertension Co-morbidities, The National Hypertension Symposium, Jubail,
Saudi Arabia. 31 May 2006.
1.1.62 Invited Speaker, Management of Hyperthyroidism. Health Outreach Locum Program, King Fahad
Hospital, Al Baha. 08-28 July 2006.
1.1.63 Invited Speaker, Endocrine Case, Health Outreach Locum Program, King Fahad Hospital, Al
Baha. 08-28 July 2006
1.1.64 Invited Speaker, Management of hypertension in diabetes.
King Fahad Hospital, Al Baha. 08-28 July 2006
1.1.65 Speaker, General Endocrinology MCQs, 6-Day Subspecialty Review Course, Department of
Medicine, King Faisal Specialist Hospital & Research Centre.
1.1.66 Invited Speaker, Endocrinology Review, 9th Saudi/Arab Board Preparatory Course for Internal
Medicine Part II. National Guard Health Affairs, King Abdulaziz Medical City. 19 September
2006.
1.1.67 Invited speaker, Insulin Therapy in Type 2 DM, Intensive Diabetes Course for Physicians.
National Guard Health Affairs, King Abdulaziz Medical City. 24 January 2007.
1.1.68 Speaker, Pheochromocytoma: Local experience & A Man with abdominal and brain Tumors.
Medical & Surgical Aspects of Neuroendocrine Disorders Symposium. King Faisal Specialist
Hospital & Research Centre, Riyadh, Saudi Arabia, 03-04 April 2007.
1.1.69 Invited speaker, Differentiated thyroid cancer; a Middle East perspective. First Joint JSEDAACE Congress Amman, Jordan. 17 May 2007.
1.1.70 Invited speaker, Co-morbidities: DM and Dyslipidemia, The First training course on the
implementation of the Saudi Hypertension Management Guidelines, Mecca Almudarama, Mecca,
30 May 2007.
1.1.71 Invited speaker, Diagnosis beyond doubt in endocrinology: role of molecular biology. 8th Pan
Arab congress on Endocrinology and Diabetes (PACED 8), Kuwait, 07-12 Nov 2007.
1.1.72 Invited Speaker, Management of Hypercalcemia, 8th Acute Medicine Symposium, Riyadh
Military Hospital, Riyadh, Saudi Arabia. 27 November 2007.
1.1.73 Invited speaker, Epidemiology of Diabetes in Saudi Arabia, 7th IEA-EMPO Scientific Meeting "
Epidemiology": Translating Research to Health Care", Epidemiology Workshop, Research Centre,
King Faisal Specialist Hospital & Research Centre, Riyadh. 27 Nov 2007.
1.1.74 Invited speaker, Management Approach (How to switch from oral hypogyny to insulin therapy,
Part I). 1st course of prevention & management of heart disease and its risk factor in Family
Medicine setting. King Abdulaziz Medical City, Riyadh, Saudi Arabia, 28 November 2007.
1.1.75 Invited speaker, Management Approach (How to switch from oral hypogyny to insulin therapy,
Part II). 1st course of prevention & management of heart disease and its risk factor in Family
Medicine setting. King Abdulaziz Medical City, Riyadh, Saudi Arabia, 29 November 2007.
1.1.76 Invited speaker, Endocrinopathies associated with HIV/AIDS, Fourth Annual HIV/AIDS
Workshop. Department of Medicine, King Faisal Specialist Hospital & Research Centre. 01
December 2007.
1.1.77 Lecturer: A Glance at the Nucleus, Wednesday Case Presentation: Department of Medicine,
KFSH&RC. 09 January 2008.
1.1.78 Invited speaker: Disorders of Vit D Deficiency-beyond the bone Second Annual Endocrine
disorders Conference, King Fahad Medical City. 27 Feb 2008.
1.1.79 Invited speaker: Thyroid Cancer, Internal medicine Update 2008. King Saud University,
Riyadh, Saudi Arabia. 05 March 2008.
1.1.80 Invited speaker: Management of thyroid nodules, Update in Diabetes & Endocrinology
Symposium, Madinah, KSA. 22-23 March 2008.
1.1.81 Invited speaker: Update in Thyroid Cancer Management, Update in Diabetes & Endocrinology
Symposium Medina, KSA.22-23 March 2008.
1.1.82 Invited speaker: Non-Surgical Treatment for Obesity, Update in Diabetes & Endocrinology
Symposium, Medina, KSA.22-23 March 2008.
1.1.83 Invited speaker: Insulin therapy in Type 2 DM, 5th Diabetes Educators Course, Postgraduate
Training Center, National Guard Hospital. 05 April 2008.
1.1.84 Invited speaker: 2nd Diabetes & Endocrinology Symposium. King Abdulaziz hospital & Oncology
Center, Jeddah, KSA, 26-27 August 2008.
1.1.85 Speaker: Pheochromocytoma: An Ever Fascinating Tumor, Medical Grand Rounds, Department
of Medicine, KFSH&RC, 20 Oct 2008.
1.1.86 Invited speaker: Pheochomocytoma, Family Medicine Educational Meeting, KFSH&RC,
Riyadh, 11 November 2008.
1.1.87 Speaker Endocrine Case Discussion, Dammam Central Hospital, Health Outreach Services, 13
May 2009.
Muhammad M. Hammami, Ali S. Alzahrani, Abdul I. Butt, M. Phil, Leticia J. Vencer, Syed S.
Hussain. Primary Hyperparathyroidism and Polyostotic Fibrous Dysplasia: A mild Variant of the
McCune Albright Syndrome (poster). The Endocrine Society Meeting, Washington, DC, 1995.
1.2.2
Zainab Muttair, Ali S. Alzahrani. Thyroid Lymphoma: Clinical, Pathological and Therapeutic
Data of a Large Series (poster). The annual meeting of the American Association of Clinical
Endocrinologists, San Diego, California, USA, 1999.
1.2.3
Majid Al Mandil, Ali S. Alzahrani, Mohammed Ahmed. The frequency and predictive factors of
malignancy in the residual thyroid tissue after partial thyroid surgery in patients with differentiated
thyroid cancer (poster). The Endocrine Society Meeting, Toronto, Ontario, Canada.
1.2.4
Ali S. Alzahrani, Majid Al Mandil, Seima Bakheet, Abdalraof Almahfouz. A High Concordance
Between Pretreatment Diagnostic Whole Body Scan (DXWBS) Using Iodine 123Isotope and Post
Therapy Iodine 131 Whole Body Scan (TXWBS) in Differentiated Thyroid Cancer (poster). The
Endocrine Society Meeting, Toronto, Ontario, Canada.
1.2.5
Alya Al-Hajjaj, Mohammed Ahmed, Ali S. Alzahrani, The Molecular Genetics, Clinical &
Histopathological Findings in Medullary Thyroid Cancer Patients: King Faisal Specialist Hospital
& Research Centre Experience (poster). The Endocrine Society Meeting, Toronto, Ontario, Canada,
2000.
1.2.6
Ali S. Alzahrani, Hussein Raef, Ali Sultan, Saif Al Sobhi, Stig Ingemansson, Mohammed Ahmed,
Abdulraof Almahfouz. Impact of Second Surgery on the Serum Thyroglobulin (TG) and the Course
of the Disease in Patients (pts) with Papillary Thyroid Cancer (PTC) Who Have Elevated TG
Levels, Negative Diagnostic Radioactive Iodine Whole Body Scan (DXWBS) and
Recurrent/Persistent Disease Limited to the Neck (oral presentation). The Endocrine Society
Meeting, Toronto, Ontario, Canada, June 2000.
1.2.7
1.2.8
Ali S. Alzahrani, Alya al-Hajjaj. Severe Hypertension Secondary to Renal Artery Stenosis and
Cushings Syndrome in a Single Patient (poster). The Endocrine Society Meeting, Toronto,
Ontario, Canada, June 2000.
1.2.9
Ali S. Alzahrani, Siema Bakheet, Majid Al Mandil, Alya Al-Hajjaj, Abdulraof AlMahfouz,
Abdallah al Haj. 123I Isotope as a diagnostic agent in the follow up of patients with differentiated
thyroid cancer:
Comparison with post therapy 131I Whole Body Scanning (speaker).
Medical/Surgical Treatment of Thyroid Disorders in the Kingdom of Saudi Arabia (symposium),
King Faisal Specialist Hospital & Research Centre, 12-14 February 2001.
1.2.10 S. Bakheet (speaker), Ali S. Alzahrani. Role of FDG-PET scanning in the Management of Thyroid
Cancer: KFSH&RC Experience. Medical/Surgical Treatment of Thyroid Disorders in the Kingdom
of Saudi Arabia, King Faisal Specialist Hospital & Research Centre (symposium), 12-14 February
2001.
1.2.11 Ali S. Alzahrani, Majid Al Mandil, Mohammed Ahmed, Gamal Eldin H. Mohammed. The
Frequency and Predictive Factors of Malignancy in Residual Thyroid Tissue After Partial Thyroid
Surgery in Patients with Differentiated Thyroid Cancer (speaker). Medical/Surgical Treatment of
Thyroid Disorders in the Kingdom of Saudi Arabia, King Faisal Specialist Hospital & Research
Centre, 12-14 February 2001.
1.2.12 Ali S. Alzahrani. Medullary Thyroid Carcinoma (speaker). Medical/Surgical Treatment of
Thyroid Disorders in the Kingdom of Saudi Arabia, King Faisal Specialist Hospital & Research
Centre, 12-14 February 2001.
1.2.13 Ali S. Alzahrani, Hussein Raef, Ali Sultan, Saif Al Sobhi, Stig Ingemansson, Mohammed Ahmed,
Abdulraof Almahfouz. Impact of second surgery on the serum thyroglobulin (TG) and the course of
the disease in patients with papillary thyroid cancer (PTC) who have elevated TG level, negative
diagnostic radioactive iodine whole body scan (DXWBS) and recurrent/persistent disease limited to
the neck (speaker). Medical/Surgical Treatment of Thyroid Disorders in the Kingdom of Saudi
Arabia, King Faisal Specialist Hospital & Research Centre, 12-14 February 2001.
1.2.14 M. Ahmed, Al. Alarifi, A. Almahfouz, Ali S. Alzahrani, A. Al Sugair, and S. Al Sobhi. PET
Scanning in adrenal cortical carcinoma (ACC). Presented at the Endocrine Society 83 rd Annual
Meeting, Denver, Colorado, 20-23 June 2001.
1.2.15 M. Ahmed, A. Alarifi, A. Al Hajjaj, A. Almahfouz, and Ali S. Alzahrani. Hemosiderin
endocrinopathies (HE) in patients with -Thalassemia major (TM). Submitted to the Endocrine
Society 83rd Annual Meeting to be held in Denver, Colorado, USA 20-23 June 2001.
1.2.16 Ali S. Alzahrani. Stem Cells Technology (speaker). Stem Cell Symposium. King Faisal Specialist
Hospital & Research Centre, Jeddah, Kingdom of Saudi Arabia, 6 August 2001.
1.2.17 Ali S. Alzahrani. Frequency of Malignancy in the Contralateral Lobe After Partial Thyroidectomy
(poster). Third Pan Arab Conference, Damascus, Syria, 25-28 October 2001.
1.2.18 Ali S. Alzahrani, Saif Al Sobhi, Hamad Al Suhaibani. Preoperative Ultrasound-Guided Surgical
Approach for Residual/Recurrent Differentiated Thyroid Cancer. Annual Endocrine Society
Meeting, San Francisco, USA June 2002.
1.2.19 Ali S. Alzahrani, Afaf Al Shammary, Bakir Bin Saddiq. Predictive Factors of Elevated
Thyroglobulin (Tg) and Negative Diagnostic Radioiodine Whole Body Scan in Differentiated
Thyroid Cancer (DTC). Annual Endocrine Society Meeting, San Francisco, USA June 2002.
1.2.20 Ali S. Alzahrani, Hassan Al Eid, Hussain Raef, Fouad Al Dayel. Pheochromocytoma: TwentyYear Experience. Annual Endocrine Society Meeting, San Francisco, USA June 2002.
1.2.21 Ali S. Alzahrani, Salwa B Alaidarous. Operating on Empty Sella for Cushings Disease: The
Value of Inferior Petrosal Sinus Sampling. Annual Endocrine Society Meeting, San Francisco,
USA June 2002.
1.2.22 Ali S. Alzahrani. Kallmanns Syndrome Presenting with Ambigious Genitalia. Annual Endocrine
Society Meeting, San Francisco, USA June 2002.
1.2.23 Ali S Alzahrani. Serum thyroglobulin at the first follow-up visit after radioactive iodine ablation
predicts the long-term course of differentiated thyroid cancer: Do we need repeated scanning? , 5th
Annual Research Promotion Day, Department of Medicine, KFSH&RC, Riyadh 27 May 2003.
1.2.24 Ali S Alzahrani. Pre-operative Neck Ultrasound Mapping for persistent/recurrent papillary thyroid
cancer. 5th Annual Research Promotion Day, Department of Medicine, KFSH&RC, Riyadh 27 May
2003.
1.2.25 Ali S Alzahrani. Sensitive assay for the determination of fluvastatin in Plasma utilizing highperformance liquid chromatography with fluorescence detection. 5th Annual Research Promotion
Day, Department of Medicine, KFSH&RC, Riyadh 27 May 2003.
1.2.26 Ali S Alzahrani. The value of high resolution ultrasonography in diagnosing recurrent persistent
differentiated thyroid carcinoma. 5th Annual Research Promotion Day, Department of Medicine,
KFSH&RC, Riyadh 27 May 2003.
1.2.27 Ali S Alzahrani. Generating an answerable questions. Evidence-Based Medicine Workshop. 2829 May 2003. King Faisal Specialist Hospital & Research Centre, Riyadh, KSA.
1.2.28 Ali S Alzahrani. Evidence-Based Medicine; Diagnosis. Evidence-Based Medicine Workshop. 2829 May 2003. King Faisal Specialist Hospital & Research Centre, Riyadh, KSA.
1.2.29 Ali S Alzahrani. How to search for Evidence. Evidence-Based Medicine Workshop. 28-29 May
2003. King Faisal Specialist Hospital & Research Centre, Riyadh, KSA.
1.2.30 Yufei Shi, Ali Alzahrani, Ranjit S Parhar, Minjing Zou. Gene Therapy for Anaplastic Thyroid
Carcinoma with a single Chain Interleukin 12 Fusion Protein. Presented at the 6 th Annual Research
Celebration Day, 24 May 2004. King Faisal Specialist Hospital & Research Centre. WinnerSecond Best score.
1.2.31 A Almahfouz, E Alfadhli, M Ahmed, H Raef, and A Alzahrani. Factors Predictive of Clinical
Responses to Pioglitazone in Uncontrolled Diabetic Patients. Presented at the 6th Annual Research
Celebration Day, 24 May 2004, King Faisal Specialist Hospital & Research Centre.
1.2.32 H Raef, H Al Suhaibani, A Alzahrani and M Ahmed. The Value of Ethanol Injeciton of local
Metastasis in the Treatment of Differentiated Thyroid carcinoma. Presented at the 6th Annual
Research Celebration Day, 24 May 2004, King Faisal Specialist Hospital & Research Centre.
1.2.33 M Mehthel, M Ahmed, A Alzahrani, A Almahfouz, A Alarifi, and H Raef. Metabolic Bone
Disease as a Clue to the Dx of Celiac Disease. Presented at the 6th Annual Research Celebration
Day, 24 May 2004, King Faisal Specialist Hospital & Research Centre.
1.2.34 Yufei Shi, Ranjit S Parhar, Minjing Zou, Essa Baitei, Ali Alzahrani, Futwan Al Mohana, Nadir R
Farid. Gene Therapy of Anaplastic Thyroid Carcinoma with a Single Chain Interleukin-12 Fusion
Protein. Presented at the Endocrine Society 85th Annual Meeting of the Endocrine Society, held in
Philadelphia, June 2003.
1.2.35 A Alzahrani, E Ba Essa, and N Al Juhani. Comparison of Familial and Sporadic Types of
Papillary Thyroid Cancer. Presented at The Endocrine Societys 86th Annual Meeting, New Orleans,
Louisiana, USA, 16-19 June 2004.
1.2.36 S Abdel Salam, M Mehthel, and A Alzahrani. Persistent Hypertension Following Complete
Resection of Extra Adrenal Pheochromocytoma (Paraganglioma). Presented at The Endocrine
Societys 86th Annual Meeting, New Orleans, Louisiana, USA, 16-19 June 2004.
1.2.37 A Alzahrani, S Abdel Salam, S Bakheet, G Mohammed, B Al Matouq and H Raef. Comparison F18-Fluorodeoxyglucose Positron Emission Tomography with Post I131 Therapy whole Body Scan
in Thyroglobulin-Positive, Scan-Negative Differentiated Thyroid Cancer. Presented at The
Endocrine Societys 86th Annual Meeting, New Orleans, Louisiana, USA, 16-19 June 2004.
1.2.38 A Alzahrani, M Al Mehthel, S Abdel Salam, A Almahfouz, and H Raef. A rare cause of
undetectable serum thyroglobulin in scan-positive widespread metastatic follicular thyroid cancer.
Presented at The Endocrine Societys 86th Annual Meeting, New Orleans, Louisiana, USA, 16-19
June 2004.
1.2.39 M Al Mehthel, S Abdel Salam, and A Alzahrani. Four months of inhospital management of severe
refractory hypocalcemia following parathyroidectomy of a single parathyroid adenoma. Presented
at The Endocrine Societys 86th Annual Meeting, New Orleans, Louisiana, USA, 16-19 June 2004.
1.2.40 A Alzahrani, G Mohamed, S Abdel Salam, S Bakheet, H Raef, and S Al Sobhi. F-1Fluorodeoxyglucose positron Emission Tomography (PET) in the follow-up of differentiated
thyroid cancer (DTC). Presented at The Endocrine Societys 86th Annual Meeting, New Orleans,
Louisiana, USA, 16-19 June 2004.
1.2.41 A Alzahrani, H Al Suhaibani, S Al Sobhi, S Al Sifri, G Mohamed, and M Akhtar. Accuracy of
Neck Ultrasonography in Predicting the presence of persisten/recurrent (P/R) differentiated thyroid
cancer. Presented at The Endocrine Societys 86th Annual Meeting, New Orleans, Louisiana, USA,
16-19 June 2004.
1.2.42 H Bin Yousef, A Alzahrani, S Al-Sobhi, H Al suhaibani, M Chaudhari and H Raef. Pre-operative
Neck Ultrasound Mapping for Persistent/Recurrent Papillary Thyroid Cancer. Presented at the
Annual Meeting of Endocrine surgeons Uppsala, Sweden, June 2004
1.2.43 Alzahrani A, Abdel Salam S, Mohammed G, Bakheet S and Raef H. The role of 18FFlourodeoxyglucose Positron Emission Tomography (PET) in the Initial Evaluation of
Differentiated Thyroid Cancer. International Congress of Endocrinology, Lisbon, Portugal, 31 Aug
04 Sept 2004.
1.2.44 Ali Alzahrani, Suzan Abdel Salam, Gamal Mohammed, Ayman Rifai, Othman Solaiman and
Abdulaziz Al Sugair. F-18-Fluorodeoxyglucose Positron Emission Tomography (PET) in the initial
evaluation of Differentiated thyroid Cancer (DTC): Comparison with Diagnostic Radioiodine
Whole Body Scan (DxWBS). Submitted to The Endocrine Societys 87th Annual Meeting, San
Diego, 04-07 June 2005.
1.2.45 Ali Alzahrani, Othman Solaiman, Suzan Abdel Salam, and Gamal Mohammed. Serum
Thyroglobulin at the First Follow-Up Visit after Radioiodine (RAI) Remnant Ablation Predicts the
long-term Course of Differentiated Thyroid Cancer (DTC). Presented at the Endocrine Societys
87th Annual Meeting, San Diego, 04-07 June 2005.
1.2.46 Ali Alzahtrani, Abdulrahman Kabbani, Suzan Abdel Salam and Ayman Rifai. Recombinant TSHstimulated I131 Therapy of Highly Functioning Skeletal Metastases of Follicular Thyroid Cancer:
Acute Thyroid Hormone Changes and Risk of Hyperthyroidism. Presented at the Endocrine
Societys 87th Annual Meeting, San Diego, 04-07 June 2005.
1.2.47 Othman Solaiman, Ali Alzahrani, Ayman Rifai and Suzan Abdel Salam. F-18-Flourodeoxyglucose
Positron Emission Tomography (PET) is more sensitive than post I131 therapy whole body scan in
Tg-positive, Scan negative Papillary Thyroid Cancer (PTC). Presented at the Endocrine Societys
87th Annual Meeting, San Diego, 04-07 June 2005.
1.2.48
Ali Alzahrani, Suzan Salam, Gamal Mohammed, Ayman Rifai, Othman Solaiman, Maha Al
Fehaily, And Saif Al Sobhi. F-18 Flourodeoxyglucose Positron Emission tomography (PET) in the
initial Evaluation of differentiated Thyroid Ca (DTC): Comparison with Histopathological
Examination of Subsequent Surgery. Presented at the Endocrine Societys 87 th Annual Meeting,
San Diego, 04-07 June 2005.
1.2.49 Almahfouz A, Alfadhli E, Ahmed M, Alzahrani A, and Raef H. Factors Predictive of Clinical
Responses to Pioglitazone in Uncontrolled Diabetic Patients. Presented at the Endocrine Societys 87th
Annual Meeting, 4-7 June 2005.
1.2.50 O Demirkaya, A Rifai, and A Alzahrani. Quantification of Tumor Lesions in Whole Body Positron
Emission Tomography Images. Presented as Oral Presentation- Annual Congress of the European
Association of Nuclear Medicine, Istanbul, Turkey. 18 October 2005.
1.2.51 Ali S Alzahrani, Essa Biatie, Yufei Shi and Minging Zou. Thiamine Transporter Gene Mutations:
an example of Monogenic Diabetes Mellitus. Presented to Endocrine Societys 88th Annual
Meeting, Boston, USA, 24-27 June 2006.
1.2.52 Ali S. Alzahrani, Hamad Al-Suhaibani, Gamal Mohammed, Saif Al Sobhi and Suzan Abdel Salam.
How Accurate is the radiologists impression of the nature of ultrasonographic findings detected during
the follow-up of differentiated thyroid cancer. Presented to Endocrine Societys 88th Annual Meeting,
Boston, USA, 24-27 June 2006.
1.2.53 Ali Alzahrani, Khalid Abu-Amero, Minjing Zou and Yufei Shi. Germline Mitochondrial DNA
Mutations in Multiple Endocrine Neoplasia Type 2a. Presented to Endocrine Societys 88th Annual
Meeting, Boston, USA, 24-27 June 2006.
1.2.54 Mohammed Sheef and Ali Alzahrani. Severe Primary Hyperparathyroidism masked by
Asymptomatic Celiac Disease. Presented to Endocrine Societys 88th Annual Meeting, Boston,
USA, 24-27 June 2006.
1.2.55 Summaya Eskandarani, Abdulraof AlMahfouz, Ali Alzahrani. An Unusual Cause of Ectopic
Adrenocorticotrophic Hormone (ACTH) Secretion: Cushings Syndrome Secondary to Prostate
Cancer. Presented at the 9th Annual Research Celebration Day, Department of Medicine, King
Faisal Specialist Hospital & Research Centre. 29 May 2007.
1.2.56 Nojoud Al Khaldi, Saleh Al-Ahmad, Ali Alzahrani. Diagnosis by Serendipity: Cushing's syndrome
Secondary to Cortisol-producing Adrenal Adenoma as the Presenting Feature of Multiple Endocrine
Neoplasia Type 1 (MEN 1). Presented at the 9th Annual Research Celebration Day, Department of
Medicine, King Faisal Specialist Hospital & Research Centre. 29 May 2007.
1.2.57 Ali Alzahrani1, Minjing Zou2, Essa Baitei2, Brian Meyer2, and Yufei Shi2. Frequent BRAF V600E
Mutation and its Association with Aggressive Behavior of Papillary Thyroid Carcinoma. Presented at
the 9th Annual Research Celebration Day, Department of Medicine, King Faisal Specialist Hospital
& Research Centre. 29 May 2007.
1.2.58 Omalkhair AlShaikh, MD, Ali Alzahrani. Multiple Paraganglioma Syndrome: a Skull Base
Paraganglioma Masquerading as Nasopharyngeal Cancer. Presented at the 9th Annual Research
Celebration Day, Department of Medicine, King Faisal Specialist Hospital & Research Centre. 29
May 2007.
1.2.59 Ali S. Alzahrani, Mohei-eldin M. Abouzeid, Suzan Abdel Salam, Gamal Mohamed, Ayman Rifai,
Abdulaziz Al Sugair, MD, Tarik Amin. The Role of F-18-Fluorodeoxyglucose Positron Emission
Tomography in the Initial Evaluation of Differentiated Thyroid Cancer. Presented at the 9th Annual
Research Celebration Day, Department of Medicine, King Faisal Specialist Hospital & Research
Centre. 29 May 2007.
1.2.60 Mohamed Al Harthi, Saud Al Harthi, Ali Alzahrani. Pheochromocytoma/Paragangliomas: A Study
of Cases Seen At KFSHRC over the Last Decade. Presented at the 9th Annual Research Celebration
Day, Department of Medicine, King Faisal Specialist Hospital & Research Centre. 29 May 2007.
1.2.61 Omar Al-Nozha, MD, Talal Dahan, MD, Ahmed Nazmi, MD, Ali Alzahrani. The Clinical,
Pathological and Outcome Profile of Thyroid Cancer in Saudi Arabia. Presented at the 9th Annual
Research Celebration Day, Department of Medicine, King Faisal Specialist Hospital & Research
Centre. 29 May 2007.
1.2.62 Ali S. Alzahrani and Mohei-eldin M. Abouzeid. The Potential Role of F-18-Flourodeoxyglucose
Positron Emission Tomography in the Work up of Adrenal Nodules. Presented at the 9th Annual
Research Celebration Day, Department of Medicine, King Faisal Specialist Hospital & Research
Centre. 29 May 2007.
1.2.63 Ali S Alzahrani. The Potential Diagnostic and Prognostic Role of F-18-Fluorodeoxyglucose
Positron Emission Tomography in the Initial Evaluation of Differentiated Thyroid Cancer. 32nd
Annual Meeting of the European Thyroid Association. Leipzig. 01-05 Sept 2007.
1.2.64 Ali Alzahrani, Muhammad Faiyaz-Ul Haque, Mohammed Tulaimat and Fouad Al Dayel. Multiple
paraganglioma Syndrome secondary to mutation in succinate dehydrogenase Type D. Presented at
the 10th Annual Research Celebration Day, Department of Medicine, King Faisal Specialist Hospital
& Research Centre. 06 May 2008. (Podium presentation)
1.2.65 Ibrahim Madhkali, Rafif Farhat, Jalaluddin Bhuiyan, Kim Nicholson, Shaikhah Al-Moussa and Ali
Alzahrani. A new approach to the diagnosis of thyrotoxicosis facticia: Measurement of stool
thyroxine level. Presented at the 10th Annual Research Celebration Day, Department of Medicine,
King Faisal Specialist Hospital & Research Centre. 06 May 2008.
1.2.66 Ali Alzahrani, Mohei-eldin Abouzeid, Suzan Salam, Gamal Mohammed, Ayman Rifai, Abdulaziz
Al sugair and Tarek Amin. Accuracy of F-18-Fluorodeoxyglucose Positron Emission Tomography
in Predicting Residual Cancer after Incomplete Thyroidectomy for Differentiated Thyroid Cancer.
Presented at the 10th Annual Research Celebration Day, Department of Medicine, King Faisal
Specialist Hospital & Research Centre. 06 May 2008.
1.2.67 Mashaal Al Mowanya, and Ali Alzahrani. An Unusual multiplicity and aggressiveness of tumors
in mulitple endocrine neoplasia type 1. Presented at the 10th Annual Research Celebration Day,
Department of Medicine, King Faisal Specialist Hospital & Research Centre. 06 May 2008.
1.2.68 Rafif Farhat, Fatma Al Zidjali and Ali Alzahrani. Outcome of treatment of male infertility due to
hypogonadotrophic hypogonadism with gonadotrophins. Presented at the 10th Annual Research
Celebration Day, Department of Medicine, King Faisal Specialist Hospital & Research Centre. 06
May 2008.
1.2.69 Ali Alzahrani, Mohei-eldin Abouzeid, Suzan Salam, Gamal Mohammed, AymanRifai, Abdulaziz
Al-Sugair and Tarek Amin. Accuracy of F-18-Fluorodeoxyglucose Positron Emission tomography
in predicting residual cancer after incomplete thyroidectomy for differentiated thyroid cancer:
radiopathological correlation study. Accepted for presentation at the Endocrine Societys 90th
Annual Meeting. San Francisco, USA, 15-18 June 2008.
1.2.70 Mohammed Al-Harthy, Saud Al Harthy and Ali Alzahrani. Comparison of head and neck
paragangliomas with below neck paraganglioma/pheochromocytomas. Accepted for presentation at
the Endocrine Societys 90th Annual Meeting. San Francisco, USA, 15-18 June 2008.
1.2.71 Rafif Farhat, Fatma Al Zidjali and Ali Alzahrani. Outcome of treatment of male infertility due to
hypogonadotrophic hypogonadism with gonadotrophins. Accepted for presentation at the
Endocrine Societys 90th Annual Meeting. San Francisco, USA, 15-18 June 2008.
1.2.72 Ali Alzahrani, Hindi Al-Hindi, Mohammed Amed, Hussein Raef, Tarek Amin, Nora Alkahtani,
Mohammed Tuli and Abdulraof Almahfouz. Response of liver metastases from duodenal
neuroendocrine tumor to indium-111 octreotide therapy and chemoembolization. The 6th Annual
ENETS (European Neuroendocrine Tumor Society) Conference, Granada, Spain, 5-7 March 2009.
1.2.73 Ali Alzahrani, Omalkhaire Al Shaikh, Summaya Eskandrani, Abdulraof Almahfouz and Hindi AlHindi. An unusual site and manifestation of a neuroendocrine tumor: Cushings syndrome
secondary to malignant neuroendocrine tumor of the prostate. The 6th Annual ENETS (European
Neuroendocrine Tumor Society) Conference, Granada, Spain, 5-7 March 2009.
1.2.74 Ali Alzahrani, Roua A Al Rijjal, Minjing Zou, Essa Baitei and Yufei Shi. A Novel Gene Mutation
of CYP27B1 in a large family with Pseudovitamin D Deficiency Rickets. 11th Annual Research
Celebration Day, Department of Medicine, 12 May 2009. (Oral presentation)
1.2.75 Ali Alzahrani, Rafif Farhat, Saud Al Harthi, Mohammed Al Harthi, Talal Dahhan, Omar Al Nozha
and Ahmed Nazmi. Impact of Therapeutic Interventions on the long-Term Outcome of Persistent
Differentiated Thyroid Cancer. The Endocrine Societys 91st Annual Meeting, Washington, DC,
USA, 10-13 June 2009.
1.2.76 Rafif Farhat, Abdullah Alarifi, Nora Al Kahtani, Imaddudin Kanaan, Mohei-eldin abouzeid and Ali
Alzahrani. The diagnostic Vaue of Fused Postiron Emission Tomography/computed Tomography
in the localization of Adrenocorticotropin-Secreting Pituitary Adenoma in cushings Disease. The
Endocrine Societys 91st Annual Meeting, Washington, DC, USA, 10-13 June 2009.
1.2.77 Omalkhaire Al Shaikh, Hala Aba Alkhail, Muhammad Faiyaz Ul-Hague, Mohammed Ahmed,
Mohammed Tualimat, Fouad Al Dayel, and Ali Alzahrani. RET Oncogene Mutation Screening
and Genotype Phenotype Correlation in Familial Medullary Thyroid Cancer and MEN 2 Syndrome:
Data from the Middle East. The Endocrine Societys 91st Annual Meeting, Washington, DC, USA,
10-13 June 2009.
1.2.78 Ali S Alzahrani, Reem Alamawi, Rafif Farhat, and Mohammed Tuli. Iodine-123 Isotope for
Recombinant Human Thyrotropin-Stimulated Diagnostic Whole Body Scanning in the follow-up of
Differentiated thyroid cancer. The Endocrine Societys 91st Annual Meeting, Washington, DC,
USA, 10-13 June 2009.
1.2.79 Ali S Alzahrani, Roua A Al Rijjal, Minjing Zou, Essa Baitei and Yufei Shi. A Novel Gene
Mutation of CYP27B1 in a large family with Pseudovitamin D Deficiency Rickets. The Endocrine
Societys 91st Annual Meeting, Washington, DC, USA, 10-13 June 2009.
1.2.80 Ali S. Alzahrani, Rafif Farhat, Omalkhaire Al-Shaikh, Sameerah Al-Shehri, Mohammed AlHarthy, Saud Al-Harthy, Ahmed Nazmi, Omar Al-Nozha, MD, and Talal Dahhan. Long-term
Outcome of Patients with Persistent Differentiated Thyroid Cancer Following the Initial
Management. The Endocrine Societys 92nd Annual Meeting, San Diego, California, USA. 19-22
June 2010.
1.2.81 Ali S. Alzahrani, Minjing Zou, Nora Al-Kahtani, John KAmartey, Essa Y Baitei, Hussein Raef,
Roua Al-Rijjal, Abdulraof Almahfouz, Ranjit S Parhar, Futwan A Al-Mohanna, Brian Meyer, and
Yufei Shi, MD. A Novel Biallelic Mutation in the Insulin Binding Domain of the Insulin Receptor
Causing Severe Insulin Resistance Syndrome in Five Unrelated Saudi Families; A Possible Founder
Mutation. The Endocrine Societys 92nd Annual Meeting, San Diego, California, USA. 19-22 June
2010.
1.2.82 Ali S. Alzahrani, MD, Omalkhaire Alshaikh, MD, Sameerah Al-Shehri, and Rafif Farhat.
Radioactive Iodine (I-131) Therapy for Thyroglobulin Positive, Scan Negative Differentiated
Thyroid Cancer. The Endocrine Societys 92nd Annual Meeting, San Diego, California, USA. 19-22
June 2010.
1.2.83 Ali S. Alzahrani, Minjing Zou, Essa Baitei, Roua Al-Rijjal, MD, Omalkhaire Al-Shaikh, and Yufei
Shi. A Novel Biallelic R94G Mutation of the Steroid 5-Reductase-2 (SRD5A2) Gene in Two
Unrelated Cases of 46XY Male Pseudohermaphordite. The Endocrine Societys 92nd Annual
Meeting, San Diego, California, USA. 19-22 June 2010.
Ali S. Alzahrani and Saeed Bohlega. Chorea and high antiphospholipid antibodies: probable
primary antiphospholipid syndrome. Eru J Neurol 1995; 2:363-367.
1.3.2
Ali S. Alzahrani, Michael A. Levine. Primary Hyperparathyroidism (review). The Lancet 1997;
340:1233-1238.
1.3.3
1.3.4
Muhammad M. Hammami, Ali S. Alzahrani, Abdul I. Butt, M. Phil, Leticia J. Vencer, Syed S.
Hussain. Primary Hyperparathyroidism-Associated Polyostotic Fibrous Dysplasia: Absence of
McCune Albright Syndrome Mutations. J. Endocrinol Invest 1997; 20:552-558.
1.3.5
Jehad Al-Watban, Ali S. Alzahrani, Zoltan Patay, and Maher Hassounah. Pits, Patches, and
Protuberances. Int J. Neurorad 1999; 5:133-135.
1.3.6
Ali S. Alzahrani. Insulin Resistance, Metabolic Diseases and Diabetic Complications (book
review), Gaetano Crepaldi, Antonio Tiengo, and Stefano Del Prato (editors) 1999. Annals of Saudi
Medicine, 2000.
1.3.7
Ali S. Alzahrani (Corresponding Author), Siema Bakheet, Majid Al Mandil, Alya Al-Hajjaj,
Abdulraouf Almahfouz, and Abdallah Al Haj. I Isotope as a Diagnostic Agent in the Follow Up of
Patients with Differentiated Thyroid Cancer: Comparison with Post 131I Therapy Whole Body
Scanning. J Clin Endocrinol Metab, Nov 2001.
1.3.8
Ali S. Alzahrani (Corresponding Author), Hussein Raef, Ali Sultan, Saif Al Sobhi, Stig
Ingemansson, Mohammed Ahmed, Abdulraof Almahfouz. Impact of Second Surgery on the Serum
Thyroglobulin (TG) and the Course of the Disease in Patients with Papillary Thyroid Cancer who
have Elevated TG Level, Negative Diagnostic Radioactive Iodine Whole Body Scan (DXWBS) and
Recurrent/Persistent Disease Limited to the Neck. J. Endocrinol Invest, May 2002.
1.3.9
Ali S. Alzahrani (Corresponding Author), Majid Al Mandil, Mohammed Ahmed, and Gamal
Eldin Mohammed. Frequency and Predictive Factors of Malignancy in Residual thyroid tissue and
cervical lymph nodes after Partial Thyroidectomy for Differentiated Thyroid Cancer. Surgery,
April 2002.
1.3.10 Al-Rawithi S, Hussein RF, Alzahrani A. Sensitive Assay for the Determination of Fluvastatin in
Plasma Utilizing High-Performance Liquid Chromatography With Fluorescence Detection. .Ther
Drug Monit. 2003 Feb;25(1):88-92.
1.3.11 Hussam Bin Yousef, Ali S Alzahrani, Mohammed Ahmed, Abdullah Alarifi, Abdulraof
Almahfouz, Hussein Raef and Saif Al Sobhi. Laparoscopic VS Open Adrenalectomy: Experience
at King Faisal Specialist Hospital & Research Centre, Riyadh. Annals of Saudi Medicine, Vol 23,
Nov 1-2, 2003
1.3.12
1.3.13 Yufei Shi, Ranjit S Parhar, Minjing Zou, Essa Baitei, George Kessie, Nadir R Farid, Ali Alzahrani
and Futwan Al-Mohanna. Gene Therapy of Anaplastic Thyroid Carcinoma with a Single Chain
Interleukin-12 Fusion Protein.
Human Gene Therapy. 2003 Dec 10;14 (18) 1741-51.
1.3.14 Hussam Bin Yousef, Ali Alzahrani (Corresponding Author), Saif Al Sobhi, Hamad Al Suhaibani,
Mohammed Chaudhari, and Hussein Raef. Preoperative Neck Ultrasonographic Mapping for
Persistent/Recurrent Papillary Thyroid Cancer. World J Surg 2004 Nov;28(11):1110-4.
1.3.15 Saleh Aldasouqi and Ali S Alzahrani (corresponding author), Terminology in Diabetes Mellitus, an
example of resistance to change. Saudi Medical Journal 2004; Vol 25(9): 1289-1291.
1.3.16 Saleh Al Dasouqi, David Nkansa-Dwamena, Samia Bokhari, Ali Alzahrani, Muthaza Khan, Amal
Reffi, and Amal Merdad. Is Subclinical Hypothyroidism Associated with Hyperhomocysteinemia.
Endocrine Practice Vol 10, No.5, September/October 2004, 399-403.
1.3.17 Abu-Amero KK, Alzahrani AS, Zou M and Shi Y. High frequency of somatic mitochondrial DNA
mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines.
Oncogene, 2005 Feb 17; 24 (8) 1455-1460.
1.3.18 Ali Alzahrani (Corresponding Author), Alya Al Hajjaj, Jehad Al Watban and Imaddudin
Kanaan. Severe Hypertension Secondary to renal artery stenosis and Cushings syndrome. Saudi
Med J 2005 Apr; 26 (4).668-73.
1.3.19 Ali S Alzahrani (Corresponding Author), Hamad Al Suhaibani, Suzan Abdel Salam, Saud Al
Sifri, Gamal Mohammed, Saif Al Sobhi, Othman Al Solaiman, and Mohammed Akhtar. Diagnostic
Accuracy of High Resolution Neck Ultrasonography in the follow-up of differentiated Thyroid
Cancer: A Prospective study. Endocr Pract. 2005 May-June; 11 (3): 165-71.
1.3.20 Alzahrani AS (Corresponding Author), Al Dasouqi S, Salam SA, Sultan A. Autoimmune
Thyroid Disease with Fluctuating Thyroid Function. Public Library of Science, Medicine (PLOS
Med) 2005 May;2 (5);e89.
1.3.21 Ali Alzahrani (Corresponding Author), Mohammed G, Al Shammary A, AlDasouqi S,
AbdelSalam S, Shoukri. Long Term Course and Predictive Factors of Elevated Serum
Thyroglobulin and Negative Diagnostic Radioiodine whole Body scan in differentiated thyroid
cancer. J Endocrinol Invest. 2005 Jun; 28 (6) 540-546.
1.3.22 Alarifi A, Alzahrani A (Corresponding Author), Salam SA, Ahmed M. Repeated Remissions of
Cushings Disease Due to Recurrent Infarctions of an ACTH-Producing Pituitary Macroadenoma.
Pituitary. 2005;8(2):81-7.
1.3.23 Alzahrani, AS (Corresponding Author). Resistin: Can we resist its role in insulin resistance?
Ann Saudi Med. 2005 Jul-Aug;25(4):281-2
1.3.24 Abu-Amero KK, Alzahrani AS, Zou M, Shi Y. Association of mitochondrial DNA transversion
mutations with familial medullary thyroid carcinoma/multiple endocrine neoplasia type 2 syndrome.
Oncogene.2006 Feb 2;25 (5):677-84.
1.3.25 Ali S. Alzahrani (Corresponding Author), Gamal E. Mohamed, Ayman Rifai, Abdalaziz S. AlSugair, Suzan A. Abdel Salam, Othman M. Sulaiman, , and Omer Demirkaya. The Role of F-18Fluorodeoxyglucose Positron Emission Tomography in the Follow-up of Differentiated Thyroid
Cancer. Endocrine Practice, 2006 Mar-Apr;12 (2):152-8.
1.3.26 Ali Alzahrani, Essa Y Baitei, Minjing Zou, and Yufei Shi. Clinical Case Seminar: Metastatic
Thyroid Follicular Carcinoma arising from congenital goiter due to a novel splice donor site
mutation in the thyroglobulin Gene. J Clin Endocrin Metab 2006 Mar;91 (3):740-6.
1.3.27 Mohammed Ahmed, Haroon Faraz, Abdulraof Almahfouz, Abdullah Alarifi, Hussein Raef, Fouad
Al Dayel, Abdulaziz Al Sugair and Ali Alzahrani. A case of vitamin D deficiency masquerading
as occult malignancy. Ann Saudi Med 2006;26 (3): 231-236.
1.3.28 Alzahrani AS, Baitei E, Zou M, Shi Y. Thiamine Transporter Mutations: an example of
Monogenic Diabetes Mellitus. Eur J Endocrinol. 2006 Dec;155(6):787-92.
1.3.29 Ali S Alzahrani (Corresponding Author). (Invited Review Article) Management of hypertension
in diabetes mellitus. Experts Rev. Endocrinol. Metab 2 (3), 2007.
1.3.30 Bouchama A, Kwaasi A, Dehbi M. Al Mohanna F, Eldali A, El-Sayed R, Tbakhi A, Alzahrani AS,
Roberts AG. Glucocorticoids do not protect against the lethal effects of experimental heatstroke in
baboons. Shock. 2007 May;27(5):578-83.
1.3.31 Elhadd TA, Al-Amoudi AA, Alzahrani AS. Epidemiology, clinical and complications profile of
diabetes in Saudi Arabia: a review. Ann Saudi Med, 2007 Jul-Aug;27 (4):241-50.
1.3.32 Siraj A, Bavi P, Abubaker J, Jehan Z, Sultana M, Al-Dayel F, Al-Nuaim A, Alzahrani A, Ahmed
M, Al-Sanea-O, Uddin S, Al-Kuraya K. Genome-wide expression analysis of Middle Eastern
papillary thyroid cancer reveals-Met as a novel target for cancer therapy. J Pathol.2007.
Oct;213(2):190-9.
1.3.33 Ahmed M, H Bin Yousef, W. Creer, HA Faraz, S. Al Sobhi, A Alzahrani, H Raef, A Al Ghamdi,
Y. Al Kadhi and F Al Dayel. Hurthle Cell Neoplasm of Thyroid Gland: Australia New Zealand
Journal of Surgery. 2008:78;139-143.
1.3.34 Alzahrani AS (Corresponding Author). Predictors of obstructive sleep apnea in snorers:
statistical errorsComment from the Annals. Ann Saudi Med. 2008 Jan-Feb;28(1):60-1.
1.3.35 Shi Y, Zou M, Baitei EY, Alzahrani AS, Parhar RS, Al-Makhalafi Z, Al-Mohanna FA.
Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment
of anaplastic thyroid carcinoma. Cancer Gene Ther. 2008 Feb;15 (2):101-7.
1.3.36 Ali Alzahrani (Corresponding Author) and Mohammed Al Sheef. Severe Primary
Hyperparathyroidism Masked by Asymptomatic Celiac Disease. Endocr Pract. 2008
Apr;14(3):347-50.
1.3.37 Alzahrani A (Corresponding Author), Abouzeid M, Abdel-Salam S, Gamal M, Rifai A, AlSugair A, Amin T. The role of F-18 Fluorodeoxyglucose Positron Emission Tomography
in the Postoperative evaluation of differentiated thyroid cancer. Eur. J. Endocrinol., May
2008;158:683-689.
1.3.38 Alzahrani AS (Corresponding Author), Goiter (Invited chapter). In: Ebell MH, ed.
Evidence at Hand. 1st ed. Hoboken, NJ: John Wiley and Sons.
with PI3K/AKT signaling pathway in papillary thyroid carcinoma. Endocr Relat Cancer.
2010 Feb 18;17 (1):191-202. Print 2010 Mar.
1.3.50 Alzahrani AS, Zou M, Baitei EY, Alshaikh OM, Al-Rijjal RA, Meyer BF, Shi Y. A novel
G102E mutation of CYP27B1 in a large family with vitamin D-dependent rickets type 1. J
Clin Endocrinol Metab. 2010 Sep;95(9):4176-83.
1.3.51 Alshaikh OM, Almanea H, Alzahrani AS (Corresponding Author). Paget disease of the
bone: Does it exist in Saudi Arabia? Ann Saudi Med. 2011 May-June: 31(3):305-10.
1.3.52 Zou M, Baitei EY, Alzahrani AS, Parhar RS, Al-Mohanna FA, Meyer BF, Shi Y. Mutation
prediction by PolyPhen of functional assay, a detailed comparison of CYP27B1 missense
mutations. Endocrine. 2011 August: 40(1).
1.3.53 Alzahrani AS, Zou M, Baitei EY, Parhar RS, Al-Kahtani N, Raef H, Almahrouz A,
Amartey JK, Al-Rijjal R, Hammami R, Meyer BF, Al-Mohanna FA, Shi Y. Molecular
Characterization of a Novel p.R118C Mutation in the Insulin Receptor Gene from Patients
with Severe Insulin Resistance. Clin Endocrinol (Oxf). 2012 Apr;76(4):540-7
1.3.54 Ali Alzahrani, Graziano Ceresini, Saleh Al Aldasouqi, Ultrasound in Thyrotoxicosis: A
non-invasive, cost-3ffective, and widely available but under-utilized diagnostic tool.
Endocr Pract. 2012 Feb 20:1-35
1.3.55 Alzahrani Ali (Corresponding Author) Al Qarawi Abdullah, Al Suhaibani Fahad, Al Mana
Hadeel, Abalkhail Halah. Pancreatic metastasis arising from BRAF-positive papillary
thyroid cancer: the role of endoscopic ultrasound - guided biopsy and response to sorafenib
therapy. Thyroid. 2012 Mar 21. [Epub ahead of print]
1.3.56 Ali Alzahrani (Corresponding Author), Omalkhaire Al Shaikh, Mahmoud Tuli, Abdulaziz
Al Sugair, Reem Alamawi, Maha Al Rasheed. Diagnostis value of recombinant human
thyrotropin stimulated iodine 123 whole body scintigraphy in the follow up of patients with
differentiated thyroid cancer. Clin Nucl Med. 2012 Mar;37(3):229-34.
Suite 200 Jacksonville, Florida 32202 Phone: (904) 353-7878 Fax: (904) 353-8185 http://www.aace.com
Abu Dhabi
Country: UAE
Email: akhalil771@gmail.com
Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the
purposes of Chapter business? __X_ yes ___ no
Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)
___ President
_X__ Vice President
___ Secretary
___ Treasurer
___ Board of Director Member
Dear Colleagues,
I would like you to join me in suppor ng the ins tu on of the rst chapter of the American Associa on
of Clinical Endocrinologists in the Gulf area as well my candidacy for the posi on of Vice -President for
the Gulf chapter Board of directors.
As stated in my brief bibliography, I have been one of the founders and ac ve par cipants of the United
Arab Emirates endocrine Club. My mission was and s ll is to contribute to the enhancement of the level
of the knowledge needed for the prac ce of clinical endocrinology.
With your support, I would like to be given the chance to serve ocially as one of your representa ve in
the rst AACE chapter in the Gulf area.
Ali Khalil
President Candidates
1. Fatma AlMarashi, MD FACE; UAE
2. Kamal A S Al-Shoumer, BSC, MB, DIC, PhD,
FRCP, FACE; Kuwait
3. Mahmoud Mohamed A Fikri, MBBCh, PhD;
UAE
4. Ahmed A K Hassoun, MD FACE; UAE
DUBAI
Country:
U.A.E.
Email: dralmarashi@gmail.com
2
Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the
purposes of Chapter business? __X_ yes ___ no
3
Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)
__X_ President
___ Vice President
___ Secretary
___ Treasurer
___ Board of Director Member
Dr. Al Marashi recently served as the Medical Director at University Hospital, part of the Mohammed Bin
Rashid Academic Medical Center in Affiliation with Harvard Medical school Dubai Center in Dubai
Healthcare City, where she developed strategy for the Medical and Physicians Affairs Department. She has
been featured in many national TV programs for Diabetes and other Endocrinological Problems. She was a
contributing writer for the Healthcare Middle-East Journal providing physician and patient education material
on the topic of Endocrinology and Diabetes. She has organized many community activities in her field for
education of the community at large besides the courses for Education of the physicians to improve the
standards of care for patients with Endocrinological problems.
Dr. Fatma AlMarashi is the first UAE physician to earn American double board certification. She is the only
UAE physician with double American Board Degrees in Endocrinology, Diabetes and Metabolism. She is
American Board certified in Endocrinology and Internal Medicine. Dr. Al Marashi earned her medical degree
from Shiraz Medical School. She focused on Internal Medicine as her first specialty as a resident at St.
Vincent Hospital, a University of Massachusetts affiliate, in Worcester, MA,U.S.A. She furthered her
specialization by completing a fellowship in Endocrinology, Diabetes and Metabolism, at the University of
Texas Medical School in Houston, TX, U.S.A.She received her training from MD- Anderson and Herman
Hospital, Houston, USA. Dr AlMarashi has active Medical licenses in USA Massachusetts, Texas and
California, besides having a CPQ license and DOHMS License, UAE.
After coming back to UAE in 1998, she was constantly trying to get the Health care Standards improved in
UAE; she founded the Department of Endocrinology, Diabetes and Metabolism at Al Baraha Hospital
/MOH , and served as the Chair for five years. In her dedicated efforts to improve the healthcare status in
the U.A.E., Dr. Al Marashi was appointed as a U.A.E. representative in the Gulf Cooperation Council for the
Diabetes Control Committee in striving to control the rising number of diabetes cases in the area. In 1999,
she founded and served as Chairperson of the U.A.E. National Diabetes Control committee ( UAE- NDCC),
in the Ministry of Health and also founded and designed the first and only stand alone Diabetes and
Endocrine Center called Alsalam Diabetes and Endocrine center. She trained the staff for the center and
headed the project She also voluntarily helped and to develop Diabetes Center in Ajman Medical district. As a
Chair of UAE- NDCC. She developed Diabetes registry plat form for MOH and Developed Diabetes
standard of care for primary care for UAE.
She has participated in several courses, lectures and symposium to Educate Physicians as well as the
community, and the policy makers.
As a member of the Drug Formulary Committee in Ministry of Health from 2001-2003 she tried to put the
policies and procedures to develop and improve the drug approval processes. Afterwards she moved on to fill
the position as Chief of the Division of Endocrinology, Diabetes and Metabolism at Welcare Hospital before
joining Dubai Healthcare City. Dr. Al Marashi has consulted at multiple healthcare facilities in the U.A.E.
including Welcare, Al Baraha, Al Kuwaiti, Neurospinal and American Hospitals
Dr AlMarashi is a member of several International and National Scientific Associations. She is member of
International committee for American Association of Clinical Endocrinologist (AACE), and recently
appointed as a member of Primary Care Physician Education Initiative Committee of AACE USA.
She was a board member of Emirates Medical Association (EMA) and chair person of EMA Scientific
committee.
Mission:
- To establish an administrative Gulf body that works to enhance the development of activities of all AACE
Chapters
- To assist endocrinologists to provide the highest quality of patient care
-To work as an advocate for patient care issues in endocrinology, diabetes, metabolism and nutrition
Channels:
- To coordinate the work of Gulf body as the official representative of AACE in the Gulf:
a. In consistence with the views, policy and guidelines established by AACE, to serve as a communication link
between members at Gulf region level.
b. To facilitate AACE policies and programs at the Gulf region.
- To develop committees where appropriate to carry out the work of chapter. Preliminary committees include: Scientific &
program committee, Membership committee, Nomination committee, and External relations committee.
- To coordinate and help all committees in the plan and assist them in implementation of their functions.
CURRICULUM VITAE
KAMAL A. S. AL-SHOUMER
B.Sc., M.B.B.Ch., D.I.C.(UK), Ph.D.(UK),
M.R.C.P.(UK), F.R.C.P. (UK), F.A.C.E.(USA)
ASSOCIATE PROFESSOR OF CLINICAL
ENDOCRINOLOGY AND MEDICINE
DEPARTMENT OF MEDICINE
FACULTY OF MEDICINE/KUWAIT UNIVERSITY
HEAD, DIVISION OF ENDOCRINOLOGY &
METABOLIC MEDICINE / FACULTY OF MEDICINE
& MUBARAK AL-KABEER UNIVERSITY
TEACHING HOSPITAL
EX-(PAST) VICE-DEAN, FACULTY OF MEDICINE,
KUWAIT UNIVERSITY
PRESIDENT OF PAN-ARAB SOCIETY OF
ENDOCRINOLOGY AND DIABETES
(NOV.2007 TO MAY 2010)
PERSONAL DETAILS
Name :
Date of birth :
Place of birth :
Nationality :
Address:
Fax:
Mobile:
E-mail
QUALIFICATIONS
B.Sc.
M.B.B.Ch
M.R.C.P. (Medicine)
F.R.C.P (UK)
F.A.C.E (USA)
SUMMARY OF POSTS
Trainee
Assistant Registrar - General Medicine
Registrar - General Medicine
Honorary Registrar - Endocrinology
Clinical Research Fellow - Endocrinology
& Senior Registrar (Kuwait)
Consultant & Head of Division of Endocrinology
& Metabolic Medicine - Dept. of Medicine Assistant Professor of Medicine - Faculty of
Medicine
Associate Professor of Medicine - Faculty of
Medicine
Vice-Dean, Faculty of Medicine
Current Post: Consultant/Head of division
Of Endocrinology & Metabolic Medicine at
Faculty of Medicine & Mubarak Al-Kabeer
Teaching hospital
2
PROFESSIONAL HISTORY:
Transitional Internship: This included rotations in the 4 major branches of medicine
1. General Surgery
July 1986 - End Oct. 1986
Farwaniya Hospital - Kuwait
Consultant:
Dr. Parkash FRCS
2. Obstetrics & Gynaecology
Nov.1986 - End Dec. 1986
Al-Adan Hospital - Kuwait
Consultant: Dr. S. Kamil MRCOG
3. General Medicine
Jan.1987 - End April 1987
Farwaniya Hospital - Kuwait
Consultant: Dr. J. Cherian FRCP
4. Paediatrics
May 1987 - End June 1987
Farwaniya Hospital - Kuwait
Consultant: Dr. Sharda MRCPaed.
Postgraduate Training Programme (PGTP) in Medicine in Kuwait:
This included rotations in all subspecialities of Medicine including general medical rotations:
As Assistant Registrar
1. General Medicine
July 1987 - End June 1988
Amiri Hospital- Kuwait
Consultants: Dr. H.K.Walia FRCP & Dr. Menon FRCP
2. General Medicine
July 1988 - End Dec. 1988
Mubarak Hospital - Kuwait
Consultants: Prof.A.Razzaq FRCP & Prof.M.Barakat MD
3. Endocrinology subspeciality
1st-End Jan 1989
Mubarak Hospital - Kuwait
Consultant: Dr. Berg MD
4. Rheumatology rotation
1st-End Feb. 1989
Mubarak Hospital - Kuwait
Consultant: Dr.M.Sattar FRCP
5. Hematology rotation
1st-End March 1989
Amiri Hospital - Kuwait
Consultant: Dr. H.Habboush MRCP MRCPath
6. Coronary Care Unit
1st- End April 1989
Amiri Hospital - Kuwait
Consultant: Dr. M.Khafaji MRCP
7. Intensive Care Unit
1st-End May 1989
Amiri Hospital - Kuwait
Consultant: Dr.Farouq
8. Oncology rotation
1st - End June 1989
Kuwait Cancer Centre
Consultant: Dr.S.Mutawe FRCS
9. Cardiology rotation
1st July - End Sep. 89
Chest Disease Hospital - Kuwait
This post includes a full responsibility of patients as a head of division of Endocrinology &
Metabolic Medicine in the Medical Department at Mubarak Al-Kabeer Hospital. It covers
services in the subspeciality of Endocrinology and Metabolism. It includes inpatient care,
outpatient care, duties, arrangement of bone densitometry and metabolic day assessments. In
addition to regular in bedside teaching for medical students and postgraduates.
2. Assistant Professor of Medicine- Department of Medicine (1997-19th June 2001)
This includes full engagement in teaching activities in the Faculty of Medicine for undergraduates
and postgraduates. Organization of the 5th year Endocrine & Diabetes system course,
presentation of lectures to postgraduate candidates in the MRCP part I and II course, presentation
of lectures to students, and supervising the activities in the departmental endocrine laboratory
(with a backdated appointment since Sept. 1993).
3. Associate Professor, Department of Medicine, Faculty of Medicine (20th June 2001-to
date)
This post was achieved based on the distinguished research, community services and clinical
teaching for students and post-graduates in the Faculty of Medicine at Kuwait University and at
the Faculty of Internal Medicine at the Post-graduate Training Program.
4. Vice-Dean (Administration & Finance), Faculty of Medicine (12 April 2004 to 11 April
2008)
ADMINISTRATIVE EXPERIENCE:
A. At the student level:
1. Director of student affairs committee, Kuwait Medical Student Association (KuMSA), the
official association representing medical students at Faculty of medicine, Kuwait
University (Oct.1981-Oct.1982)
2. Vice-President of KuMSA and Director of students affairs committee in KuMSA
(Oct.1982- Oct.1983)
3. Director of the Standing Committee of Refugees (SCOR) at the International Federation
of Medical Students Association (IFMSA) (1983-1985)
4. Vice-president of the General Assembly of the IFMSA 1984 meeting held at Solbaka,
Sweden
5. President, KuMSA at Faculty of Medicine, Kuwait University and President of Standing
Committee for IFMSA (Oct.1984- Oct.1985)
B. At the Post-Graduate level:
1. President, National Union of Kuwaiti students UK and Ireland branch, the official
association representing scholar Kuwaiti under- and post-graduate students at UK and
Ireland. (Sept. 1993-Sept.1994)
C. At the Faculty of Medicine level:
Department of Medicine:
1. Head of Division of Endocrinology & Metabolic Medicine (1997-to date).
2. Member, of the departmental Research Committee (1997-1999).
3. Chief Coordinator, of departmental Research Committee (1999-2002)
ACADEMIC ACTIVITIES :
PublishedResearch papers in refereed cited journals:
1. Al-Shoumer KAS, Beshyah SA & Johnston DG. (1994) Growth hormone and malignancy.
Endocrine-Related Cancer; 1 : 19-26
2. Al-Shoumer KAS, Beshyah SA, Niththyanathan R & Johnston DG. (1995) Effect of
glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in
hypopituitary adults. Clinical Endocrinology; 42: 85-90
3. Al-Shoumer KAS, Ali K, Anyaoku V, Niththyananthan R & Johnston DG. (1996) Overnight
metabolic fuel deficiency in patients treated conventionally for hypopituitarism. Clinical
Endocrinology; 45, 171-178.
4. Al-Shoumer KAS, Page B, Thomas E, Murphy M, Beshyah SA & Johnston DG. (1996)
Effects of four years treatment with biosynthetic human growth hormone (GH) on body
composition in GH-deficient hypopituitary adults. European Journal of Endocrinology ; 135:
559-567.
5. Al-Shoumer KAS, Cox K, Hughes C, Richmond W & Johnston DG. (1997) Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy.
Journal of Clinical Endocrinology and Metabolism ; 82: 2653-2659.
6. Al-Shoumer KAS, Anyaoku V, Ali K & Johnston DG. (1997) Metabolic effects of short-term
reproduction of the normal diurnal cortisol rhythm in hypopituitary adults. Endocrinology &
Metabolism ; 4: 207-214.
7. Al-Shoumer KAS, Anyaoku V, Richmond W & Johnston DG.(1997) Elevated leptin
concentrations in growth hormone-deficient hypopituitary adults. Clinical Endocrinology; 47:
153-159.
8. Al-Shoumer KAS, Gray R, Anyaoku V, Hughes C, Beshyah SA, Richmond W & Johnston
DG. (1998) Effects of four years treatment with biosynthetic human growth hormone (GH) on
glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults. Clinical
Endocrinology, 48, 795-802.
9. Kousta E, Chrisoulidou A, Lawrence N J, Al-Shoumer KAS, Parker KH, McCarthy MI &
Johnston DG. (1998) The circadian rhythm of leptin is preserved in growth hormone deficient
hypopituitary adults.Clinical Endocrinology; 48, 685-690.
7
10. Johnston DG, Al-Shoumer KAS, Chrisoulidou A, Kousta E, Beshyah S and Robinson S.
(1999). Long-term effects of GH therapy on intermediary metabolism and insulin sensitivity in
hypopituitary adults. Journal of Endocrinological Investigation , 22, 37-40.
11. Kousta E, Chrisoulidou A, Lowrence NJ, Anyaoku V, Al-Shoumer KAS & Johnston DG.
(2000) The effects of growth hormone replacement therapy on overnight metabolic fuels in
hypopituitary patients.Clinical Endocrinology 52, 17-24
12. Al-Shoumer KAS, Vasanthy BK, Makhlouf HA & Al-Zaid MM. (2000) Leptin levels in
Arabs with primary hyperthyroidism. Annals of Saudi Medicine, 20, 113-118.
13. Doi SAR, Loutfi I & Al-Shoumer KAS. (2001) A mathematical model of optimized
radioiodine-131 treatment of Graves hyperthyroidism. BMC Nuclear Medicine 1:1
14. Parappil A, Doi SAR & Al-Shoumer KAS. (2002) Diagnostic criteria for diabetes revisited:
making use of combined criteria. BMC Endocrine Disorders 2:1
15. Al-Gharabally A, Doi SAR, Al-Shoumer KAS (2002) Spironolactone for the treatment of
hypercalcuric hypocalcemia. Journal of Bone and Mineral Metabloism 20, 243-247
16. Abalkhail S, Doi SAR, Al-Shoumer KAS. (2003) The use of corticosteroids versus other
treatments for Graves ophthalmopathy: a quantitative evaluation. Medical Sciences Monitor
9(11), CR477-483.
17. Mehraj S, Doi SAR, Al-Shoumer KAS.(2004) Technical observations on the assessment of
thyroid volume by palpation and ultrasonography. Journal of Ultrasound in Medicine 23(2), 261266.
18. Doi SA, Al-Zaid M, Towers PA, Scott CJ, Al-Shoumer KAS. Irregular cycles and steroid
hormones in polycystic ovary syndrome. Hum Reprod. 2005 Sep;20(9):2402-8.
19. Lasheen I, Doi SA, Al-Shoumer KAS. Glucocorticoid replacement in panhypopituitarism
complicated by myelinolysis. Med Princ Pract. 2005 Mar-Apr;14(2):115-7.
20. Doi SA, Al-Zaid M, Towers PA, Scott CJ, Al-Shoumer KAS. Ovarian steroids modulate
neuroendocrine dysfunction in polycystic ovary syndrome. J Endocrinol Invest. 2005 Nov
28(10):882-92.
21. Al-Shoumer KAS, Vasanthy BA, Al-Zaid MM. Effects of treatment of hyperthyroidism on
glucose homeostasis, insulin secretion and markers of bone turnover. Endocrine Practice 2006,
12 (2): 121-130.
22. Doi SA, Lasheen I, Al-Humood K, Al-Shoumer KAS. Relationship between cortisol
increment and basal cortisol: implications for the low dose short adrenocorticotrophic hormone
stimulation test. Clin Chem. 2006 Apr; 52(4):746-9.
23. Doi SA, Al-Zaid M, Towers PA, Scott CJ, Al-Shoumer KAS. Steroidogenic alterations and
adrenal androgen excess in PCOS. Steroids. 2006, 71: 751-759.
24. S. A.R. Doi, D. Issac, S. Abalkhail, M. M. Al-Qudhaiby, M. F. Hafez, and KAS Al-Shoumer.
TRH Stimulation When Basal TSH is Within the Normal Range: Is There "Sub-Biochemical"
Hypothyroidism? Clin. Med. Res., October 1, 2007; 5(3): 145 - 148.
25. Sheikh, M; Abalkhail, S; Doi, SAR; Al-Shoumer, KAS. Normal measurement of orbital
structures: Implications for the assessment of Graves' ophthalmopathy. Australasian Radiology.
51(3):253-256, June 2007.
26. Kamal Al-Shoumer, Hafez Mohamad, Suhail Doi. A case of hypocortisolemic clinical
Cushings syndrome. Annals of Saudi Medicine (2008): 28(2):124-127.
27. Kamal Al-Shoumer, Adnan Al-Asoosi, Suhail Doi, Bagavathy Vasanthy. Serum leptin and
metabolic variables in Arabs with type 2 diabetes. Annals of Saudi Medicine (2008): 28(5): 267370.
28. Kamal Al-Shoumer & Bagavathy Vasanthy. Serum chromogranin A concentration in
hyperthyroidism before and After medical treatment. Journal of Clinical Endocrinology &
Metabolism (2009): 94: 23212324. Published online on April 14, 2009 as doi:10.1210/jc.20082231
29. Moussa Alkhalaf and Kamal Al-Shoumer. Cytogenetic abnormalities and azoospermia
factor (AZF) microdeletions in infertile men from Kuwait. J Mol Genet Med (2010), 4(1), 232234
30. Kamal Al-Shoumer & Vasanthy Nair. Prevalence of low bone mass in post-menopausal
Kuwaiti women resident in the largest province at Kuwait. Archives of osteoporosis (2012 In
press)
Published Reviews, Book Chapters:
31. Al-Shoumer KAS, Kousta E, Beshyah S & Johnston DG. Growth hormone (GH) deficiency Does it cause atherosclerosis ? In Proceedings of 3rd International hGH Symposium on GHD in
adults (1996) (ed. JS Christiansen, JOL Jrgensen, AVZ Mhlen & W Waldhusl), pp. 20-25,
Medical Forum International, The Netherlands.
32. Johnston DG, Al-Shoumer KAS, Beshyah SA, Chrisoulidou A, Kousta E & Anyaoku V.
Interactions of cortisol and growth hormone replacement: intermediary metabolism. In The
diagnosis and treatment of pituitary insufficiency (1997) (ed.SWJ Lamberts), pp. 63-77.
BioScientifica Ltd, Bristol.
33. Johnston DG, Al-Shoumer KAS, Beshyah SA, Chrisoulidou A, Kousta E & Anyaoku V.
Growth hormone replacement in young adults: if and when to continue?. In Adolescent
Endocrinology (1998) (ed.R Stanhope), pp. 17-23. BioScientifica Ltd, Bristol.
34. Doi SA, Towers PA, Scott CJ, Al-Shoumer KAS. PCOS: an ovarian disorder that leads to
dysregulation in the hypothalamic-pituitary-adrenal axis? Eur J Obstet Gynecol Reprod Biol.
2005 Jan 10;118(1):4-16
35. Perros P & Al-Shoumer KAS. Endocrinology alarm bells. Textbook: Alarm Bells in
Medicine 2005, BMJ Books, Blackwell Publ, 25-29.
36. Doi SA, Abalkhail S, Al-Qudhaiby MM, Al-Humood K, Hafez MF, Al-Shoumer KAS.
Optimal use and interpretation of the aldosterone rennin ratio to detect aldosterone excess in
hypertension. J Human Hypertens. 2006 Jul 20 (7):482-9.
37. Al-Shoumer KAS. Vitamin D: A Methodological Update. United Updates 2011, Jan. Issue 4:
12-17.
38. Al-Shoumer KAS & Gharib Hossein. Hyperthyroidism: Toxic Nodular Goiter and Graves
Disease. Surgery of the Thyroid and Parathyroid Gland, Second Edition. Edited by Gregory W.
Randolph, M.D., F.A.C.S (in press 2012)
Editor of a book:
39. Al-Shoumer KAS. Reflections of Health Sciences Center Poster Days 1996-2001, April
2001, Kuwait.
40. Diabetes: The hidden pandemic and its impact on the middle east and northern Africa.
Published and distributed on MENA Diabetes Leadership forum 2010 Dubai, 1-38. (12-13 Dec.
2010)
Published abstracts in refereed journals & presented (Posters) in meetings
41. Al-Shoumer KAS, Beshyah SA, Niththynanathan R & Johnston DG. (1993) Glucocorticoid
replacement regimen and glucose tolerance in hypopituitary adults. Journal of Endocrinology;
139 (Suppl.): P126.
42. Al-Shoumer KAS, Beshyah SA, Niththynanathan R & Johnston DG. (1994) Day to day
variation in glucose tolerance and intermediary metabolites caused by glucocorticoid replacement
therapy in hypopituitary adults. Clinical Science; 86 (Suppl.30): 22P.
43. Al-Shoumer KAS, Andres C, Beshyah SA, Gray IP & Johnston DG. (1994) Day to day
variation in pancreatic beta cell products caused by glucocorticoid replacement therapy in
hypopituitary adults. Journal of Endocrinology; 140 (Suppl.): P164.
44. Al-Shoumer KAS, Ali K, Niththyanathan R & Johnston DG. (1994) 24 Hour glucose and
insulin profiles in hypopituitary adults on conventional replacement therapy.Diabetic Medicine;
11(Suppl.2): P54.
45. Al-Shoumer KAS, Anyaoku V & Johnston DG. (1995) Total plasma cortisol profiles in
hypopituitary adults with growth hormone deficiency on conventional replacement therapy.
Endocrinology and Metabolism ; 2 (Suppl.B): page 143.
46. Al-Shoumer KAS, Hughes C, Ali K, Richmond W & Johnston DG. (1995) Abnormalities of
lipid metabolism in ACTH-deficient hypopituitary adults on conventional replacement therapy.
Journal of Endocrinology; 144 (Suppl.): P107.
47. Al-Shoumer KAS, Anyaoku V, Ali K & Johnston DG. Plasma free cortisol profiles in
conventionally treated hypopituitary adults. 77th Annual Meeting of the American Endocrine
Society: Washington DC, held on 14-17 June (1995). Conference Programme and Abstract Book
(Poster P3-75, page 487).
48. Al-Shoumer KAS, Gedroyc W, Beshyah SA, Anyaoku V & Johnston DG. Does growth
hormone (GH) treatment cause reactivation or recurrence of pituitary tumours in hypopituitary
patients (HP). Fifth International Congress on Hormones and Cancer: Quebec City, held on 16-20
September (1995). Conference Programme and abstract Book (Poster 94, page 118).
49. Al-Shoumer KAS, Cox K, Richmond W & Johnston DG. (1995) Plasma lipid profiles over
24 hours in hypopituitary adults (HPA) on conventional replacement therapy.Journal of
Endocrinology; 147 (Suppl.): P67.
50. Al-Shoumer KAS, Anyaoku V, Niththyanathan R & Johnston DG. (1996) Abnormalities of
intermediary metabolites in hypopituitary adults with growth hormone (GH) deficiency on
conventional replacement. Endocrinology and Metabolism ; 3 (Suppl A), 122.
51. Al-Shoumer KAS, Anyaoku V, Gray R & Johnston DG. (1996) Effects on glucose and
insulin of short- term reproduction of the normal diurnal cortisol rhythm in ACTH-deficient
hypopituitary adults.Journal of Endocrinology ; 148 (Suppl.): P141.
52. Al-Shoumer KAS, Page B, Anyaoku V, Beshyah S & Johnston DG. (1996) Body
composition in hypopituitary adults (HPA): results after four years of growth hormone (GH)
replacement therapy. Journal of Endocrinology ; 148 (Suppl.): P142.
10
53. Al-Shoumer KAS, Gray R, Barr J, Anyaoku V, Ali K & Johnston DG. (1996) Plasma
glucose and insulin in hypopituitary adults: results after 4 years of growth hormone (GH)
replacement. Diabetic Medicine ; 13 (Suppl.3): P50: S27-28.
54. Al-Shoumer KAS, Gray R, Barr J, Anyaoku V, Hughes C, Richmond W & Johnston DG.
Carbohydrate tolerance and lipid metabolism in hypopituitary adults after long-term growth
hormone (GH) replacement. 10th International Congress of Endocrinology: San Francisco, held
on 12-15 June (1996). Conference Programme and Abstract Book (Poster P2-464, page 520).
55. Al-Shoumer KAS, Kyd P, Murphy M, Thomas E & Johnston DG. (1996) Preserved increase
in bone turnover and maintained level of bone mass in growth hormone (GH) deficient
hypopituitary adults treated with human biosynthetic GH for four years.Journal of
Endocrinology;151(Suppl.): P66.
56. Al-Shoumer KAS, Anyaoku V, Gray R, Hughes C, Richmond W & Johnston DG.(1997)
Anthropometric and metabolic effects of four years treatment with biosynthetic human growth
hormone (GH) in hypopituitary adults (HPA). Endocrinology and Metabolism ; 4 (Suppl. A),
P047, page 53.
57. Al-Shoumer KAS, Kousta E, Richmond W & Johnston DG. (1997) Increased prevalence of
abnormal fasting lipids and lipoproteins in growth hormone (GH) deficient hypopituitary adults.
Endocrinology and Metabolism ; 4 (Suppl. B), Poster A3, page 157.
58. Kousta E, Chrisoulidou A, Lawrence N, Al-Shoumer KAS, Markou A & Johnston DG. The
circadian rhythm of leptin is preserved in hypopituitary patients. 24th International Symposium
on Growth Hormone and Growth factors in Endocrinology and Metabolism, Antwerp, held on 34 October (1997). Conference Programme and abstract Book (Poster A7, page 54).
59. Al-Shoumer KAS, Ali K, Anyaoku V & Johnston DG. (1997) Intravenous versus oral
hydrocortisone replacement therapy in ACTH-deficient hypopituitary adults: effects on metabolic
fuels. Journal of Endocrinology; 155 (Suppl. 2): P47.
60. Chrisoulidou A, Anyaoku V, Beshyah SA, Al-Shoumer KAS, Robinson S & Johnston DG.
(1998) Effects of GH treatment for 7 years versus no treatment on anthropometry and vascular
risk factors in adult hypopituitarism. Journal of Endocrinology , 156 (Supp.), P151.
61. Al-Shoumer KAS, Makhlouf HA, Al-Zaid MM, Qurtum M & Hussein AAA. Effects of
treatment of thyrotoxicosis on carbohydrate metabolism in hyperthyroid adults. Third Health
Sciences Poster day, Faculty of Medicine, Kuwait University, Kuwait, April 20, 1998,
Conference Programme and abstract Book (page 40).
62. Al-Shoumer KAS, Vasanthy BK, Makhlouf HA & Al-Zaid MM. Increased bone turnover in
untreated thyrotoxicosis. Third Health Sciences Poster day, Faculty of Medicine, Kuwait
University, Kuwait, April 20, 1998, Conference Programme and abstract Book (page 41).
63. Al-Shoumer KAS, Kyd P, Murphy M, Thomas E, Beshyah SA & Johnston DG. Effects of
longterm growth hormone (GH) therapy on bone metabolism in GH-deficient adults. 80th Annual
Meeting of the American Endocrine Society: New Orleans, Louisiana, held on 24-27 June 1998.
Conference Programme and Abstract Book (P1-213, page 165).
64. Al-Shoumer KAS, Vasanthy BK & Makhlouf HA. (1998) Leptin concentration in thyrotoxic
patients. Journal of Endocrinology ; 159 (Supp): P87.
65. Al-Shoumer KAS, Vasanthy BK & Makhlouf HA. Effects of treatment of hyperthyroidism
on leptin concentrations. 2nd Meeting of the British Thyroid Association. St. Thomas Hospital,
London, held on 25 November 1998. Programme and Abstract Book ( P11, page 17).
11
66. Kousta E, Chrisoulidou A, Lowrence NJ, Anyaoku V, Al-Shoumer KAS & Johnston DG.
The effects of GH therapy on overnight metabolic fuels in hypopituitary patients. 26th
International Symposium on GH and Growth Factors in Endocrinology and Metabolism. Palma
de Mallorca, held on 23-24 October, 1998. Programme and Abstract Book (B3, page 68).
67. Al-Shoumer KAS, Al-Zaid MM & Vasanthy BK. Leptin concentration in women with
hirsutism. Forth Health Sciences Poster day, Faculty of Medicine, Kuwait University, Kuwait,
April 25, 1999, Conference Programme and abstract Book (page 56).
68. Al-Shoumer KAS, AlBony A, El-Gazzar A & Vasanthy BK. Outcome of radionuclide
technetium thyroid scan (TC-99M pertechnetate) over twelve months in Mubarak Al-Kabeer
Hospital. Fourth Health Sciences Poster day, Faculty of Medicine, Kuwait University, Kuwait,
April 25, 1999, Conference Programme and abstract Book (page 94).
69. Al-Juwaiser A, Abdulla MA & Al-Shoumer KAS. Fine needle aspiration biopsy of the
thyroid gland in Mubarak Al-Kabeer Hospital. Fourth Health Sciences Poster day, Faculty of
Medicine, Kuwait University, Kuwait, April 25, 1999, Conference Programme and abstract Book
(page 135).
70. Al-Shoumer KAS & Vasanthy BK. Reduced leptin concentration in women with hirsutism.
81st Annual Meeting of the American Endocrine Society: San Diego, California, held on 12-15
June 1999. Conference Programme and Abstract Book (P1-449, page 230).
71. Al-Shoumer KAS, Al-Zaid MM & Vasanthy BK.(1999) Leptin levels in Arab women with
hirsutism and its metabolic correlations. Journal of Endocrinology ; 163 (Suppl): P67.
72. Al-Shoumer KAS, Vasanthy BK & Al-Zaid MM. Effects of antithyroid therapy on
biochemical markers of bone turnover in primary hyperthyroidism. Fifth Health Sciences Poster
day, Faculty of Medicine, Kuwait University, Kuwait, April 24, 2000, Conference Programme
and abstract Book (page 63).
73. Al-Shoumer KAS, Vasanthy BK, Shalabi FM, Makhlouf HA & Al-Zaid MM.
Hyperproinsulin-aemia and insulin resistance in primary hyperthyroidism. Fifth Health Sciences
Poster day, Faculty of Medicine, Kuwait University, Kuwait, April 24, 2000, Conference
Programme and abstract Book (page 64).
74. Al-Shoumer KAS, Al-Assoussi A & Doi S. (2000) Variations in leptin concentrations in type
2 diabetes in Arabs. Diabetes, 49 (Suppl 1): 1424-PO, page A340.
75. Al-Shoumer KAS , Vasanthy BK & Al-Zaid MM. Effects of hyperthyroidism on glucose
homeostasis, insulin secretion and markers of bone turnover. 82nd Annual Meeting of the
American Endocrine Society: Toronto, Canada, held on 21-24 June 2000. Conference Programme
and Abstract Book (2429, page 587-8).
76. Al-Shoumer KAS, Vasanthy BK, Al-Assoussi A & Doi A (2000) Leptin level in Arabs with
type 2 diabetes (Second Pan-Arab Congress of Diabetes and Endocrinology and The 10th
International Clinical Genetics Seminar, October 20-24, 2000, OP-61, page 87).
77. Al-Shoumer KAS , Vasanthy BK & Al-Zaid MM. Glucose homeostasis and bone
metabolism in hyperthyroidism: Follow up after therapy. 11th International Congress of
Endocrinology. Australia, Sydney, held on 29 October-2 November 2000. Conference
Programme and Abstract Book (Abstract P764, page 285).
78. Al-Shoumer KAS, Doi SAR, Vasanthy BK & Al-Asoussi A. Bone metabolism in type 2
diabetes. Sixth Health Sciences Poster day, Faculty of Medicine, Kuwait University, Kuwait,
April 23, 2001, Conference Programme and abstract Book (page 70).
12
79. Al-Shoumer KAS, Vasanthy BA & Akanji A. Lipoprotein (a) in hyperthyroidism: effects of
medical therapy. Sixth Health Sciences Poster day, Faculty of Medicine, Kuwait University,
Kuwait, April 23, 2001, Conference Programme and abstract Book (page 71).
80. Ghanem H, El-Meliegy A, Mansi M, Younis N, Al-Shoumer K, Al-Rubaei S & Merhej S.
(2001) Hormone replacement therapy for PADAM: Outcome and safety (Middle East Multicenter
Trial), The Journal of Andrology, May/June Sup, P5/6-073, page 172.
81. Al-Shoumer KAS , Doi SA & Vasanthy BK. (2001) Markers of bone turnover and
longstanding type 2 diabetes in Kuwait. 83rd Annual Meeting of the American Endocrine
Society: Denver, USA, held on 20-23 June 2001. Conference Programme and Abstract Book (P376, page 465).
82. Al-Shoumer KAS, Vasanthy BK, Shalabi FM & Al-Zaid MM. Bone metabolism in hirsute
women. Seventh Health Sciences Poster day, Faculty of Medicine, Kuwait University, Kuwait,
April 22, 2002, Conference Programme and abstract Book (page 74).
83. Al-Shoumer KAS, Vasanthy BK & Al-Zaid MM. Sreum interleukin-6 (IL-6) and soluble
interleukin-6 Receptor (sIL-6) in hyperthyroidism due to Graves disease: effects of medical
therapy. Seventh Health Sciences Poster day, Faculty of Medicine, Kuwait University, Kuwait,
April 22, 2002, Conference Programme and abstract Book (page 75).
84. Al-Shoumer KAS, Vasanthy BK, Shalabi FM & Al-Zaid MM. (2002) Markers of bone
metabolism in hirsute women. 84th Annual Meeting of the American Endocrine Society: San
Francisco, USA, held on 19-22 June 2002. Conference Programme and Abstract Book (P2-630,
page 467-8).
85. Al-Shoumer KAS, Vasanthy BK, Al-Zaid MM. Human Chromogranin A (CgA) in patients
with hyperthyroidism, Eighth Annual Health Sciences Poster Day 2003, P. 71
86. Al-Shoumer KAS, Vasanthy BK. Leptin and metabolic variables in Arab patients with type 2
diabetes in a University teaching hospital in Kuwait. 2003 Syllabus AACE 14-18th May, San
Diego, Abs # 77, P. 318-319.
87. Johnston, DG, Kearney T, Robinson S, Venkatesan S, Chrisoulidou A, Bannister P,
Anayaoku V, Parker K, Beshyah S, Al-Shoumer KAS (2003) Hypopituitarism and
atherosclerosis. 85th Annual Meeting of the American Endocrine Society: Philadelphia, USA,
held on 19-22 June 2003. Conference Programme and Abstract Book (S29-1).
88. AL-Qudaiby MM, Doi SAR, Al-Shoumer KAS. Reversible renal dys function in immune
thrombocytopenic diabetic patient induced by Intravenous Immunoglobulin (IVIG). Ninth
Annual Health Sciences Poster Conference, Faculty of Medicine, Kuwait University, Kuwait,
April 19-21, 2004, Conference Programme and abstract Book (page 75).
89. Naddaf S , Anim H, Farghaly M, Behbehani AM, Al-Shoumer KAS, Collier D, Elgazzar A.
Ultrastructure Of Hyperfunctioning Parathyroid Glands: Does It Explain Various Patterns Of
Sestamibi Uptake? Ninth Annual Health Sciences Poster Conference, Faculty of Medicine,
Kuwait University, Kuwait, April 19-21, 2004, Conference Programme and abstract Book (page
61).
90. Girgis M.,Chadha G., Doi SAR, Al Shoumer KAS, Al Shammari S. Kearns Sayre Syndrome
in a young Kuwaiti male-A case report. Ninth Annual Health Sciences Poster Conference, Faculty
of Medicine, Kuwait University, Kuwait, April 19-21, 2004, Conference Programme and abstract
Book (page 82).
91. Doi SAR, Parappil A, Sheikha A, Al-Shoumer KAS. Redefining Optimal Glucose Cutoffs
In The Diagnosis Of Diabetes. Ninth Annual Health Sciences Poster Conference, Faculty of
13
Medicine, Kuwait University, Kuwait, April 19-21, 2004, Conference Programme and abstract
Book (page 79).
92. Lasheen I, Doi SAR, Al-Shoumer KAS, Al-Aqeel AAA. Glucocorticoid replacement in
panhypopituitarism complicated by myelinolysis: A Case Report. Ninth Annual Health Sciences
Poster Conference, Faculty of Medicine, Kuwait University, Kuwait, April 19-21, 2004,
Conference Programme and abstract Book (page 86).
93. Al-Shoumer K.A.S., Doi S.A.R., Abalkhail S, Nair V.S.Is osteoporosis common in Arab
women in Kuwait? Ninth Annual Health Sciences Poster Conference, Faculty of Medicine,
Kuwait University, Kuwait, April 19-21, 2004, Conference Programme and abstract Book (page
77).
94. Al-Shoumer KAS , Doi SAR & Vasanthy BK. (2004) Prevalence of low bone mass in Arab
women in the largest district area in Kuwait. 86th Annual Meeting of the American Endocrine
Society: New Orleans, USA, held on 16-19 June 2004. Conference Programme and Abstract
Book (P2-527).
95. Al-Shoumer K.A.S., Vasanthy BA, Al-Zaid M. New markers for disease activity in
hyperthyroidism. Tenth Annual Health Sciences Poster Conference, Faculty of Medicine, Kuwait
University, Kuwait, April 25-27, 2005, Conference Programme and abstract Book (page 95).
96. Doi SA, Al-Zaid M, Tower PA, Scott CJ, Al-Shoumer K.A.S. Pathophysiology of
neuroendocrine dysfunction in polycystic ovary syndrome. Tenth Annual Health Sciences Poster
Conference, Faculty of Medicine, Kuwait University, Kuwait, April 25-27, 2005, Conference
Programme and abstract Book (page 91).
97. Al-Shoumer KAS , Vasanthy BA, Al-Zaid MM. (2005) New marker of disease activity in
hyperthyroidism: human chromogranin A (CgA). 87th Annual Meeting of the American
Endocrine Society: San Diego, USA, held on 4-7 June 2005. Conference Programme and
Abstract Book (P1-579).
98. Al-Shoumer K.A.S., Vasanthy BA, Doi SA, Abalkhail S, Al-Gudhaiby MM. Risk factors and
predictors of increased risk for type 2 diabetes in Arabs resident in Kuwait. Eleventh Annual
Health Sciences Poster Conference, Faculty of Medicine, Kuwait University, Kuwait, April 2426, 2006, Conference Programme and abstract Book (page 93).
99. Al-Shoumer K.A.S., Vasanthy BA, Doi SA. The relation between intact proinsulin and
adiponectin with insulin resistance. Eleventh Annual Health Sciences Poster Conference, Faculty
of Medicine, Kuwait University, Kuwait, April 24-26, 2006, Conference Programme and abstract
Book (page 96).
100. Al-Shoumer KAS , Vasanthy BA, Doi SA, Abalkhail S, Al-Gudhaiby MM (2006)
Cytokines and obesity-related hormones in Arabs with type 2 diabetes resident in Kuwait. 88th
Annual Meeting of the American Endocrine Society: Boston, USA, held on 24-27 June 2006.
Conference Programme and Abstract Book (P2-594).
101. Al-Shoumer K.A.S., Vasanthy BA, Doi SA. Abnormal cardiovascular risk profel in Arab
patients with polycystic ovary syndrome Twelvth Annual Health Sciences Poster Conference,
Faculty of Medicine, Kuwait University, Kuwait, April 24-26, 2007, Conference Programme and
abstract Book (page 96).
102. Al-Shoumer KAS , Vasanthy BA, Abalkhail S, Doi SA, Al-Gudhaiby MM (2007) Intact
proinsulin to adiponectin ratio is a strong predictor of insulin resistance in type 2 diabetes. 89th
Annual Meeting of the American Endocrine Society: Torronto, Canada, held on 24-27 June 2007.
Conference Programme and Abstract Book (P2-594).
14
103. Al-Shoumer K.A.S., Vasanthy BA, Doi SA, Abalkhail S, Hafez MF. Spectrum of bone
mineral density in Arab women resident in Kuwait. Thirteenth Annual Health Sciences Poster
Conference, Faculty of Medicine, Kuwait University, Kuwait, April 24-26, 2008, Conference
Programme and abstract Book (page 96).
104. Al-Shoumer KAS , Vasanthy BA, Doi SA, Abalkhail S, Al-Gudhaiby MM, Hafez MF
(2008) Arab women with polycystic ovary syndrome: cardiovascular risk profile. 90th Annual
Meeting of the American Endocrine Society: San Francisco, USA, held on 15-18 June 2008.
Conference Programme and Abstract Book (P3-574).
105. Abalkhail S., Hilali N., Al-Kandari N., Doi SA, Al-Duaij S, Hafez MF, Nair VS, Ali AH,
Al-Shoumer K.A.S. Oscillations on osteocalcin levels in uremic patients Maintained on regular
hemodialysis. 14Th Annual Health Sciences Poster Conference, Faculty of Medicine, Kuwait
University, Kuwait, April 21-23, 2009, Conference Programme and abstract Book (page 72).
106. Al-Otaibi FK, Al-Bader MD, Al-Shoumer K.A.S, Al-Yatama FI. The effect of clothing and
cultural practice on bone mineral density (BMD) in Kuwaiti pre-menopausal women. 14Th
Annual Health Sciences Poster Conference, Faculty of Medicine, Kuwait University, Kuwait,
April 21-23, 2009, Conference Programme and abstract Book (page 183).
107. Al-Shoumer KAS & Vasanthy BA. (2009) Low bone mass is prevalent in young Arab
women resident at Kuwait. 91ST Annual Meeting of the American Endocrine Society:
Washington DC, USA, held on 10-13 June 2009. Conference Programme and Abstract Book (P2237).
108. Al-Shoumer K.A.S., Nair VS, Ali AH, Haider MZ. Genotyping of non-classical congenital
adrenal hyperplasia (NCCAH) in a subgroup of Kuwaiti females. 15th Annual Health Sciences
Poster Conference, Faculty of Medicine, Kuwait University, Kuwait, April 20-22, 2010,
Conference Programme and abstract Book (page 71).
109. Al-Shoumer K.A.S., Nair VS, Ali AH. Genetic Assessment of a Subgroup of Kuwaiti
Females with Non-Classical Congenital Adrenal Hyperplasia (NCCAH). Endocrine
Reviews, Supplement 1, June 2010, 31[3]: S733.
110. Al-Shoumer K.A.S., Nair VS, Ali AH. Vitamin D levels in Kuwaiti subjects with type 2
diabetes. 16th Annual Health Sciences Poster Conference, Faculty of Medicine, Kuwait
University, Kuwait, May 3-5, 2011, Conference Programme and abstract Book (page 68).
111. Al-Shoumer K.A.S., Nair VS, Abalkhail S. Changes in acid-labile subunit and insulinlike growth factor 1 in hyperthyroidism after medical treatment. 93rd Annual Meeting of the
American Endocrine Society: Boston, USA, held on 4-7 June 2011. Conference Programme and
Abstract Book (P3-593, P. 197)
112. Ali A.H., Nair V.S. and Al-Shoumer K.A.S. Effects of lifestyle and environmental factors
on bone mineral density in healthy Kuwaiti females. 17th Annual Health Sciences Poster
Conference, Faculty of Medicine, Kuwait University, Kuwait, May 8-10, 2012, Conference
Programme and abstract Book (page 46).
113. Al-Shoumer K.A.S., Nair VS, Ali A.H. Does Insulin Resistant Type 2 Diabetes Alter
Vitamin D Status. 94th Annual Meeting of the American Endocrine Society: Houston, USA, held
on 23-26 June 2012. Conference Programme and Abstract Book (Mon-369. P. 166))
ORAL PRESENTATIONS:
I. INTERNATIONAL CONFERENCE & INVITED SPEAKER (Presented & published)
15
114. Al-Shoumer KAS, Niththyanathan R & Johnston DG. (1994) Profiles of intermediary
metabolites in hypopituitary adults on conventional replacement therapy. Journal of
Endocrinology; 143 (Suppl.): O31 (London, 23-25 November, 185th Meeting of the Society for
Endocrinology).
115. Al-Shoumer KAS, Hughes C, Richmond W, Beshyah S & Johnston DG. (1995) Beneficial
changes in plasma lipids, lipoproteins and apolipoproteins in hypopituitary adults (HPA) after 4
years of growth hormone (GH) replacement therapy. Journal of Endocrinology ; 147 (Suppl.):
O47 (London, 22-23 November, 186th Meeting of the Society for Endocrinology).
116. Al-Shoumer KAS, Anyaoku V & Johnston DG. (1996) Serum leptin and its anthropometric,
gender and metabolic relations in hypopituitary adults with growth hormone (GH) deficiency.
Journal of Endocrinology; 151 (Suppl.): O11 (London, 26-28 November, 187th Meeting of the
Society for Endocrinology).
117. Al-Shoumer KAS, Kousta E, Richmond W & Johnston DG. (1997) Increased prevalence of
abnormal fasting lipids and lipoproteins in growth hormone (GH) deficient hypopituitary adults.
Endocrinology and Metabolism ; 4 (Suppl. B), P. A3, page 157 (Berlin, Germany).
118. Al-Shoumer KAS, Al-Zaid MM & Vasanthy BK. (1999) Changes in leptin values in Arabs
with hirsutism: Mubarak Al-Kabeer University teaching hospital experience in Kuwait.(First PanArab Congress of Endocrinology and Metabolic Diseases, October 20-23, 1999, OPS 10).
119. Al-Shoumer KAS, Vasanthy BK, Al-Assoussi A & Doi A (2000) Leptin level in Arabs
with type 2 diabetes (Second Pan-Arab Congress of Diabetes and Endocrinology and The 10th
International Clinical Genetics Seminar, October 20-24, 2000, Amman, Jordan, OP-61, page 87).
120. Al-Shoumer KAS, Doi SAR & Al-Assousi A (2001). Markers of bone turnover and
metabolic abnormalities in type 2 diabetes in Kuwait. Conference of Diabetes in The Arab World,
24-26th March 2001, Bahrain, Oral presentation, Abstract book page 55.
121. Al-Shoumer KAS , Doi SA & Vasanthy BK. (2001) Bone metabolism in Arab with type 2
diabetes mellitus. Third Pan Arab Congress on Edocrinology and Diabetes 25-28 October 2001,
Damascus. OP. 83 page 103
II. AS AN INTERNATIONAL INVITED SPEAKER
122. Al-Shoumer KAS. (2001) Syndrome X : the clinical presentation of insulin resistance. 5Th
Pan Arab Conference On Diabetes, 27-30 March 2001, Cairo, Egypt, OPII 005.
123. Al-Shoumer KAS (2001) Dysleptinemia in endocrinology and Metabolism. Third Pan Arab
Congress on Edocrinology and Diabetes 25-28 October 2001, Damascus. Plennary talk, page 6
124. Al-Shoumer KAS (2002) The role of endocrine and metabolic disorders in the outcome of
pregnancy and fertility. International Symposium: Recent advances in the management of
infertility. March 9-11 2002, Kuwait Absract book page 34-35.
125. Al-Shoumer KAS (2002) Is diabetes mellitus associated with osteoporosis. 6Th Pan Arab
Conference on Diabetes. March 26-29, 2002, Cairo, Egypt.
126. Al-Shoumer KAS (2002) Subclinical thyroid diseases. Fourth Pan Arab Congress on
Endocrinology and Diabetes 23-26 October 2002, Tunisia. Plennary talk, Symposium on thyroid.
127. Al-Shoumer KAS (2004) Chronic complications of Diabetes mellitus (cardiovascular
disease). Fifth Pan Arab Congress on Endocrinology and Diabetes 28 Feb. to 2nd March 2004,
Riyadh. Main session talk.
16
128. Al-Shoumer KAS (2005) Adult hypopituitarism and growth hormone deficiency. The 1st
Jordanian Congress of Endocrinology, Diabetes & Metabolic Diseases, Amman 12-14 April, P.
21
129. Al-Shoumer KAS (2005) Leptinology and endocrinology. The 1st Jordanian Congress of
Endocrinology, Diabetes & Metabolic Diseases, Amman 12-14 April, P. 32.
130. Al-Shoumer KAS (2005) Overview of osteoporosis. The 1st Jordanian Congress of
Endocrinology, Diabetes & Metabolic Diseases, Amman 12-14 April, P. 26
131. Al-Shoumer KAS (2005) The Syndrome of adult GH deficiency: Clinical implications. The
2nd International conference of Endocrinology & Diabetes , Jeddah 11-12 April, P. 21
132. Al-Shoumer KAS (2005) Obesity and diabetes mellitus. The 14nd Annual scientific Meeting
of the Syrian Diabetes Association, Lattakia- Syria 10-12 November
133. Al-Shoumer KAS (2006) Adrenal incidentaloma. Seventh Pan Arab Congress on
Endocrinology and Diabetes 4-7 May 2006, Rabat- Morocco. Main session talk.
134. Al-Shoumer KAS (2008) Obesity, DM & ED. Second AACE/ESEO meeting in Alexandria,
23rd to 25th of April, 2008.
135. Al-Shoumer KAS (2009) Epidemiology of thyroid diseases. Merck Serono 's 1st
International Forum on Thyroid disorders in the Middle East. - Dubai, U.A.E. - 19-20 February
2009
136. Al-Shoumer KAS (2010) Initiation and adjustments of lanreotide autogel therapy in
acromegaly: case-based examples from Kuwait. In Symposium: Novel treatment in the
management of acromegaly. Ritz carlton, Istanbul-Turkey, March 18th 2010.
137. Al-Shoumer KAS (2011) Challenges in the management of acromegaly. In Symposium:
Therapeutic strategies in growth hormone secreting adenoma. Dubai UAE, 16-18th March
2011
II. LOCAL CONFERENCE LECTURES PRESENTATIONS (invited speaker):
1. Growth hormone in IDDM adolescents in Update in Diabetes, 17-19 November 1997,
Faculty of Medicine - KIMS.
2. Thyroid diseases in adult clinical practice in Workshop on Thyroid Diseases, 13-16 June
1998, Faculty of Laboratory Medicine - KIMS.
3. Secondary dyslipidaemia-Thyroid disease in Workshop on Disorders of Lipid Metabolism,
3-5 May 1999, Faculty of Laboratory Medicine - KIMS.
4. Leptin and endocrine disorders in Update in Endocrinology and Metabolism (UEM), 1-4
November 1999, Faculty of Medicine, Kuwait.
5. Fitness to work for Diabetes mellitus in Symposium of fitness to work in Kuwait, 22-26
April, 2000, Kuwait Medical Association, Kuwait.
6. Evaluation of a patient with a thyroid nodule in Update in Endocrinology and Metabolism, 78th April 2001, CME activity, Faculty of Medicine, Kuwait.
7. Primary amenorrhea in Training progromme For Obst & Gynecology, 7-11th April 2001,
Kuwait Medical Association, Kuwait.
8. Association between diabetes mellitus and osteoporosis Update in Endocrinology and
Metabolism, 1-2 April 2002, Faculty of Medicine, Kuwait
9. Subclinical thyroid disease. Update in Endocrinology and metabolism, 26-27th April 2003.
Faculty of Medicine, Kuwait
17
10. Controversial aspects of GH therapy in adults. Update on Growth Hormone therapy. 14-15
Feb. 2004, Kuwait Medical Association.
11. Solitary thyroid nodule: clinical approach in Workshop on Thyroid Diseases, 9th Feb 2005,
Faculty of Laboratory Medicine - KIMS.
12. DM, obesity and erectile dysfunction in 2nd Diabetic workshop of Sheikh Nasser Alsabah
Medicak health Center. 2-3rd April 2005.
13. Definition and diagnosis of osteoporosis. Update in Endocrinology and metabolism:
workshop on osteoporosis, 4th April 2005. Faculty of Medicine, Kuwait
14. New modalities of treatment for osteoporosis. Update in Endocrinology and metabolism:
workshop on osteoporosis, 5th April 2005. Faculty of Medicine, Kuwait
15. Andropause. The first Amiri Endocrinology Conference Obesity-Endocrine problems after
5th decade 18-19 April 2005
16. Osteoporosis. Workshop on women health, Ministry of Health, 2-4th May 2005, Kuwait.
17. Evaluation and preoperative assessment of adrenal masses. 1st Update in Urologic
laparoscopy. 14th 15th May 2005
18. Definition of insulin resistance. Update in Endocrinology and metabolism: Insulin resistance
syndrome: the endocrine perspective, 17th April 2006. Faculty of Medicine, Kuwait
19. Leo Pharma meeting. Falls and Fractures in Osteoporosis: Osteoporosis overview, Radisson
SAS Hotel, Kuwait 7 June 2006. Speaker and chairman of session.
20. Chairman of symposium Testosterone administration: new androgel preparations. Dec.
2008, Crown Plaza Hotel, Kuwait.
21. Chairman of workshop: Plain Vitamin D or its active analogue in osteoporosis, 12 Jan.
2009, Radissons SAS Kuwait.
22. Update on metabolic syndrome. Lecture: Adipocytokines. 29-30 April 2009, Faculty of
Medicine, Kuwait.
23. Update in Mens Health. Lecture: Male Menopause. 23-24 April 2011, Movenpick Hotel %
Resort Al-Bida, Kuwait
III. EDUCATIONAL LECTURES TO MEDICAL SUBSPECIALITIES:
1. Endocrine emergencies in the programmed schedule to emergency medicine in Mubarak AlKabeer Hospital, 26th April 1997, Mubarak Al-Kabeer Hospital, Kuwait.
2. Management of diabetic Ketoacidosis and hyperosmolar coma in the programmed schedule
to emergency medicine in Mubarak Al-Kabeer Hospital, 15th Dec. 1997, Mubarak Al-Kabeer
Hospital, Kuwait.
3. Hirsutism and polycystic ovary syndrome in Programmed polyclinic activities, 26th May
1999, Salmiyah specialized centre, Hawalli area, Kuwait.
4. Presentation of monthly endocrine talks in department of medicine at Mubarak Al-Kabeer
Hospital to other subspecialities
5. Polycystic ovary syndrome in training programme for Salmiya speciality center, 27th May
2001, Kuwait.
6. Osteoporosis Symposium for Primary care physicians, Overview on osteoporosis and the
relations with diabetes. 12th April 2004. Kuwait Medical Association.
7. Diabetes mellitus, obesity and erectile dysfunction in 2nd Diabetic Workshop: diabetes and
ED, 2-3 April 2005, KMA
18
8. Update on the current Treatment of Vitamin D deficiency: Tuesday 16th March 2010, Hisham
Al-Obaidan meeting room, Mubarak Al-Kabeer Hospital, Kuwait
9. Update on osteoporosis to orthopaedic surgeons. Al-Razi Orthopedic Hospital, 27 Jan 2011,
Kuwait.
RESEARCH
1.Cardiovascular risk factors in hypopituitarism (1992-1995) at St. Marys Hospital, London
2. Research grant (MM041, Kuwait University 1999) Metabolic abnormalities in patients with
primary hyperthyroidisim Completed Sept. 2000, Kuwait
3. Hirsutism in Arab populations : intermediary metabolites and obesity related-factors
(completed 2002), Kuwait.
4. Pattern of behaviour of type 2 Diabetes Mellitus in Kuwait in relation to pathogenesis
(completed 2004), Kuwait.
5. Correlation between histopathological and clinical diagnosis in hyperparathyroidism (Kuwait
University granted, MN01/01)
6. Prevalence of low bone mass in Kuwait (ongoing)
7. Bone mineral density in patients with rheumatoid arthritis at various disease activity
8. Bone metabolism in patients with Multiple sclerosis
19
15. Evista Global Medical conference & 21st Annual Meeting of the American Society for Bone
and Mineral Research. Indianapolis/St. Louis, Sept. 27 - October 4, 1999.
16. 81ST Annual Meeting of the American Endocrine Society, San Diego, California 12-15 June
1999.
17. The 2nd World Congress on The Aging Male, Geneva, Switzerland, February 9-13, 2000.
18. 82nd Annual Meeting of the American Endocrine Society, Toronto, Canada 21-24 June 2000
19. 11th International Congress of Endocrinology, Sydney, Australia 29th Oct -2nd Nov. 2000.
20. VIIth International Congress of Andrology, Montreal, Canada, 15-19th June 2001.
21. 83rd Annual Meeting of the American Endocrine Society, Denver, USA 20-23 June 2001
22. Symposium of Treating to target in type 2 diabetes mellitus, Prague, Czech Republic May 558th, 2002.
23. 84th Annual Meeting of the American Endocrine Society, San francisco, USA 19-22 June
2002
24. Thyroid Ultrasound Accreditation Course, Washington DC, USA 24-25 August 2002
25. Obesity Workshop: Reductil Medical Education Programme 23 July 2003, Cairo, Egypt
26. 18th International Diabetes Federation Congress, August 24-29, 2003, Paris, France.
27. Diabetes Regional Experts Avandia Meeting (DREAM). Athenes, September 20-21. 2003
28. Bone mineral density certification course. Amman Dec 18th 2003.
29. Osteoporosis and needs for action. Rome 15th march 2004.
30. Therapeutic Innovation in the osteoporosis field. El Gouna, Red Sea, Egypt, April 23-24,
2004.
31. 86th Annual Meeting of the American Endocrine Society, New Orleans, USA 16-19 June
2004.
32. 40Th Annual Meeting of the European Association for the Study of Diabetes, 5-9 September
2004, Munich, Germany
33. Intensive Pediatric Workshop on Insulin Pump Therapy & CGMS. Kuwait SAS, 24
September 2004.
34. The first International GGSD Conference. Dubai 13-15th Feb. 2005
35. Six Pan Arab Congress of Endocrinology & Diabetes, Alexandria 2-4 th March 2005
36. Advancing to new levels in osteoporosis management, Rome March 13th 2005
37. 87th Annual Meeting of the American Endocrine Society, San diego, USA 4-7 June 2005.
38. The 14th Annual scientific Meeting of the Syrian Diabetes Association, Lattakia- Syria 10-12
November 2005.
39. Conference:New approach for the treatment of postmenopausal osteoporosis, Cairo-Egypt 89 Dec. 2005
40. Sixth European Congress on Clinical and Economic Aspects of Osteoporosis and
Osteoarthritis. Vienna, Austria 15-18th March 2006.
41. Seventh Pan Arab Congress of Endocrinology & Diabetes, Rabat- Morroco 4-7th May 2006.
42. Leo Pharma meeting. Falls and Fractures in Osteoporosis, Radisson SAS Hotel, Kuwait 7
June 2006
43. 88th Annual Meeting of the American Endocrine Society, Boston, USA 24-27 June 2006.
44. 89th Annual Meeting of the American Endocrine Society, Toronto, Canada 24-27 June 2007.
45. 90th Annual Meeting of the American Endocrine Society, San Francisco USA 15-18th June
2008.
20
46. 91st Annual Meeting of the American Endocrine Society, Washington DC, USA 10-13th June
2009.
47. The 3rd International Conference of Gulf Group for the Study of Diabetes (GGSD), 9-11 Feb.
2010, Jeddah, KSA, Invited as Chairperson, session II first day.
48. 92nd Annual Meeting of the American Endocrine Society, San Diego, USA 19-22 June 2010.
49. 93rd Annual Meeting of the American Endocrine Society, Boston, USA 4-7 June 2011.
50. ASBMR 2011 Annual Meeting of the Society for Bone and Mineral Research. San Diego
USA, September 16 - 20, 2011
51. 93rd Annual Meeting of the American Endocrine Society, Houston, USA 23-26 June 2012.
52. 2012 Pituitary Masterclass meeting. Massachusetts General Hospital at Boston, USA. 28th
June to 1st July 2012.
21
11. Johnston DG, Al-Shoumer KAS, Beshyah SA, Chrisoulidou A, Kousta E & Anyaoku V.
Growth hormone replacement in young adults: if and when to continue?. In Adolescent
Endocrinology (1998) (ed.R Stanhope), pp. 17-23. BioScientifica Ltd, Bristol.
12. Pancreatic & Salivary secretion in Current Awareness in Biomedicine (1998) Vol 20 (15), 18.
13. Evans LM, Davies JS, Goodfellow J, Rees JAE & Scanlon. (1999) Endocthelial dysfunction
in hypopituitary adults with growth hormone deficiency. Clinical Endocrinology 50, 457-464.
14. Al-Shoumer KAS, Gray R, Anyaoku V, Hughes C, Beshyah SA, Richmond W & Johnston
DG. (1998) Effects of four years treatment with biosynthetic human growth hormone (GH) on
glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults. Clinical
Endocrinology, 48, 795-802.
15. Gill MS, Toogood AA, Jones J, Clayton PE & Shalet SM. (1999) Serum leptin response to
acute and chronic administration of growth hoemone (GH) to elderly subjects with GH
deficiency. Journal of Clinical Endocrinology and Metabolism 84, 1288-1295.
16. Rodriguez-Arnao J, Jabbar A, Fulchert K, Besser GM & Ross RJM. (1999) Effects of growth
hormone replacement on physical performance and body composition in GH deficient adults.
Clinical Endocrinology 51, 53-60.
17. Leonssson M, Oscarsson J, Bosaeus I, Lundgren BK, Johannsson G, Wiklund O & Bentgsson
B-A. (1999) Growth hormone (GH) therapy in GH-deficient adults influences the response to
dietary load of cholesterol and saturated fat in terms of cholesterol synthesis, but not serum low
density lipoprotein cholesterol levels. Journal of Clinical Endocrinology and Metabolism 84,
1296-1303.
18. Peacey SR, Guo CY, Eastell R & Weetman AP. (1999) Optimization of glucocorticoid
replacement therapy: the long-term effect on bone mineral density. Clinical Endocrinology 50,
815-819.
19. Abs R, Bentgtsson B-A, Hernberg-Stahl E et al (1999) GH replacement in 1034 growth
hormone deficient hypopituitwry adults: demographic and clinical characteristics, dosing and
safety. Clinical Endocrinology 50, 703-713.
20. Barretto ES, Gill MS, de Freitas MES et al (1999) Serum leptin and body composition in
children with familial GH deficiency (GHD) due to a mutation in the growth-hormone-releasing
hormone (GHRH) receptor. Clinical Endocrinology 51, 559-564.
21. Brennan BMD, Rahim A, Blum WF, Adams JA, Eden OB & Shalet SM (1999)
Hyperleptinaemia in young adults following cranial irradiation in childhood: growth hormone
deficiency or leptin insensitivity. Clinical Endocrinology 50, 163-169.
22. Beshyah SA & Desmond Johnston (1999) Cardiovascular disease and risk factors in adults
with hypopituitarism. Clinical Endocrinology 50, 1-15.
23. Johnston DG, Al-Shoumer KAS, Chrisoulidou A, Kousta E, Beshyah S and Robinson S.
(1999). Long-term effects of GH therapy on intermediary metabolism and insulin sensitivity in
hypopituitary adults. Journal of Endocrinological Investigation , 22, 37-40.
24. ONeal DN, Hew FL, Best JD & Alford F. (1999) The effect of 24 months recombinant
human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in
hypopituitary adults previously treated with conventional replacement therapy. Growth Hormone
& IGF Research 9, 165-173.
22
25. Kousta E, Chrisoulidou A, Lowrence NJ, Anyaoku V, Al-Shoumer KAS & Johnston DG.
(2000) The effects of growth hormone replacement therapy on overnight metabolic fuels in
hypopituitary patients.Clinical Endocrinology 52, 17-24
26. Damjanovic SS, Petakov MS, Raicevic S, Micic D, Marinkovic J, Diegues C, Casanueva FF
& Popovic V (2000) Serum leptin in patients with acromegaly before and after correction of
hypersomatotropism by transsphenidal surgery. Journal of Clinical Endocrinology and
Metabolism 85, 147-154.
27. Abdu TAM, Neary R, Elhadd TA, Akbaer M & Clayton RN (2001) Coronory risk in growth
hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile
abnormalities. Clinical Endocrinology 55, 209-216.
28. French human growth hormone recepients. (1999) American J Epidemiology 147, 597-604
29. Hawkins EP (1999) Nutrients in the news - human growth hormone. Natural Pharmacy
30. Kuhnel W (1997) Leptin - Neue Mglichkeiten in Diagnostik und Therapie. Med Research
Review 17 (3), 225-234.
31. Braught L. Liquid mineral fortified HGH: A tremendous advancement in anti-aging.
Published by Reality Health Research.
32. Jeffcoate W (1999) Assessment of corticosteroid replacement therapy in adults with adrenal
insufficiency. Ann Clin Biochem 36, 151-157.
33. Vance M L, Mauras N (1999) Growth hormone therapy in adults and children. The New
England Journal of Medicine 341 916), 1206-1216.
34. Pfeifer M (2001) Syndrome of growth hormone deficiency in adults: effects of growth
hormone replacement therapy. Zdrav Vestn 70, 296-299.
35. Sulaiman AM, Freaney R, Smith TP, McBrinn Y, Murray B, Mckenna TJ (2003) The impact
of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in
patients with adrenal insufficisncy. Clinical Endocrinology 59, 380-387.
TEACHING ACTIVITIES:
1. Undergraduate teaching:
A. Faculty of Medicine:
1. Full teaching load consisting of Formal lectures, seminars, case discussions, tutorials and
bedside teaching. This comes to approximately over 120 hours per year as follows:
- Participation in lecturing for the Endocrinology system course teaching for BSc
students at St. Marys Hospital (1994-1996, didactic 3 hours per course, # of
students=70 per yr)
- Teaching in the theory Endocrinology system course for the fifth year students
(1997-) (12 hrs didactic per course of 36 hours over 4 weeks every year, # of
students=72-94 per yr)
- Bedside clinical teaching for fifth year clinical students in Mubarak Hospital (1997-)
(2 hours per week over 36 weeks every year, # of students=72-93 per yr divided
into groups, each of 6 students)
- Bedside clinical teaching for seventh year clinical students in Mubarak Hospital (1997-)
(2 hours alternating with 3 hours per week over 36 weeks every year, # of
students=48 per yr, divided into groups, each of 4 students)
- Preparation and execution of examination for undergraduates (1997-)
B. Faculty of Pharmacy:
23
- Teaching the third year students in the Pathophysiology course No. 332 (1999-)
(2 hours per course every year, # of students=40 per yr)
C. Ministry of Health : To paramedics:
- Teaching of basic handling, investigation and treatment of endocrine disorders
- Legislation and formation of standard protocols for dynamic tests in endocrinology
2. Postgraduate Teaching:
- Member, Faculty of Medicine, Kuwait Institute for Medical Specializations (KIMS)
- KIMS, Postgraduate training program in Medicine - program (PGTP) coordinator for
Mubarak Al-Kabeer Hospital (2000-2004)
- Teaching of candidates to MRCP part I (November 1997)
- Clinical session teaching for PGTP and MRCPII candidates in Mubarak AlKabeer Hospital
- Journal Club Teaching to PGTP candidates in Mubarak Al-Kabeer Hospital (1997-)
- Teaching in the program for postgraduates in Immunology in Faculty of
Medicine (1998-9)
- Teaching Residants in the board program for postgraduates in Nuclear Medicine
in Faculty of Medicine (2000-)
- Arrangement of educational sessions to members of endocrinology division
every fortnight
- Attendance, participation and presentations at intra and interdepartmental medical
clinical meetings and grand rounds accounting for approximately 120 hours per year
24
4. Member, Diabetes Team: Committee for prevention and control of Diabetes mellitus
(1998-2003)
C. Societies:
International:
1. Collegiate member, Royal College of Physicians of London.
2. Member, Medical & Scientific section, British Diabetic Association (BDA).
3. Member, British Society for Endocrinology (BES).
4. Member, Growth Hormone Research Society (GRS).
5. Member, British Medical Association (BMA).
6. Member, American Endocrine Society.
7. Member, American Diabetes Association (ADA).
8. Member, New York Academy for Science.
9. Member, American Association of Clinical Endocrinologists (AACE).
10. Member, International Diabetes Federation (IDF).
11. President, Pan-Arab Society of Endocrinology and Diabetes (2007-to 2010)
Faculty of Medicine committees:
Faculty:
1. Member, of the organizing committee for the annual poster day in the Health
Sciences Center (1997 to 2004).
2. Member, the executive board of Medical Research Council (MRC) of the
Faculty (1998-2001).
3. Member of the Faculty of Medicine Scientific Affairs Advisory Committee (1999)
4. Chairman, Committee for staff salary cadre recommendations (2005-6)
5. Chairman, Committee for space allocation in faculty of medicine (2005-6)
6. Chairman, Recruitment Committee for support academic staff at Faculty of Medicine
(2006 -2008)
Department of Medicine:
1. Member, of the departmental Research Committee (1997-1999).
2. Chief Coordinator, of departmental Research Committee (1999-2002)
3. Member, of departmental Postgraduate Committee (1999 to date).
4. Chief Coordinator, department Examination Committee (2002-2004)
D. Journals:
1. Referee of papers submitted to Kuwait Medical Association Journal (1997-todate)
2. Referee papers submitted to Annals of Saudi Medicine Journal (2001 to date)
3. Referee of papers submitted to MPP , Faculty of Medicine Journal (2000 to date)
4. Referee to Journal of Woman Health (2008-)
5. Referee to JCEM (2010 to date)
5. Co-editor of the 4th Health Science Center Poster day programme & abstract book.
6. Local Editorial Board (member), Kuwait Medical Journal (2000- to date)
7. Advisory Board member, Diabetes Care, Mediteranian issues
E. Other Community services:
1. Provision of health services to patients with endocrinological disorders
2. Educational television and radio programmes (more than 30 appearances) and
newspaper articles (more than 30 short and long topics).
25
3. Head of University Faculty Association mission to Saudi Arabia for Mekka (2325th Feb 2000)
F. Other Professional Achievements:
1. Evaluator of grants for projects to the Faculty of Medicine.
2. Referee to grants submitted to the Kuwait Foundation for the Advancement of
Sciences.
3. Coordinator & founding member of the thyroid disease study group - established in July
1997.
4. Coordinator of the Endocrinology system course to the 5th year students in the
Faculty of Medicine (1998 to 2011).
5. Member of the organizing committee for the Diabetes Update 17-19th November 1997.
6. Holder of an active licence for use of radioactive materials (1997 to date).
7. Holder of Full registration in the General Medical Council in London (1993 to date).
8. Holder of a certificate from the American College of Endocrinology on thyroid
Ulrasound Accreditated course
9. Chief Coordinator of Update on Endocrinology & Metabolism (UEM) in 1-4
November 1999.
10. Chief Coordinator of Update in Endocrinology and Metabolism CME in 7-8th
April 2001.
11. Member of Expert Panell of Middle East on Hormone Replacement Therapy
12. Listed in WhosWho in the World, 19th Edition 2002
13. Listed in WhosWho in Medicine and Healthcare 2002-2003
14. Invited as Conference Chairman, New approach for the treatment of postmenopausal
osteoporosis Cairo-Egypt 8-9th Dec. 2005.
15. Coordinator and team leader on the endocrine block for the curriculum reforms phase
II in the faculty of Medicine (2005 to date)
16. Invited as Chairperson, session II first day of the 3rd International Conference of Gulf
Group for the Study of Diabetes (GGSD), 9-11 Feb. 2010, Jeddah, KSA
G. Honors:
Winner of best clinical abstract in the 8th Health Sciences Annual Poster Day (2003),
Faculty of Medicine. Abstract : Al-Shoumer KAS, Vasanthy BK, Al-Zaid MM. Human
Chromogranin A (CgA) in patients with hyperthyroidism, Annual Health Sciences Poster
Day 2003, P. 71
Listed in WhosWho in the World, 19th Edition 2002
Listed in WhosWho in Medicine and Healthcare 2002-2003
President, Ninth Annual Health Sciences Poster Conference 2004.
Chief Representative of Faculty of Medicine, Kuwait on the third Conference
of Arab Society of Medical faculties, held on 12-13 April 2006, Irbid, Jordan
H. Examiner ;
Faculty of Medicine, Undergraduate students (2001- to date)
MRCP (PACES) Postgraduate UK examination (October 2003-Oman Center, October
2004-Oman Center, 26-28th March 2006-Oman center, October 2006-Oman Center,
October 2007 Kuwait, 26th March 2009, Kuwait; 24TH March 2010, Kuwait,
November 2010, Kuwait; 24 March 2011, Kuwait, March 2012)
26
Saudi Medical Board post-graduate program, KSA, examiner 9-13 December 2006
Saudi Commission for Health specialities- Sub-speciality examination, Saudi Board of
Endocrinology and Metabolism in adults, 23 Jan. 2010.
Oman Medical College, Sohar Medical campus. Examiner on 2011.
Master thesis examiner:
1. Diabetic hand syndromes among with Type 2 Diabetes Mellitus: its related factors,
and its associations with microvascular complications (May 2008, in NCDEG,
Jordon).
2. Factors associated with poor glycemic control among patients with type 2 diabetes
attending NCDEG (May 2008, in NCDEG, Jordon).
3. The Effect of Clothing on Vitamin D Status, Bone Turnover Markers and Bone
Mineral Density in Young Unmarried Kuwaiti Females (Kuwait University, Faculty of
Medicine, Physiology Department, June 2010).
27
Dubai
Country:
Email:
2
Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the
purposes of Chapter business? yes ___ no
3
Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)
___ President
___ Vice President
___ Secretary
___ Treasurer
___ Board of Director Member
Statement of why I would like to serve for the AACE Gulf Chapter Board of
members
From my current positions and status that I have in this country and in the Gulf
region, as I represent the Assistant undersecretary for Health policies and as I am
the Chairman of the National Committee for control of Diabetes and as a member
of the Gulf NCDs, I see working as a president for AACE Gulf chapter will represent
an opportunity to influence policies and decision making processes for Diabetes
control and for Capacity Building of manpower for Diabetes and strengthening
the alliances and cooperation with international, regional and local public or
private sectors and institutions working in the field of Diabetes and
endocrinology.
This is in addition to my long association with AACE and their activities in this
country. I have the honor of facilitating and strengthening the ties of AACE with
UAE MOH since 2009 when we have started our collaboration in training the
Medical doctors in Diabetes by conducting the First international AACE Diabetes
training in the country, later on in 2010 2011 we have managed to bring on
board participants of this course from the other Gulf Countries. In addition to our
participation in the first AACE Diabetes Conference held in Doha/Qatar.
For all of this reasons, I am definitely capable of performing the duties of the
president of the AACE Gulf Chapter.
Dr. Mahmoud Fikri
Assistant Undersecretary Health policies
Chairman National Committee for Control of Diabetes
CURRICULUM VITAE
A. PERSONAL INFORMATION:
Name
: MAHMOUD MOHAMED A. FIKREE
Date and Place of Birth : October 1st 1953, Kalba-Sharjah
Sex
: Male
Marital Status
: Married
Nationality
: United Arab Emirates (UAE)
Designation
: Assistant Undersecretary for Preventive Medicine
Address
: Resi: Sharjah, P O Box 32222, Tel: 971-65487333
Fax: 971-6-5487773
Off: Ministry of Health, Abu Dhabi, P O Box 848
UAE. Tel: 971-2-6323480, Fax: 971-2-632691
E-mail:
dr.m.fikri@gmail.com
Honorary positions:
a) Member of International Advisory Committee of World Congress on Vaccines
/ Infections Control World Organization.
b) Nominated for appointment as Assistance to the Director General of World
Health Organization, (Geneva, 2005)
c) Member of the Advisory Council of the Emirates of Sharjah and Chairman of
the Health Committee of the Council 2000
d) Member of the Board Directors for the WHO Center for Health Development
and Research in Japan (KOBE)
e) Member of the Board of Directors of the World Surveys Council-WHO
(COHERD)
f) Vice Chairman of the World Health Assembly-Geneva 2005
g) Member of Advisory Board of UK COCHRANE Center- Bahrain Branch
h) Member of Advisory Board of GCC Health Counsel (1996-2005)
B. EDUCATION
Qualification
School / University
MFPHM
Royal College of Physicians of the United
Membership
Kingdom, UK (faculty of Public Health)
FACP
American College of Physicians, USA
Ph. D. in
Dermatology
Membership of
ACP
Year
2000
1999
1999
1997
Member of AACE
2011
Fellowship of
Community
Medicine
M Sc.
Dermatology and
Venereology
DTM and Hygiene
1996
1989
1984
Internship
1980
MBBCh.
1979
High School
1973
May 1996-1997
Mar 1998 2006
2009 to Date
2009 to Date
2009 to Date
2006 to Date
2002 to Date
1991 to Date
April 2006-2009
Other posts
1986 to 2006
1996-2002
1992-2000
1996
1
2
3
4
5
2011
2010
2009
2003
1990
G. TRAINING COURSES
Period
Place
Name and Place of the Course
1994
Saudi Arabia Course on Epidemiology of Diabetes Mellitus, King Saud
University,
1992
UAE
Course on Decision Making for Managers, UAE
1985
Bahrain
International Course on the Management and Control of
Diarrhoeal Diseases organized by the World Health
Organization, Eastern Mediterranean Region
1983
Oman
International Course on the Management and Control of
Diarrhoeal Diseases organized by the World Health
Organization, Eastern Mediterranean Region
1983
Bahrain
International Course on the Management of Expanded
Program of Immunization, organized by the World Health
Organization
1983
UAE
Course on Response to Oil Pollution, organized by the
United States Coast Guard, Abu Dhabi
1980
Bahrain
Course on the Expanded Program of Immunization,
organized by the World Health Organization
H. RESEARCH
Published Research
Title of article
Incidence and Prevalence of HBV among
health workers in UAE,
Role of Micro-Organisms in the
pathogenesis of Seborrhic Dermatitis,
Incidence and Prevalence of Smoking
among a certain age group-School
children
Global School Health Survey
Global School Health Survey
I. TO BE PUBLISHED RESEARCH
-
Epidemiology and Diabetes Type 2: Associated Risk Factor Among Different Age
Groups (MOH, Baker Institute, University Of Sharjah and WHO) 2010-2012.
Assessment of Diabetes Mellitus among School Children (MOH and RCDR)
2010-2011.
National Nutritional Survey Among Different Public Age Groups (MOH, UAE
University and WHO) 2009-2011.
S No.
1
2
3
4
5
6
7
8
9
1
2
3
4
UAE
UAE
UAE
Since
2008
2000
1999
2006
1989-1998
1989- to
date
1984-1988
1993
1996
1986-1988
Name:
Address:
City:
DUBAI
Country:
Email:
aakhass@yahoo.com
Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the
purposes of Chapter business? YES
Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)
President
___ Vice President
___ Secretary
___ Treasurer
___ Board of Director Member
CV or bio-sketch included